2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web:
www.eosmedchem.comEmail: info@eosmedchem.com ; eosmedchem@gmail.com
| Drug_Names: 4-Bromo-2-methoxy-6-methylphenol, CAS: 86232-54-4, stock 281.8g, assay 98.9%, MWt 217.06, Formula C8H9BrO2, Purity >98%, SMILES COC1=C(O)C(C)=CC(Br)=C1, MDL NA |
| Drug_Names: 4-Bromo-2-iodo-5-methylaniline, CAS: 1609264-62-1, stock 145.9g, assay 98.3%, MWt 311.95, Formula C7H7BrIN, Purity >98%, SMILES CC1=C(Br)C=C(I)C(N)=C1, MDL NA |
| Drug_Names: 4-Bromo-2-chloro-6-methylpyridine, CAS: 1206250-53-4, stock 241.4g, assay 98.5%, MWt 206.47, Formula C6H5BrClN, Purity >98%, SMILES CC1=NC(Cl)=CC(Br)=C1, MDL NA |
| Drug_Names: 4-Bromo-2,6-diethylpyridine hydrochloride, CAS: 2055841-93-3, stock 620.7g, assay 98.3%, MWt 250.56, Formula C9H13BrClN, Purity >98%, SMILES Cl.CCC1=CC(Br)=CC(CC)=N1, MDL NA |
| Drug_Names: 4-Bromo-2,3-dimethyl-2H-indazole, CAS: 1159511-85-9, stock 489.6g, assay 98%, MWt 225.09, Formula C9H9BrN2, Purity >98%, SMILES CN1N=C2C=CC=C(Br)C2=C1C, MDL NA |
| Drug_Names: 4-Bromo-2,3-dihydro-1H-inden-2-one, CAS: 846032-36-8, stock 439.5g, assay 98.3%, MWt 211.06, Formula C9H7BrO, Purity >98%, SMILES BrC1=C2CC(=O)CC2=CC=C1, MDL NA |
| Drug_Names: 4-Bromo-2,3-dihydro-1H-inden-1-amine, CAS: 903557-28-8, stock 7.4g, assay 98.7%, MWt 212.09, Formula C9H10BrN, Purity >98%, SMILES NC1CCC2=C1C=CC=C2Br, MDL NA |
| Drug_Names: 4-Bromo-1-propyl-1H-pyrazole, CAS: 141302-33-2, stock 819.9g, assay 98.5%, MWt 189.05, Formula C6H9BrN2, Purity >98%, SMILES CCCN1C=C(Br)C=N1, MDL NA |
| Drug_Names: 4-Bromo-1-methyl-1H-indazole-3-carboxylic acid, CAS: 1363380-97-5, stock 5g, assay 98.5%, MWt 255.07, Formula C9H7BrN2O2, Purity >98%, SMILES CN1N=C(C(O)=O)C2=C1C=CC=C2Br, MDL NA |
| Drug_Names: 4-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carboxylic acid, CAS: 1190321-81-3, stock 370.3g, assay 98.6%, MWt 241.04, Formula C8H5BrN2O2, Purity >98%, SMILES OC(=O)C1=CC(Br)=C2C=CNC2=N1, MDL NA |
| Drug_Names: 4-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile, CAS: 1190310-18-9, stock 77.3g, assay 98.3%, MWt 222.04, Formula C8H4BrN3, Purity >98%, SMILES BrC1=C2C=CNC2=NC(=C1)C#N, MDL NA |
| Drug_Names: 4-Bromo-1H-pyrazolo[4,3-c]pyridine, CAS: 1159829-63-6, stock 128.7g, assay 98.6%, MWt 198.02, Formula C6H4BrN3, Purity >98%, SMILES BrC1=C2C=NNC2=CC=N1, MDL MFCD12401001 |
| Drug_Names: 4-Bromo-1H-indole-6-carboxylic acid, CAS: 374633-27-9, stock 258.8g, assay 98.6%, MWt 240.05, Formula C9H6BrNO2, Purity >98%, SMILES OC(=O)C1=CC(Br)=C2C=CNC2=C1, MDL NA |
| Drug_Names: 4-Bromo-1H-indole-6-carbonitrile, CAS: 374633-29-1, stock 219g, assay 99%, MWt 221.05, Formula C9H5BrN2, Purity >98%, SMILES BrC1=CC(=CC2=C1C=CN2)C#N, MDL NA |
| Drug_Names: 4-Bromo-1H-indazole-6-carbaldehyde, CAS: 1168721-41-2, stock 244.8g, assay 98.7%, MWt 225.04, Formula C8H5BrN2O, Purity >98%, SMILES BrC1=CC(C=O)=CC2=C1C=NN2, MDL NA |
| Drug_Names: 4-Bromo-1H-indazol-7-amine, CAS: 1190319-80-2, stock 827.4g, assay 98.8%, MWt 212.05, Formula C7H6BrN3, Purity >98%, SMILES NC1=CC=C(Br)C2=C1NN=C2, MDL NA |
| Drug_Names: 4-Bromo-1H-indazol-5-ol, CAS: 478838-52-7, stock 213.6g, assay 98.7%, MWt 213.03, Formula C7H5BrN2O, Purity >98%, SMILES OC1=C(Br)C2=C(NN=C2)C=C1, MDL NA |
| Drug_Names: 4-Bromo-1H-imidazo[4,5-c]pyridine, CAS: 1086398-12-0, stock 868g, assay 98.9%, MWt 198.02, Formula C6H4BrN3, Purity >98%, SMILES BrC1=C2N=CNC2=CC=N1, MDL NA |
| Drug_Names: 4-Bromo-1H,2H,3H-pyrrolo[2,3-b]pyridine, CAS: 1393534-35-4, stock 393g, assay 98.8%, MWt 199.05, Formula C7H7BrN2, Purity >98%, SMILES BrC1=CC=NC2=C1CCN2, MDL NA |
| Drug_Names: 4-Bromo-1-ethyl-1,2-dihydropyridin-2-one, CAS: 832735-58-7, stock 196.3g, assay 98.5%, MWt 202.05, Formula C7H8BrNO, Purity >98%, SMILES CCN1C=CC(Br)=CC1=O, MDL NA |
| Drug_Names: 4-Bromo-1,3-dimethyl-1H-pyrazol-5-amine, CAS: 19848-99-8, stock 853.5g, assay 98.4%, MWt 190.04, Formula C5H8BrN3, Purity >98%, SMILES CN1N=C(C)C(Br)=C1N, MDL NA |
| Drug_Names: 4-Bromo-1,3-dimethyl-1H-indazole, CAS: 1159511-76-8, stock 787.5g, assay 98.8%, MWt 225.09, Formula C9H9BrN2, Purity >98%, SMILES CN1N=C(C)C2=C1C=CC=C2Br, MDL NA |
| Drug_Names: 4-Bromo-1,1-difluorocyclohexane, CAS: 1196156-51-0, stock 890.7g, assay 98.1%, MWt 199.04, Formula C6H9BrF2, Purity >98%, SMILES FC1(F)CCC(Br)CC1, MDL NA |
| Drug_Names: 4-Bromo-1-(oxetan-3-yl)-1H-pyrazole, CAS: 1374657-02-9, stock 566.6g, assay 98.8%, MWt 203.04, Formula C6H7BrN2O, Purity >98%, SMILES BrC1=CN(N=C1)C1COC1, MDL NA |
| Drug_Names: 4-Bromo-1-(oxan-2-yl)-1H-indazole, CAS: 1022158-35-5, stock 486.4g, assay 98.2%, MWt 281.15, Formula C12H13BrN2O, Purity >98%, SMILES BrC1=CC=CC2=C1C=NN2C1CCCCO1, MDL NA |
| Drug_Names: 4-Bromo-1-(methanesulfonylmethyl)-1H-pyrazole, CAS: 1799792-00-9, stock 545.9g, assay 98.6%, MWt 239.09, Formula C5H7BrN2O2S, Purity >98%, SMILES CS(=O)(=O)CN1C=C(Br)C=N1, MDL NA |
| Drug_Names: Morpholino(phenyl)methanone, CAS: 1468-28-6, stock 82.7g, assay 98.7%, MWt 191.23, Formula C11H13NO2, Purity >98%, SMILES O=C(N1CCOCC1)C1=CC=CC=C1, MDL MFCD00188446 |
| Drug_Names: 4-Aminothieno[3,2-d]pyrimidine-7-carboxylic acid, CAS: 1318242-98-6, stock 806.6g, assay 99%, MWt 195.20, Formula C7H5N3O2S, Purity >98%, SMILES NC1=C2SC=C(C(O)=O)C2=NC=N1, MDL MFCD22571378 |
| Drug_Names: 4-Aminotetrahydro-N-methyl-2H-pyran-4-carboxamide, CAS: 1268883-06-2, stock 899g, assay 98.2%, MWt 158.20, Formula C7H14N2O2, Purity >98%, SMILES CNC(=O)C1(N)CCOCC1, MDL NA |
| Drug_Names: 4-Aminopyrrolo[2,1-f][1,2,4]triazine-5-carboxylic acid, CAS: 1236201-15-2, stock 70.3g, assay 98.8%, MWt 178.15, Formula C7H6N4O2, Purity >98%, SMILES NC1=NC=NN2C=CC(C(O)=O)=C12, MDL NA |
| Drug_Names: 4-Aminopyrrolidin-2-one, CAS: 88016-17-5, stock 557.5g, assay 98.6%, MWt 100.12, Formula C4H8N2O, Purity >98%, SMILES NC1CNC(=O)C1, MDL NA |
| Drug_Names: 4-Aminopiperidine-2,6-dione hydrochloride, CAS: 1957235-82-3, stock 551.7g, assay 98.5%, MWt 164.59, Formula C5H9ClN2O2, Purity >98%, SMILES Cl.NC1CC(=O)NC(=O)C1, MDL NA |
| Drug_Names: 4-Aminopiperidin-2-one trifluoroacetate, CAS: 1523618-06-5, stock 10.1g, assay 98.6%, MWt 228.17, Formula C7H11F3N2O3, Purity >98%, SMILES OC(=O)C(F)(F)F.NC1CCNC(=O)C1, MDL NA |
| Drug_Names: 4-Aminooxane-4-carboxylic acid, CAS: 39124-20-4, stock 134.3g, assay 98.8%, MWt 145.16, Formula C6H11NO3, Purity >98%, SMILES NC1(CCOCC1)C(O)=O, MDL NA |
| Drug_Names: 4-Amino-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid, CAS: 1488-48-8, stock 411.9g, assay 98.6%, MWt 178.15, Formula C7H6N4O2, Purity >98%, SMILES NC1=C2C(NC=C2C(O)=O)=NC=N1, MDL NA |
| Drug_Names: 4-Amino-6-methylpyridine-3-carbonitrile, CAS: 886371-97-7, stock 132.1g, assay 98.6%, MWt 133.15, Formula C7H7N3, Purity >98%, SMILES CC1=CC(N)=C(C=N1)C#N, MDL NA |
| Drug_Names: 4-Amino-6-methyl-2,3-dihydropyridazin-3-one, CAS: 13925-21-8, stock 465g, assay 98.8%, MWt 125.13, Formula C5H7N3O, Purity >98%, SMILES CC1=NNC(=O)C(N)=C1, MDL NA |
| Drug_Names: 4-Amino-6-fluoro-1H-pyridin-2-one, CAS: 105252-99-1, stock 215.8g, assay 98.7%, MWt 128.10, Formula C5H5FN2O, Purity >98%, SMILES NC1=CC(=O)NC(F)=C1, MDL MFCD18427750 |
| Drug_Names: 4-Amino-5-chloro-2,3-dihydro-1-benzofuran-7-carboxylic acid, CAS: 123654-26-2, stock 27.4g, assay 98.5%, MWt 213.62, Formula C9H8ClNO3, Purity >98%, SMILES NC1=C2CCOC2=C(C=C1Cl)C(O)=O, MDL NA |
| Drug_Names: 4-Amino-5-bromopyridine-2-carboxylic acid, CAS: 1363381-01-4, stock 585.1g, assay 98.6%, MWt 217.02, Formula C6H5BrN2O2, Purity >98%, SMILES NC1=CC(=NC=C1Br)C(O)=O, MDL NA |
| Drug_Names: 4-Amino-5-bromopyridine-2-carbonitrile, CAS: 1234616-76-2, stock 530.1g, assay 98.9%, MWt 198.02, Formula C6H4BrN3, Purity >98%, SMILES NC1=CC(=NC=C1Br)C#N, MDL NA |
| Drug_Names: 4-Amino-3,3-dimethylpyrrolidin-2-one, CAS: 1505180-72-2, stock 232.9g, assay 98.1%, MWt 128.17, Formula C6H12N2O, Purity >98%, SMILES CC1(C)C(N)CNC1=O, MDL NA |
| Drug_Names: 4-Amino-3,3-dimethyl-1-[(1R)-1-phenylethyl]pyrrolidin-2-one, CAS: 1788065-53-1, stock 381.3g, assay 98.2%, MWt 232.32, Formula C14H20N2O, Purity >98%, SMILES C[C@@H](N1CC(N)C(C)(C)C1=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 4-Amino-2-methyl-2,3-dihydro-1H-isoindol-1-one, CAS: 682757-53-5, stock 623.9g, assay 98.9%, MWt 162.19, Formula C9H10N2O, Purity >98%, SMILES CN1CC2=C(N)C=CC=C2C1=O, MDL NA |
| Drug_Names: 4-Amino-2-hydroxy-1,1,1-trifluorobutane, CAS: 57165-84-1, stock 690.1g, assay 98.1%, MWt 143.11, Formula C4H8F3NO, Purity >98%, SMILES NCCC(O)C(F)(F)F, MDL NA |
| Drug_Names: 4-Amino-2,3-dihydro-1H-isoindol-1-one, CAS: 366452-98-4, stock 896.9g, assay 98.3%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES NC1=C2CNC(=O)C2=CC=C1, MDL MFCD08234883 |
| Drug_Names: 4-Amino-1-methylpyrrolidin-2-one, CAS: 933744-16-2, stock 138.6g, assay 98.4%, MWt 114.15, Formula C5H10N2O, Purity >98%, SMILES CN1CC(N)CC1=O, MDL NA |
| Drug_Names: 4-Amino-1-methylpiperidin-2-one hydrochloride, CAS: 1373223-45-0, stock 551g, assay 98.4%, MWt 164.63, Formula C6H13ClN2O, Purity >98%, SMILES Cl.CN1CCC(N)CC1=O, MDL NA |
| Drug_Names: 4-Amino-1-methylcyclohexan-1-ol, CAS: 233764-32-4, stock 427.7g, assay 98.7%, MWt 129.20, Formula C7H15NO, Purity >98%, SMILES CC1(O)CCC(N)CC1, MDL NA |
| Drug_Names: 4-Amino-1-ethyl-1,2-dihydropyridin-2-one hydrochloride, CAS: 1523618-09-8, stock 735.8g, assay 98.3%, MWt 174.63, Formula C7H11ClN2O, Purity >98%, SMILES Cl.CCN1C=CC(N)=CC1=O, MDL NA |
| Drug_Names: 4-Amino-1-benzylpiperidin-2-one, CAS: 1315495-55-6, stock 436g, assay 98.3%, MWt 204.27, Formula C12H16N2O, Purity >98%, SMILES NC1CCN(CC2=CC=CC=C2)C(=O)C1, MDL NA |
| Drug_Names: 4-Amino-1-[(2-chlorophenyl)methyl]pyrrolidin-2-one, CAS: 1114822-42-2, stock 407.8g, assay 98.1%, MWt 224.69, Formula C11H13ClN2O, Purity >98%, SMILES NC1CN(CC2=CC=CC=C2Cl)C(=O)C1, MDL NA |
| Drug_Names: 4-Amino-1-(trifluoromethyl)cyclohexan-1-ol hydrochloride, CAS: 1421602-78-9, stock 360.7g, assay 98.7%, MWt 219.63, Formula C7H13ClF3NO, Purity >98%, SMILES Cl.NC1CCC(O)(CC1)C(F)(F)F, MDL NA |
| Drug_Names: 4-Amino-1-(propan-2-yl)-1,2-dihydropyridin-2-one hydrochloride, CAS: 2102409-05-0, stock 441.7g, assay 98.5%, MWt 188.65, Formula C8H13ClN2O, Purity >98%, SMILES Cl.CC(C)N1C=CC(N)=CC1=O, MDL NA |
| Drug_Names: 4-Acetylpiperazin-2-one, CAS: 17796-61-1, stock 772.4g, assay 98.9%, MWt 142.16, Formula C6H10N2O2, Purity >98%, SMILES CC(=O)N1CCNC(=O)C1, MDL NA |
| Drug_Names: 4-Acetyl-2-methoxyphenyl acetate, CAS: 54771-60-7, stock 870.6g, assay 98.2%, MWt 208.21, Formula C11H12O4, Purity >98%, SMILES COC1=C(OC(C)=O)C=CC(=C1)C(C)=O, MDL NA |
| Drug_Names: 4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazole, CAS: 952518-97-7, stock 549.7g, assay 98.5%, MWt 185.19, Formula C9H7N5, Purity >98%, SMILES N1C=C(C=N1)C1=NC=NC2=C1C=CN2, MDL NA |
| Drug_Names: 4-{3,9-Diazaspiro[5.5]undecan-3-yl}-2-methoxyaniline, CAS: 2007917-26-0, stock 69g, assay 98.1%, MWt 275.39, Formula C16H25N3O, Purity >98%, SMILES COC1=CC(=CC=C1N)N1CCC2(CCNCC2)CC1, MDL NA |
| Drug_Names: 4-{2-Cchloropyrrolo[2,1-f][1,2,4]triazin-4-yl}morpholine, CAS: 1801294-68-7, stock 482.3g, assay 99%, MWt 238.67, Formula C10H11ClN4O, Purity >98%, SMILES ClC1=NN2C=CC=C2C(=N1)N1CCOCC1, MDL NA |
| Drug_Names: 4-{2,6-Diethenylpyrrolo[2,1-f][1,2,4]triazin-4-yl}morpholine, CAS: 2007917-19-1, stock 575.3g, assay 98.3%, MWt 256.30, Formula C14H16N4O, Purity >98%, SMILES C=CC1=CN2N=C(C=C)N=C(N3CCOCC3)C2=C1, MDL NA |
| Drug_Names: 4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy}piperidine, CAS: 1103501-11-6, stock 168.4g, assay 98%, MWt 367.27, Formula C18H20Cl2N2O2, Purity >98%, SMILES ClC1=CC=CC(Cl)=C1C1=NOC(C2CC2)=C1COC1CCNCC1, MDL NA |
| Drug_Names: 4-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)thiomorpholine 1,1-dioxide, CAS: 1469440-25-2, stock 256.6g, assay 98.8%, MWt 369.26, Formula C17H25BFNO4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=C(F)C=C(CN2CCS(=O)(=O)CC2)C=C1, MDL NA |
| Drug_Names: 4-{[(tert-Butoxy)carbonyl]amino}oxolane-3-carboxylic acid, CAS: 1521431-12-8, stock 636.9g, assay 98.2%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES CC(C)(C)OC(=O)NC1COCC1C(O)=O, MDL NA |
| Drug_Names: 4-((tert-Butoxycarbonyl)amino)-1H-pyrazole-3-carboxylic acid, CAS: 896466-71-0, stock 528.6g, assay 98.9%, MWt 227.22, Formula C9H13N3O4, Purity >98%, SMILES CC(C)(C)OC(=O)NC1=CNN=C1C(O)=O, MDL NA |
| Drug_Names: 4-(Benzyloxycarbonylamino)bicyclo[2.2.2]octane-1-carboxylic acid, CAS: 444344-91-6, stock 299.2g, assay 98.1%, MWt 303.35, Formula C17H21NO4, Purity >98%, SMILES OC(=O)C12CCC(CC1)(CC2)NC(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: (S)-4-(10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)butanoic acid, CAS: 1523530-65-5, stock 496.1g, assay 98.1%, MWt 340.37, Formula C19H20N2O4, Purity >98%, SMILES O[C@H]1CC2=C(C=CC=C2)N(C(=O)NCCCC(O)=O)C2=CC=CC=C12, MDL NA |
| Drug_Names: 4-(4-(Trifluoromethoxy)phenoxy)piperidine, CAS: 287952-67-4, stock 730.7g, assay 98.8%, MWt 261.24, Formula C12H14F3NO2, Purity >98%, SMILES FC(F)(F)OC1=CC=C(OC2CCNCC2)C=C1, MDL NA |
| Drug_Names: 4-(4-(3-Nitrophenyl)-1H-1,2,3-triazol-1-yl)butan-1-amine, CAS: 1626413-51-1, stock 855.5g, assay 98.7%, MWt 261.28, Formula C12H15N5O2, Purity >98%, SMILES NCCCCN1C=C(N=N1)C1=CC(=CC=C1)[N+]([O-])=O, MDL NA |
| Drug_Names: 4-(2-(1-(Azetidin-3-yl)-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenoxy)-5-chloro-2-fluoro-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide, CAS: 1354818-96-4, stock 71.5g, assay 98.3%, MWt 574.96, Formula C21H15ClF4N6O3S2, Purity >98%, SMILES FC1=CC(OC2=C(C=C(C=C2)C(F)(F)F)C2=CC=NN2C2CNC2)=C(Cl)C=C1S(=O)(=O)NC1=NN=CS1, MDL NA |
| Drug_Names: (R)-4-(((1-Propyl-1H-imidazol-5-yl)methyl)sulfinyl)aniline, CAS: 854764-37-7, stock 76.6g, assay 98.9%, MWt 263.36, Formula C13H17N3OS, Purity >98%, SMILES NC1=CC=C([S@@](CC2=CN=CN2CCC)=O)C=C1, MDL NA |
| Drug_Names: 4-(4-Bromo-3-fluorobenzyl)thiomorpholine 1,1-dioxide, CAS: 1973485-27-6, stock 882.8g, assay 98.2%, MWt 322.19, Formula C11H13BrFNO2S, Purity >98%, SMILES FC1=CC(CN2CCS(CC2)(=O)=O)=CC=C1Br, MDL NA |
| Drug_Names: 3-(3-Fluorobenzyl)-4-((3-fluorobenzyl)oxy)benzaldehyde, CAS: 1000370-24-0, stock 283.1g, assay 98.2%, MWt 338.35, Formula C21H16F2O2, Purity >98%, SMILES [H]C(=O)C1=CC=C(OCC2=CC(F)=CC=C2)C(CC2=CC(F)=CC=C2)=C1, MDL NA |
| Drug_Names: 4-(2-Chloro-6-fluorobenzyl)piperidine hydrochloride, CAS: 1523618-16-7, stock 821.1g, assay 98.4%, MWt 264.17, Formula C12H16Cl2FN, Purity >98%, SMILES Cl.FC1=CC=CC(Cl)=C1CC1CCNCC1, MDL NA |
| Drug_Names: 4-[(1R,2S)-rel-2-aminocyclopropyl]phenol, CAS: 104777-77-7, stock 243g, assay 98.1%, MWt 149.19, Formula C9H11NO, Purity >98%, SMILES N[C@H]1C[C@@H]1C1=CC=C(O)C=C1, MDL NA |
| Drug_Names: 4,8-Dichloro-1,7-naphthyridine, CAS: 1279894-03-9, stock 18.8g, assay 98%, MWt 199.04, Formula C8H4Cl2N2, Purity >98%, SMILES ClC1=C2C=CN=C(Cl)C2=NC=C1, MDL NA |
| Drug_Names: 4,7-Dichloro-1,8-naphthyridine-3-carbonitrile, CAS: 1234616-32-0, stock 745.6g, assay 98.8%, MWt 224.05, Formula C9H3Cl2N3, Purity >98%, SMILES ClC1=CC=C2C(Cl)=C(C=NC2=N1)C#N, MDL NA |
| Drug_Names: 4,7-Dibromopyrazolo[1,5-a]pyridine, CAS: 1473425-66-9, stock 593.6g, assay 98.2%, MWt 275.93, Formula C7H4Br2N2, Purity >98%, SMILES BrC1=CC=C(Br)C2=CC=NN12, MDL NA |
| Drug_Names: 4,7-Dibromo-6-fluoro-2,3-dihydro-1H-indol-2-one, CAS: 2007921-27-7, stock 561g, assay 98.7%, MWt 308.93, Formula C8H4Br2FNO, Purity >98%, SMILES FC1=C(Br)C2=C(CC(=O)N2)C(Br)=C1, MDL NA |
| Drug_Names: 4,7-Diazaspiro[2.5]octane oxalate, CAS: 1389264-25-8, stock 595.5g, assay 98.4%, MWt 202.21, Formula C8H14N2O4, Purity >98%, SMILES OC(=O)C(O)=O.C1CC11CNCCN1, MDL NA |
| Drug_Names: 4,7-Diazaspiro[2.5]octan-5-one hydrochloride, CAS: 1199794-52-9, stock 26.7g, assay 98.3%, MWt 162.62, Formula C6H11ClN2O, Purity >98%, SMILES Cl.O=C1CNCC2(CC2)N1, MDL NA |
| Drug_Names: 4,6-Dimethyl-3(2H)-pyridazinone, CAS: 7007-92-3, stock 575g, assay 98%, MWt 124.14, Formula C6H8N2O, Purity >98%, SMILES CC1=NNC(=O)C(C)=C1, MDL NA |
| Drug_Names: 4,6-Dimethoxypyrimidine-5-carboxylic acid, CAS: 4319-93-1, stock 237.7g, assay 98.7%, MWt 184.15, Formula C7H8N2O4, Purity >98%, SMILES COC1=NC=NC(OC)=C1C(O)=O, MDL NA |
| Drug_Names: 4,6-Dimethoxypyrimidine-2-carbonitrile, CAS: 139539-63-2, stock 627.1g, assay 98.1%, MWt 165.15, Formula C7H7N3O2, Purity >98%, SMILES COC1=CC(OC)=NC(=N1)C#N, MDL NA |
| Drug_Names: 4,6-Dichloropyrido[3,4-d]pyrimidine, CAS: 171178-48-6, stock 726.4g, assay 98.7%, MWt 200.02, Formula C7H3Cl2N3, Purity >98%, SMILES ClC1=NC=C2N=CN=C(Cl)C2=C1, MDL NA |
| Drug_Names: 4,6-Dichloropyrido[3,2-d]pyrimidine, CAS: 175358-02-8, stock 131.3g, assay 98.3%, MWt 200.02, Formula C7H3Cl2N3, Purity >98%, SMILES ClC1=NC2=C(C=C1)N=CN=C2Cl, MDL NA |
| Drug_Names: 4,6-Dichloro-5-fluoropyridine-3-carboxylic acid, CAS: 154012-18-7, stock 478g, assay 98.1%, MWt 209.99, Formula C6H2Cl2FNO2, Purity >98%, SMILES OC(=O)C1=C(Cl)C(F)=C(Cl)N=C1, MDL NA |
| Drug_Names: 4,6-Dichloro-3-methyl-1H-pyrrolo[2,3-b]pyridine, CAS: 1638771-47-7, stock 358.3g, assay 99%, MWt 201.05, Formula C8H6Cl2N2, Purity >98%, SMILES CC1=CNC2=C1C(Cl)=CC(Cl)=N2, MDL NA |
| Drug_Names: 4,6-Dichloro-3-methoxy-2-methylpyridine, CAS: 1019929-89-5, stock 887.4g, assay 98.1%, MWt 192.04, Formula C7H7Cl2NO, Purity >98%, SMILES COC1=C(C)N=C(Cl)C=C1Cl, MDL NA |
| Drug_Names: 4,6-Dichloro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine, CAS: 1256801-93-0, stock 615.9g, assay 98.8%, MWt 255.02, Formula C8H3Cl2F3N2, Purity >98%, SMILES FC(F)(F)C1=CNC2=C1C(Cl)=CC(Cl)=N2, MDL NA |
| Drug_Names: 4,6-Dichloro-2-(5-methyl-1H-pyrazol-1-yl)pyrimidine, CAS: 2102412-65-5, stock 859.4g, assay 98.4%, MWt 229.07, Formula C8H6Cl2N4, Purity >98%, SMILES CC1=CC=NN1C1=NC(Cl)=CC(Cl)=N1, MDL NA |
| Drug_Names: 4,6-Dichloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine, CAS: 98141-42-5, stock 423.3g, assay 98.9%, MWt 203.03, Formula C6H4Cl2N4, Purity >98%, SMILES CN1N=CC2=C(Cl)N=C(Cl)N=C12, MDL NA |
| Drug_Names: 4,6-Dichloro-1-methyl-1h-pyrazolo[3,4-b]pyridine, CAS: 1227089-74-8, stock 397.7g, assay 98.7%, MWt 202.04, Formula C7H5Cl2N3, Purity >98%, SMILES CN1N=CC2=C1N=C(Cl)C=C2Cl, MDL NA |
| Drug_Names: 4,6-Dichloro-1-isopropyl-1h-pyrazolo[3,4-b]pyridine, CAS: 1628459-82-4, stock 399.7g, assay 98.7%, MWt 230.09, Formula C9H9Cl2N3, Purity >98%, SMILES CC(C)N1N=CC2=C1N=C(Cl)C=C2Cl, MDL NA |
| Drug_Names: 4,6-Dichloro-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile, CAS: 1632368-33-2, stock 776.8g, assay 98.1%, MWt 212.04, Formula C8H3Cl2N3, Purity >98%, SMILES ClC1=NC2=C(C(=CN2)C#N)C(Cl)=C1, MDL NA |
| Drug_Names: 4,6-Dichloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, CAS: 1190322-13-4, stock 92.2g, assay 98.9%, MWt 203.03, Formula C7H4Cl2N2O, Purity >98%, SMILES ClC1=NC2=C(CC(=O)N2)C(Cl)=C1, MDL NA |
| Drug_Names: 4,6-Dichloro-1,7-naphthyridine, CAS: 1301714-24-8, stock 598.4g, assay 98%, MWt 199.04, Formula C8H4Cl2N2, Purity >98%, SMILES ClC1=CC2=C(Cl)C=CN=C2C=N1, MDL NA |
| Drug_Names: 4,5-Difluoro-1-benzofuran-2-carboxylic acid, CAS: 1521284-52-5, stock 567.4g, assay 98.2%, MWt 198.12, Formula C9H4F2O3, Purity >98%, SMILES OC(=O)C1=CC2=C(O1)C=CC(F)=C2F, MDL NA |
| Drug_Names: 4,5-Dichloropyrrolo[2,1-f][1,2,4]triazine, CAS: 888720-61-4, stock 597.3g, assay 98.3%, MWt 188.01, Formula C6H3Cl2N3, Purity >98%, SMILES ClC1=C2N(C=C1)N=CN=C2Cl, MDL NA |
| Drug_Names: 4,5-Dichloro-3-nitropyridin-2-amine, CAS: 662116-67-8, stock 543.2g, assay 98.7%, MWt 208.00, Formula C5H3Cl2N3O2, Purity >98%, SMILES NC1=NC=C(Cl)C(Cl)=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 4,5-Dichloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, CAS: 1190315-26-4, stock 193.8g, assay 98.8%, MWt 203.03, Formula C7H4Cl2N2O, Purity >98%, SMILES ClC1=C(Cl)C2=C(NC(=O)C2)N=C1, MDL NA |
| Drug_Names: 4,5,6,7-Tetrahydro-1H-indazol-5-amine dihydrochloride, CAS: 74197-17-4, stock 765.6g, assay 98.1%, MWt 210.10, Formula C7H13Cl2N3, Purity >98%, SMILES NC1CCC2=C(C=NN2)C1.Cl.Cl, MDL NA |
| Drug_Names: 3,3-Difluoropiperidine-4,4-diol hydrochloride, CAS: 1788044-01-8, stock 820.6g, assay 98.4%, MWt 189.59, Formula C5H10ClF2NO2, Purity >98%, SMILES Cl.OC1(O)CCNCC1(F)F, MDL NA |
| Drug_Names: 4,4-Dimethyl-1-[(1R)-1-phenylethyl]pyrrolidine-2,3,5-trione, CAS: 2055848-74-1, stock 846.6g, assay 98.1%, MWt 245.27, Formula C14H15NO3, Purity >98%, SMILES C[C@@H](N1C(=O)C(=O)C(C)(C)C1=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 4,4-Dimethoxyoxan-3-one, CAS: 693245-80-6, stock 782.6g, assay 98.7%, MWt 160.17, Formula C7H12O4, Purity >98%, SMILES COC1(CCOCC1=O)OC, MDL NA |
| Drug_Names: 4,4-Difluoropyrrolidin-3-ol hydrochloride, CAS: 1638764-82-5, stock 303.9g, assay 98.6%, MWt 159.56, Formula C4H8ClF2NO, Purity >98%, SMILES Cl.OC1CNCC1(F)F, MDL NA |
| Drug_Names: 4,4-Difluoroazepane hydrochloride, CAS: 1160721-05-0, stock 436.2g, assay 98.8%, MWt 171.62, Formula C6H12ClF2N, Purity >98%, SMILES Cl.FC1(F)CCCNCC1, MDL NA |
| Drug_Names: 4,4-difluoro-1-(hydroxymethyl)cyclohexan-1-ol, CAS: 1256545-48-8, stock 384.8g, assay 98.1%, MWt 166.17, Formula C7H12F2O2, Purity >98%, SMILES OCC1(O)CCC(F)(F)CC1, MDL NA |
| Drug_Names: 4,4,5,5-Tetramethyl-2-(3-methylthiophen-2-yl)-1,3,2-dioxaborolane, CAS: 885692-91-1, stock 152.9g, assay 98.6%, MWt 224.13, Formula C11H17BO2S, Purity >98%, SMILES CC1=C(SC=C1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 4,4,5,5-Tetrachlorospiro[2.2]pentane-1-carboxylic acid, CAS: 1788041-68-8, stock 347.6g, assay 98.7%, MWt 249.91, Formula C6H4Cl4O2, Purity >98%, SMILES OC(=O)C1CC11C(Cl)(Cl)C1(Cl)Cl, MDL NA |
| Drug_Names: 4-(Trifluoromethyl)pyrrolidin-2-one, CAS: 664304-83-0, stock 310.7g, assay 98.5%, MWt 153.10, Formula C5H6F3NO, Purity >98%, SMILES FC(F)(F)C1CNC(=O)C1, MDL NA |
| Drug_Names: 4-(Trifluoromethyl)tetrahydro-2H-pyran-4-amine hydrochloride, CAS: 1354961-50-4, stock 386.6g, assay 98.8%, MWt 205.61, Formula C6H11ClF3NO, Purity >98%, SMILES Cl.NC1(CCOCC1)C(F)(F)F, MDL NA |
| Drug_Names: 4-(Trifluoromethyl)cyclohexanamine, CAS: 58665-70-6, stock 405g, assay 98.5%, MWt 167.17, Formula C7H12F3N, Purity >98%, SMILES NC1CCC(CC1)C(F)(F)F, MDL NA |
| Drug_Names: 4-(Trifluoromethyl)-1H-pyrrole-2-carboxylic acid, CAS: 149427-58-7, stock 713.6g, assay 98.1%, MWt 179.10, Formula C6H4F3NO2, Purity >98%, SMILES OC(=O)C1=CC(=CN1)C(F)(F)F, MDL NA |
| Drug_Names: 4-(Trifluoromethoxy)cyclohexane-1-carboxylic acid, CAS: 1227187-82-7, stock 173g, assay 98.7%, MWt 212.17, Formula C8H11F3O3, Purity >98%, SMILES OC(=O)C1CCC(CC1)OC(F)(F)F, MDL NA |
| Drug_Names: 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarbonitrile, CAS: 1310384-20-3, stock 850.2g, assay 98.8%, MWt 233.11, Formula C13H20BNO2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CCC(CC1)C#N, MDL NA |
| Drug_Names: 4-Isopropoxyaniline, CAS: 7664-66-6, stock 351.5g, assay 98.5%, MWt 151.21, Formula C9H13NO, Purity >98%, SMILES CC(C)OC1=CC=C(N)C=C1, MDL NA |
| Drug_Names: 4-(Piperidin-3-yl)benzoic acid hydrochloride, CAS: 2044705-22-6, stock 421.3g, assay 98.2%, MWt 241.71, Formula C12H16ClNO2, Purity >98%, SMILES Cl.OC(=O)C1=CC=C(C=C1)C1CCCNC1, MDL NA |
| Drug_Names: 4-(Oxetan-3-yloxy)aniline, CAS: 1349715-80-5, stock 471.7g, assay 98.5%, MWt 165.19, Formula C9H11NO2, Purity >98%, SMILES NC1=CC=C(OC2COC2)C=C1, MDL NA |
| Drug_Names: 4-(Oxetan-3-yl)piperidine oxalate(2:1), CAS: 1523606-46-3, stock 403.8g, assay 98.5%, MWt 372.46, Formula C18H32N2O6, Purity >98%, SMILES OC(=O)C(O)=O.C1OCC1C1CCNCC1.C1OCC1C1CCNCC1, MDL NA |
| Drug_Names: 4-(Methoxymethyl)piperidine, CAS: 399580-55-3, stock 583.6g, assay 98.3%, MWt 129.20, Formula C7H15NO, Purity >98%, SMILES COCC1CCNCC1, MDL NA |
| Drug_Names: 4-(Methoxymethyl)-1H-pyrazole, CAS: 37599-34-1, stock 195.2g, assay 98.1%, MWt 112.13, Formula C5H8N2O, Purity >98%, SMILES COCC1=CNN=C1, MDL NA |
| Drug_Names: 4-(Hydroxymethyl)piperidin-4-ol hydrochloride, CAS: 240401-25-6, stock 567.8g, assay 98.1%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES Cl.OCC1(O)CCNCC1, MDL NA |
| Drug_Names: 4-(Hydroxymethyl)piperidin-2-one, CAS: 53611-47-5, stock 563.2g, assay 98.1%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES OCC1CCNC(=O)C1, MDL NA |
| Drug_Names: 4-(Hydroxymethyl)bicyclo[2.2.2]octan-1-ol, CAS: 72948-89-1, stock 46.5g, assay 98.3%, MWt 156.22, Formula C9H16O2, Purity >98%, SMILES OCC12CCC(O)(CC1)CC2, MDL NA |
| Drug_Names: 4-(Hydroxymethyl)azetidin-2-one, CAS: 74694-48-7, stock 9.1g, assay 98.1%, MWt 101.10, Formula C4H7NO2, Purity >98%, SMILES OCC1CC(=O)N1, MDL NA |
| Drug_Names: 4-(Hydroxymethyl)-1-methylpyrrolidin-2-one, CAS: 59887-20-6, stock 577.8g, assay 98.1%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES CN1CC(CO)CC1=O, MDL NA |
| Drug_Names: 4-(Hydroxymethyl)-1-methylpiperidin-2-one, CAS: 20845-32-3, stock 813.2g, assay 98.2%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CN1CCC(CO)CC1=O, MDL NA |
| Drug_Names: 4-(Hydroxymethyl)-1-methylpyridin-2(1H)-one, CAS: 371765-69-4, stock 642.8g, assay 98.2%, MWt 139.15, Formula C7H9NO2, Purity >98%, SMILES CN1C=CC(CO)=CC1=O, MDL NA |
| Drug_Names: 4-(Hydrazinylmethyl)pyridine trihydrochloride, CAS: 1349717-75-4, stock 201.6g, assay 98.9%, MWt 232.54, Formula C6H12Cl3N3, Purity >98%, SMILES Cl.Cl.Cl.NNCC1=CC=NC=C1, MDL NA |
| Drug_Names: 4-(Fluoromethyl)piperidine hydrochloride, CAS: 787564-27-6, stock 410.3g, assay 98.4%, MWt 153.63, Formula C6H13ClFN, Purity >98%, SMILES Cl.FCC1CCNCC1, MDL NA |
| Drug_Names: 4-(Fluoromethyl)piperidin-4-ol hydrochloride, CAS: 1253929-33-7, stock 275.6g, assay 98.6%, MWt 169.62, Formula C6H13ClFNO, Purity >98%, SMILES Cl.OC1(CF)CCNCC1, MDL NA |
| Drug_Names: 4-(Ethoxymethyl)piperidin-4-ol, CAS: 50675-14-4, stock 341.6g, assay 98.8%, MWt 159.23, Formula C8H17NO2, Purity >98%, SMILES CCOCC1(O)CCNCC1, MDL NA |
| Drug_Names: 4-(Ethoxycarbonyl)-1H-indole-6-carboxylic acid, CAS: 1638772-15-2, stock 785.7g, assay 98.2%, MWt 233.22, Formula C12H11NO4, Purity >98%, SMILES CCOC(=O)C1=CC(=CC2=C1C=CN2)C(O)=O, MDL NA |
| Drug_Names: 4-(Dimethylamino)-4-phenylcyclohexanone, CAS: 65619-20-7, stock 706.8g, assay 98.9%, MWt 217.31, Formula C14H19NO, Purity >98%, SMILES CN(C)C1(CCC(=O)CC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 4-(Dimethylamino)-4-(3-fluorophenyl)cyclohexan-1-one, CAS: 863514-54-9, stock 362.7g, assay 98%, MWt 235.30, Formula C14H18FNO, Purity >98%, SMILES CN(C)C1(CCC(=O)CC1)C1=CC=CC(F)=C1, MDL NA |
| Drug_Names: 4-(Difluoromethyl)piperidin-4-ol hydrochloride, CAS: 1803595-35-8, stock 590.4g, assay 98.6%, MWt 187.62, Formula C6H12ClF2NO, Purity >98%, SMILES Cl.OC1(CCNCC1)C(F)F, MDL NA |
| Drug_Names: 4-(Difluoromethoxy)piperidine hydrochloride, CAS: 1630907-16-2, stock 91.4g, assay 98.3%, MWt 187.62, Formula C6H12ClF2NO, Purity >98%, SMILES Cl.FC(F)OC1CCNCC1, MDL NA |
| Drug_Names: 4-(Dibenzylamino)tetrahydro-2H-pyran-4-carbonitrile, CAS: 1630906-81-8, stock 335g, assay 98.3%, MWt 306.40, Formula C20H22N2O, Purity >98%, SMILES N#CC1(CCOCC1)N(CC1=CC=CC=C1)CC1=CC=CC=C1, MDL NA |
| Drug_Names: 4-(Cyclopropanesulfonyl)aniline, CAS: 1147558-13-1, stock 839g, assay 98.8%, MWt 197.25, Formula C9H11NO2S, Purity >98%, SMILES NC1=CC=C(C=C1)S(=O)(=O)C1CC1, MDL NA |
| Drug_Names: 4-(Cyclohex-1-en-1-yl)-3-(trifluoromethyl)benzoic acid, CAS: 1034188-31-2, stock 85.5g, assay 98.6%, MWt 270.25, Formula C14H13F3O2, Purity >98%, SMILES OC(=O)C1=CC=C(C2=CCCCC2)C(=C1)C(F)(F)F, MDL NA |
| Drug_Names: 4-(Chlorosulfonyl)-3-fluorobenzoic acid, CAS: 244606-33-5, stock 328.8g, assay 98.8%, MWt 238.62, Formula C7H4ClFO4S, Purity >98%, SMILES OC(=O)C1=CC(F)=C(C=C1)S(Cl)(=O)=O, MDL NA |
| Drug_Names: 4-(Chlorosulfonyl)-2-fluorobenzoic acid, CAS: 1354962-26-7, stock 177g, assay 98.2%, MWt 238.62, Formula C7H4ClFO4S, Purity >98%, SMILES OC(=O)C1=C(F)C=C(C=C1)S(Cl)(=O)=O, MDL NA |
| Drug_Names: 4-Chloromethyl-piperidine hydrochloride, CAS: 1822-61-3, stock 867g, assay 98.9%, MWt 170.08, Formula C6H13Cl2N, Purity >98%, SMILES Cl.ClCC1CCNCC1, MDL NA |
| Drug_Names: 4-(Chloromethyl)-5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole, CAS: 1268245-50-6, stock 570.8g, assay 98.3%, MWt 302.58, Formula C13H10Cl3NO, Purity >98%, SMILES ClCC1=C(ON=C1C1=C(Cl)C=CC=C1Cl)C1CC1, MDL NA |
| Drug_Names: 4-(Chloromethyl)-3-methylpyridine hydrochloride, CAS: 117934-36-8, stock 879.7g, assay 98.5%, MWt 178.06, Formula C7H9Cl2N, Purity >98%, SMILES Cl.CC1=C(CCl)C=CN=C1, MDL NA |
| Drug_Names: 4-(Chloromethyl)-2-methoxypyridine hydrochloride, CAS: 193001-96-6, stock 574.5g, assay 98.5%, MWt 194.06, Formula C7H9Cl2NO, Purity >98%, SMILES Cl.COC1=NC=CC(CCl)=C1, MDL NA |
| Drug_Names: 4-(Chloromethyl)-1H-indazole, CAS: 944898-78-6, stock 840.5g, assay 98.8%, MWt 166.61, Formula C8H7ClN2, Purity >98%, SMILES ClCC1=CC=CC2=C1C=NN2, MDL NA |
| Drug_Names: 4-(Bromomethyl)-2,2-dimethyloxetane, CAS: 1408074-88-3, stock 347.6g, assay 98.9%, MWt 179.05, Formula C6H11BrO, Purity >98%, SMILES CC1(C)CC(CBr)O1, MDL NA |
| Drug_Names: 4-(Bromomethyl)-1-methyl-1H-pyrazole hydrobromide, CAS: 528878-44-6, stock 40g, assay 98.4%, MWt 255.94, Formula C5H8Br2N2, Purity >98%, SMILES Br.CN1C=C(CBr)C=N1, MDL NA |
| Drug_Names: 4-(Bromomethyl)-1,1-difluorocyclohexane, CAS: 858121-94-5, stock 266g, assay 98.3%, MWt 213.06, Formula C7H11BrF2, Purity >98%, SMILES FC1(F)CCC(CBr)CC1, MDL NA |
| Drug_Names: 4-(Benzyloxy)piperidin-3-ol hydrochloride, CAS: 2055839-82-0, stock 244.3g, assay 98.5%, MWt 243.73, Formula C12H18ClNO2, Purity >98%, SMILES Cl.OC1CNCCC1OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 4-(Benzyloxy)-3,3-difluoropiperidine hydrochloride, CAS: 1416440-29-3, stock 756.4g, assay 98.1%, MWt 263.71, Formula C12H16ClF2NO, Purity >98%, SMILES Cl.FC1(F)CNCCC1OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 4-(Benzyloxy)-2-methylbenzoic acid, CAS: 17819-91-9, stock 325.6g, assay 98.7%, MWt 242.27, Formula C15H14O3, Purity >98%, SMILES CC1=C(C=CC(OCC2=CC=CC=C2)=C1)C(O)=O, MDL NA |
| Drug_Names: 4-(Azetidine-3-carbonyl)morpholine hydrochloride, CAS: 1619991-15-9, stock 530.5g, assay 98.2%, MWt 206.67, Formula C8H15ClN2O2, Purity >98%, SMILES Cl.O=C(C1CNC1)N1CCOCC1, MDL NA |
| Drug_Names: 4-(Azetidin-3-yl)thiomorpholine 1,1-dioxide dihydrochloride, CAS: 178312-02-2, stock 410.5g, assay 98.8%, MWt 263.19, Formula C7H16Cl2N2O2S, Purity >98%, SMILES Cl.Cl.O=S1(=O)CCN(CC1)C1CNC1, MDL NA |
| Drug_Names: 4-(Azetidin-3-yl)morpholine hydrochloride, CAS: 223381-71-3, stock 175g, assay 98.2%, MWt 178.66, Formula C7H15ClN2O, Purity >98%, SMILES Cl.C1NCC1N1CCOCC1, MDL NA |
| Drug_Names: 4-(Azetidin-3-yl)-2,2-dimethylmorpholine bis(2,2,2-trifluoroacetate), CAS: 1523606-35-0, stock 715g, assay 98.7%, MWt 398.30, Formula C13H20F6N2O5, Purity >98%, SMILES OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CC1(C)CN(CCO1)C1CNC1, MDL NA |
| Drug_Names: 4-(Azetidin-1-yl)-4-phenylcyclohexan-1-one, CAS: 1002916-47-3, stock 650.6g, assay 98%, MWt 229.32, Formula C15H19NO, Purity >98%, SMILES O=C1CCC(CC1)(N1CCC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 4-(Aminomethyl)pyrrolidin-2-one hydrochloride, CAS: 1400764-39-7, stock 167.3g, assay 98.3%, MWt 150.61, Formula C5H11ClN2O, Purity >98%, SMILES Cl.NCC1CNC(=O)C1, MDL NA |
| Drug_Names: 4-(Aminomethyl)bicyclo[2.2.1]heptane-1-carboxylic acid hydrochloride, CAS: 28333-76-8, stock 70.9g, assay 98.3%, MWt 205.68, Formula C9H16ClNO2, Purity >98%, SMILES Cl.NCC12CCC(CC1)(C2)C(O)=O, MDL NA |
| Drug_Names: 4-(Aminomethyl)-1-methylpyrrolidin-2-one, CAS: 933723-27-4, stock 1.5g, assay 98.9%, MWt 128.17, Formula C6H12N2O, Purity >98%, SMILES O=C1N(C)CC(CN)C1, MDL NA |
| Drug_Names: 4-(Aminomethyl)-1-methylpiperidin-4-ol hydrochloride, CAS: 168818-68-6, stock 705.9g, assay 98.6%, MWt 180.68, Formula C7H17ClN2O, Purity >98%, SMILES Cl.CN1CCC(O)(CN)CC1, MDL NA |
| Drug_Names: 4-(Aminomethyl)-1-methylpiperidin-2-one hydrochloride, CAS: 1630907-14-0, stock 167.3g, assay 98.8%, MWt 178.66, Formula C7H15ClN2O, Purity >98%, SMILES Cl.CN1CCC(CN)CC1=O, MDL NA |
| Drug_Names: 4-(Aminomethyl)-1-methyl-1,2-dihydropyridin-2-one hydrochloride, CAS: 1523572-01-1, stock 86.5g, assay 99%, MWt 174.63, Formula C7H11ClN2O, Purity >98%, SMILES Cl.CN1C=CC(CN)=CC1=O, MDL NA |
| Drug_Names: 4-(Aminomethyl)-1H,2H,3H-pyrrolo[2,3-b]pyridin-2-one dihydrochloride, CAS: 1818847-61-8, stock 543.8g, assay 98.2%, MWt 236.10, Formula C8H11Cl2N3O, Purity >98%, SMILES Cl.Cl.NCC1=CC=NC2=C1CC(=O)N2, MDL NA |
| Drug_Names: 4-(Aminomethyl)-1,3-oxazolidin-2-one hydrochloride, CAS: 1803589-70-9, stock 509.8g, assay 98.7%, MWt 152.58, Formula C4H9ClN2O2, Purity >98%, SMILES Cl.NCC1COC(=O)N1, MDL NA |
| Drug_Names: 4-(Aminomethyl)-1,2-dihydropyridin-2-one hydrochloride, CAS: 943751-21-1, stock 414.4g, assay 98.3%, MWt 160.60, Formula C6H9ClN2O, Purity >98%, SMILES Cl.NCC1=CC(=O)NC=C1, MDL NA |
| Drug_Names: 5-Bromo-2-chloro-4-morpholinopyrimidine, CAS: 139502-01-5, stock 494g, assay 98.8%, MWt 278.53, Formula C8H9BrClN3O, Purity >98%, SMILES ClC1=NC(N2CCOCC2)=C(Br)C=N1, MDL NA |
| Drug_Names: 4-(4-(tert-Butyl)-2-ethoxyphenyl)-2-(2,6-difluorophenyl)-4,5-dihydrooxazole, CAS: 153233-91-1, stock 499.5g, assay 98.6%, MWt 359.41, Formula C21H23F2NO2, Purity >98%, SMILES CCOC1=C(C=CC(=C1)C(C)(C)C)C1COC(=N1)C1=C(F)C=CC=C1F, MDL NA |
| Drug_Names: 4-(4-Ethyl-1-piperazinyl)-3-fluoro-benzenamine, CAS: 873537-27-0, stock 738.2g, assay 98.3%, MWt 223.29, Formula C12H18FN3, Purity >98%, SMILES CCN1CCN(CC1)C1=C(F)C=C(N)C=C1, MDL NA |
| Drug_Names: 4-(4-Chloro-2-fluorophenyl)-2-methylpyridine-3-carboxylic acid, CAS: 1551407-47-6, stock 92.5g, assay 99%, MWt 265.67, Formula C13H9ClFNO2, Purity >98%, SMILES CC1=NC=CC(C2=CC=C(Cl)C=C2F)=C1C(O)=O, MDL NA |
| Drug_Names: 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-7-(trifluoromethyl)-1H-indazole, CAS: 1186334-80-4, stock 646.3g, assay 98.1%, MWt 312.10, Formula C14H16BF3N2O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=C2C=NNC2=C(C=C1)C(F)(F)F, MDL NA |
| Drug_Names: 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1H-indole, CAS: 955978-82-2, stock 634.4g, assay 98.4%, MWt 311.11, Formula C15H17BF3NO2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=C2C=CNC2=CC(=C1)C(F)(F)F, MDL NA |
| Drug_Names: 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)-1h-indole, CAS: 955978-84-4, stock 725.5g, assay 98%, MWt 311.11, Formula C15H17BF3NO2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=C2C=C(NC2=CC=C1)C(F)(F)F, MDL NA |
| Drug_Names: 4-(3-Methyloxetan-3-yl)aniline, CAS: 1225380-12-0, stock 852.9g, assay 98.6%, MWt 163.22, Formula C10H13NO, Purity >98%, SMILES CC1(COC1)C1=CC=C(N)C=C1, MDL NA |
| Drug_Names: 4-(3-Chloropropyl)morpholine hydrochloride, CAS: 57616-74-7, stock 318.9g, assay 98.9%, MWt 200.11, Formula C7H15Cl2NO, Purity >98%, SMILES Cl.ClCCCN1CCOCC1, MDL NA |
| Drug_Names: 4-(3-Bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, CAS: 543739-81-7, stock 205.1g, assay 98.3%, MWt 407.56, Formula C16H15BrCl3N, Purity >98%, SMILES Cl.CN1CC(C2=CC(Br)=CC=C2)C2=CC(Cl)=CC(Cl)=C2C1, MDL NA |
| Drug_Names: 4-(2-Methoxyethyl)piperidine hydrochloride, CAS: 868849-54-1, stock 312.9g, assay 98.9%, MWt 179.69, Formula C8H18ClNO, Purity >98%, SMILES Cl.COCCC1CCNCC1, MDL NA |
| Drug_Names: 4-(2H-1,2,3,4-tetrazol-5-yl)piperidine hydrochloride, CAS: 91419-60-2, stock 767.7g, assay 98%, MWt 189.65, Formula C6H12ClN5, Purity >98%, SMILES Cl.C1CC(CCN1)C1=NNN=N1, MDL NA |
| Drug_Names: 4-(2-Aminopropan-2-yl)-1-Boc-piperidine, CAS: 530116-33-7, stock 545.1g, assay 98.3%, MWt 242.36, Formula C13H26N2O2, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC(CC1)C(C)(C)N, MDL NA |
| Drug_Names: 5-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2H-tetrazole, CAS: 775351-40-1, stock 732.1g, assay 98.1%, MWt 272.11, Formula C13H17BN4O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CC=C(C=C1)C1=NN=NN1, MDL NA |
| Drug_Names: 4-(1H-1,3-benzodiazol-2-yl)-1,2,5-oxadiazol-3-amine, CAS: 332026-86-5, stock 531.4g, assay 98.9%, MWt 201.18, Formula C9H7N5O, Purity >98%, SMILES NC1=NON=C1C1=NC2=C(N1)C=CC=C2, MDL NA |
| Drug_Names: 4-(1,4-Dimethylpiperidin-4-yl)aniline, CAS: 1242153-34-9, stock 595.5g, assay 98.3%, MWt 204.31, Formula C13H20N2, Purity >98%, SMILES CN1CCC(C)(CC1)C1=CC=C(N)C=C1, MDL NA |
| Drug_Names: (3R,4R)-rel-3-Methylpiperidin-4-ol hydrochloride, CAS: 955028-91-8, stock 521.7g, assay 98.2%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.C[C@@H]1CNCC[C@H]1O, MDL NA |
| Drug_Names: 4-Methylcyclohex-2-en-1-one, CAS: 5515-76-4, stock 116.9g, assay 99%, MWt 110.15, Formula C7H10O, Purity >98%, SMILES O=C1C=CC(C)CC1, MDL NA |
| Drug_Names: 4-Hydroxy-6-(propan-2-yl)-2H-pyran-2-one, CAS: 220809-37-0, stock 599.3g, assay 98.7%, MWt 154.16, Formula C8H10O3, Purity >98%, SMILES O=C1C=C(O)C=C(C(C)C)O1, MDL NA |
| Drug_Names: 3-Thia-9-azaspiro[5.5]undecane 3,3-dioxide hydrochloride, CAS: 1803582-31-1, stock 325.4g, assay 98.3%, MWt 239.76, Formula C9H18ClNO2S, Purity >98%, SMILES O=S1(CCC2(CCNCC2)CC1)=O.[H]Cl, MDL NA |
| Drug_Names: (R)-2,2-Dimethylthiomorpholine-3-carboxylic acid, CAS: 774243-35-5, stock 869.8g, assay 98.1%, MWt 175.25, Formula C7H13NO2S, Purity >98%, SMILES CC1(C)SCCN[C@@H]1C(O)=O, MDL NA |
| Drug_Names: 3-Amino-3-methylthietane 1,1-dioxide, CAS: 943438-02-6, stock 259.2g, assay 98.4%, MWt 135.18, Formula C4H9NO2S, Purity >98%, SMILES CC1(N)CS(=O)(=O)C1, MDL NA |
| Drug_Names: 3-Thia-9-azabicyclo[3.3.1]nonan-7-one 3,3-dioxide hydrochloride, CAS: 1419101-38-4, stock 758.6g, assay 98.8%, MWt 225.69, Formula C7H12ClNO3S, Purity >98%, SMILES Cl.O=C1CC2CS(=O)(=O)CC(C1)N2, MDL NA |
| Drug_Names: 3-Thia-9-azabicyclo[3.3.1]nonan-7-one hydrochloride, CAS: 1523572-09-9, stock 684.2g, assay 98.7%, MWt 193.69, Formula C7H12ClNOS, Purity >98%, SMILES Cl.O=C1CC2CSCC(C1)N2, MDL NA |
| Drug_Names: N-Ethyl-1-methylpyrrolidin-3-amine, CAS: 1096325-56-2, stock 100g, assay 98%, MWt 128.22, Formula C7H16N2, Purity >98%, SMILES CCNC1CCN(C)C1, MDL NA |
| Drug_Names: N-Ethyl-1-methylpiperidin-3-amine, CAS: 1248952-99-9, stock 196.9g, assay 98%, MWt 142.24, Formula C8H18N2, Purity >98%, SMILES CCNC1CCCN(C)C1, MDL NA |
| Drug_Names: 3-Phenylcyclobutan-1-amine, CAS: 90874-41-2, stock 595.3g, assay 99%, MWt 147.22, Formula C10H13N, Purity >98%, SMILES NC1CC(C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Phenoxyazetidine, CAS: 76263-18-8, stock 508.5g, assay 98.9%, MWt 149.19, Formula C9H11NO, Purity >98%, SMILES C1NCC1OC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Oxocyclobutyl benzoate, CAS: 1081559-36-5, stock 429.7g, assay 98.8%, MWt 190.20, Formula C11H10O3, Purity >98%, SMILES O=C(OC1CC(=O)C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Oxo-3-(oxolan-3-yl)propanenitrile, CAS: 1186610-03-6, stock 570.8g, assay 98.2%, MWt 139.15, Formula C7H9NO2, Purity >98%, SMILES O=C(CC#N)C1CCOC1, MDL NA |
| Drug_Names: 3-Oxabicyclo[3.2.0]heptane-2,4-dione, CAS: 4462-96-8, stock 595.5g, assay 98.1%, MWt 126.11, Formula C6H6O3, Purity >98%, SMILES O=C1OC(=O)C2CCC12, MDL NA |
| Drug_Names: 3-Oxa-9-azabicyclo[3.3.1]nonane hydrochloride, CAS: 100368-29-4, stock 144.5g, assay 98.7%, MWt 163.65, Formula C7H14ClNO, Purity >98%, SMILES Cl.C1CC2COCC(C1)N2, MDL NA |
| Drug_Names: 3-Oxa-7-azabicyclo[3.3.1]nonan-9-one hydrochloride, CAS: 1228600-54-1, stock 662.1g, assay 98.3%, MWt 177.63, Formula C7H12ClNO2, Purity >98%, SMILES Cl.O=C1C2CNCC1COC2, MDL NA |
| Drug_Names: 3-Oxa-6-azabicyclo[3.1.1]heptane hydrochloride, CAS: 1860028-23-4, stock 765.9g, assay 98.8%, MWt 135.59, Formula C5H10ClNO, Purity >98%, SMILES Cl.C1C2COCC1N2, MDL NA |
| Drug_Names: 3-Oxa-1,9-diazaspiro[5.5]undecan-2-one, CAS: 1389264-24-7, stock 483.8g, assay 98.8%, MWt 170.21, Formula C8H14N2O2, Purity >98%, SMILES O=C1NC2(CCNCC2)CCO1, MDL NA |
| Drug_Names: 3-Nitropicolinonitrile, CAS: 51315-07-2, stock 656.8g, assay 98.5%, MWt 149.11, Formula C6H3N3O2, Purity >98%, SMILES [O-][N+](=O)C1=CC=CN=C1C#N, MDL MFCD06658499 |
| Drug_Names: 3-Nitropyrazolo[1,5-a]pyrimidine, CAS: 55405-64-6, stock 863.3g, assay 98.3%, MWt 164.12, Formula C6H4N4O2, Purity >98%, SMILES [O-][N+](=O)C1=C2N=CC=CN2N=C1, MDL NA |
| Drug_Names: 3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine, CAS: 148777-84-8, stock 85.2g, assay 98.5%, MWt 168.15, Formula C6H8N4O2, Purity >98%, SMILES [O-][N+](=O)C1=C2NCCCN2N=C1, MDL NA |
| Drug_Names: 3-Methylthietan-3-ol, CAS: 27832-57-1, stock 406.3g, assay 98.8%, MWt 104.17, Formula C4H8OS, Purity >98%, SMILES CC1(O)CSC1, MDL NA |
| Drug_Names: 3-Cyano-3-methylpyrrolidine hydrochloride, CAS: 1205750-61-3, stock 204.1g, assay 98.1%, MWt 146.62, Formula C6H11ClN2, Purity >98%, SMILES Cl.CC1(CCNC1)C#N, MDL NA |
| Drug_Names: 3-Methylpiperidine-3-carboxylic acid hydrochloride, CAS: 116140-22-8, stock 288.2g, assay 98.9%, MWt 179.64, Formula C7H14ClNO2, Purity >98%, SMILES Cl.CC1(CCCNC1)C(O)=O, MDL NA |
| Drug_Names: 3-Methylpiperidine-3-carboxylic acid, CAS: 116140-49-9, stock 68.8g, assay 98.6%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CC1(CCCNC1)C(O)=O, MDL NA |
| Drug_Names: 3-Methylpiperidin-4-ol hydrochloride, CAS: 1185293-84-8, stock 170.5g, assay 98.4%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CC1CNCCC1O, MDL NA |
| Drug_Names: 3-Methylpiperidin-3-ol, CAS: 473730-88-0, stock 63g, assay 98.4%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CC1(O)CCCNC1, MDL NA |
| Drug_Names: 3-Methyltetrahydrofuran-3-carboxylic acid, CAS: 1158760-45-2, stock 534.1g, assay 98.3%, MWt 130.14, Formula C6H10O3, Purity >98%, SMILES CC1(CCOC1)C(O)=O, MDL NA |
| Drug_Names: 3-Methyltetrahydrofuran-3-amine, CAS: 1158760-25-8, stock 438.8g, assay 98.3%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES CC1(N)CCOC1, MDL NA |
| Drug_Names: 3-Methyloxetane-3-carbonitrile, CAS: 170128-14-0, stock 492.7g, assay 98.7%, MWt 97.12, Formula C5H7NO, Purity >98%, SMILES CC1(COC1)C#N, MDL NA |
| Drug_Names: 3-Methylbicyclo[1.1.1]pentane-1-carboxylic acid, CAS: 65862-01-3, stock 245.4g, assay 98.3%, MWt 126.15, Formula C7H10O2, Purity >98%, SMILES CC12CC(C1)(C2)C(O)=O, MDL NA |
| Drug_Names: 3-Methylbicyclo[1.1.1]pentan-1-amine hydrochloride, CAS: 796963-34-3, stock 247.1g, assay 98.9%, MWt 133.62, Formula C6H12ClN, Purity >98%, SMILES Cl.CC12CC(N)(C1)C2, MDL NA |
| Drug_Names: 3-Methylazetidin-3-amine dihydrochloride, CAS: 124668-47-9, stock 201.6g, assay 98.4%, MWt 159.06, Formula C4H12Cl2N2, Purity >98%, SMILES Cl.Cl.CC1(N)CNC1, MDL NA |
| Drug_Names: 3-Methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, CAS: 1300582-52-8, stock 88.8g, assay 98.9%, MWt 257.14, Formula C15H20BNO2, Purity >98%, SMILES CC1=CNC2=C1C=CC(=C2)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 3-Methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, CAS: 1227911-51-4, stock 123.6g, assay 99%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CC1=NNC2=C1C=CC(=C2)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 3-Methyl-5-nitro-1H-pyrrolo[2,3-b]pyridine, CAS: 1288998-66-2, stock 644.5g, assay 98.4%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES CC1=CNC2=NC=C(C=C12)[N+]([O-])=O, MDL NA |
| Drug_Names: 3-Methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine, CAS: 1111637-76-3, stock 486.2g, assay 98.7%, MWt 259.11, Formula C13H18BN3O2, Purity >98%, SMILES CC1=NNC2=NC=C(C=C12)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 3-Methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, CAS: 851524-90-8, stock 47.2g, assay 98.7%, MWt 257.14, Formula C15H20BNO2, Purity >98%, SMILES CC1=CNC2=C1C=C(C=C2)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 3-Methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, CAS: 864771-17-5, stock 857.3g, assay 98.4%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CC1=NNC2=C1C=C(C=C2)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 3-Methyl-4-nitro-1H-pyrrolo[2,3-b]pyridine, CAS: 1363380-52-2, stock 107.9g, assay 98.8%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES CC1=CNC2=NC=CC(=C12)[N+]([O-])=O, MDL NA |
| Drug_Names: 3-Methyl-3-azabicyclo[3.1.1]heptan-6-amine dihydrochloride, CAS: 2089649-12-5, stock 168.8g, assay 98.1%, MWt 199.12, Formula C7H16Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CC2CC(C1)C2N, MDL NA |
| Drug_Names: 3-Methyl-3-azabicyclo[3.1.0]hexan-1-amine dihydrochloride, CAS: 489438-94-0, stock 457.4g, assay 98.5%, MWt 185.09, Formula C6H14Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CC2CC2(N)C1, MDL NA |
| Drug_Names: 3-Methyl-3,8-diazabicyclo[3.2.1]octane dihydrochloride, CAS: 52407-92-8, stock 790.9g, assay 98.5%, MWt 199.12, Formula C7H16Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CC2CCC(C1)N2, MDL NA |
| Drug_Names: 3-Methyl-3,6-diazabicyclo[3.2.0]heptane bis(trifluoroacetic acid), CAS: 2007909-47-7, stock 689.1g, assay 98.1%, MWt 340.22, Formula C10H14F6N2O4, Purity >98%, SMILES OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CN1CC2CNC2C1, MDL NA |
| Drug_Names: 3-Methyl-3,6-diazabicyclo[3.1.1]heptane bis(trifluoroacetic acid), CAS: 1059700-17-2, stock 627.2g, assay 98.5%, MWt 340.22, Formula C10H14F6N2O4, Purity >98%, SMILES OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CN1CC2CC(C1)N2, MDL NA |
| Drug_Names: 3-Methyl-3,6-diazabicyclo[3.1.1]heptane dihydrochloride, CAS: 2089649-86-3, stock 0.7g, assay 98.6%, MWt 185.09, Formula C6H14Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CC2CC(C1)N2, MDL NA |
| Drug_Names: 3-Methyl-2-sulfanylidene-1,3-thiazolidin-4-one, CAS: 4807-55-0, stock 86.6g, assay 98.5%, MWt 147.22, Formula C4H5NOS2, Purity >98%, SMILES CN1C(=O)CSC1=S, MDL NA |
| Drug_Names: 3-Methyl-2-nitropyridine, CAS: 18368-73-5, stock 176.3g, assay 98%, MWt 138.12, Formula C6H6N2O2, Purity >98%, SMILES O=[N+](C1=NC=CC=C1C)[O-], MDL MFCD00971950 |
| Drug_Names: 3-Methyl-1H-pyrrolo[3,2-c]pyridine, CAS: 22930-75-2, stock 292.8g, assay 98.6%, MWt 132.16, Formula C8H8N2, Purity >98%, SMILES CC1=CNC2=C1C=NC=C2, MDL NA |
| Drug_Names: 3-Methyl-1H-pyrrolo[2,3-b]pyridin-5-amine, CAS: 1289082-81-0, stock 766.9g, assay 98.8%, MWt 147.18, Formula C8H9N3, Purity >98%, SMILES CC1=CNC2=NC=C(N)C=C12, MDL NA |
| Drug_Names: 3-Methyl-1H-pyrazolo[4,3-c]pyridine, CAS: 120422-91-5, stock 282g, assay 98.6%, MWt 133.15, Formula C7H7N3, Purity >98%, SMILES CC1=NNC2=CC=NC=C12, MDL NA |
| Drug_Names: 3-Methyl-1H-pyrazolo[3,4-b]pyrazine, CAS: 1131041-58-1, stock 293.8g, assay 98.7%, MWt 134.14, Formula C6H6N4, Purity >98%, SMILES CC1=NNC2=C1N=CC=N2, MDL NA |
| Drug_Names: 3-Methyl-1H-indol-6-ol, CAS: 1125-89-9, stock 255.7g, assay 98.3%, MWt 147.17, Formula C9H9NO, Purity >98%, SMILES CC1=CNC2=C1C=CC(O)=C2, MDL NA |
| Drug_Names: 3-Methyl-1H-indol-6-amine, CAS: 83696-97-3, stock 537.1g, assay 98.2%, MWt 146.19, Formula C9H10N2, Purity >98%, SMILES CC1=CNC2=C1C=CC(N)=C2, MDL NA |
| Drug_Names: 3-Methyl-1H-indol-4-amine, CAS: 873056-75-8, stock 367.5g, assay 98.6%, MWt 146.19, Formula C9H10N2, Purity >98%, SMILES CC1=CNC2=C1C(N)=CC=C2, MDL NA |
| Drug_Names: 3-Methyl-1H-indazole-7-carboxylic acid, CAS: 1555382-87-0, stock 704.1g, assay 98.5%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CC1=NNC2=C1C=CC=C2C(O)=O, MDL NA |
| Drug_Names: 3-Methyl-1H-indazole-7-carbonitrile, CAS: 1554584-26-7, stock 546.1g, assay 98.6%, MWt 157.17, Formula C9H7N3, Purity >98%, SMILES CC1=NNC2=C1C=CC=C2C#N, MDL NA |
| Drug_Names: 3-Methyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole hydrochloride, CAS: 1389264-31-6, stock 336.2g, assay 98.9%, MWt 159.62, Formula C6H10ClN3, Purity >98%, SMILES CC1=NNC2=C1CNC2.[H]Cl, MDL NA |
| Drug_Names: 3-Methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine dihydrochloride, CAS: 157327-46-3, stock 547.1g, assay 98.8%, MWt 210.10, Formula C7H13Cl2N3, Purity >98%, SMILES Cl.Cl.CC1=NNC2=C1CNCC2, MDL NA |
| Drug_Names: 3-Methyl-1H,2H,3H-pyrrolo[2,3-b]pyridin-2-one, CAS: 1330055-85-0, stock 587.6g, assay 98.8%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES CC1C(=O)NC2=NC=CC=C12, MDL NA |
| Drug_Names: 3-Methyl-1,2,3,4-tetrahydroquinoxalin-2-one, CAS: 34070-68-3, stock 34.3g, assay 99%, MWt 162.19, Formula C9H10N2O, Purity >98%, SMILES CC1NC2=CC=CC=C2NC1=O, MDL NA |
| Drug_Names: 3-Methoxypiperidine, CAS: 4045-29-8, stock 110.2g, assay 98.8%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES COC1CCCNC1, MDL NA |
| Drug_Names: 3-Methoxyoxan-4-one, CAS: 624734-17-4, stock 735.4g, assay 99%, MWt 130.14, Formula C6H10O3, Purity >98%, SMILES COC1COCCC1=O, MDL NA |
| Drug_Names: 3-Methoxycyclohexan-1-ol, CAS: 89794-53-6, stock 516.1g, assay 98.3%, MWt 130.18, Formula C7H14O2, Purity >98%, SMILES COC1CCCC(O)C1, MDL NA |
| Drug_Names: 3-Methoxycyclobutane-1-carboxylic acid, CAS: 480450-03-1, stock 555.9g, assay 98.8%, MWt 130.14, Formula C6H10O3, Purity >98%, SMILES COC1CC(C1)C(O)=O, MDL NA |
| Drug_Names: 3-Methoxycyclobutan-1-amine hydrochloride, CAS: 1404373-83-6, stock 774.6g, assay 98.4%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.COC1CC(N)C1, MDL NA |
| Drug_Names: 3-Methoxyazetidine-3-carboxylic acid hydrochloride, CAS: 1392804-40-8, stock 350.4g, assay 98%, MWt 167.59, Formula C5H10ClNO3, Purity >98%, SMILES Cl.COC1(CNC1)C(O)=O, MDL NA |
| Drug_Names: 3-Methoxy-1H-pyrazolo[3,4-b]pyridin-5-amine, CAS: 1186609-65-3, stock 677.1g, assay 98.3%, MWt 164.16, Formula C7H8N4O, Purity >98%, SMILES COC1=NNC2=NC=C(N)C=C12, MDL NA |
| Drug_Names: 3-Methoxy-1H-indazol-6-amine, CAS: 1056619-82-9, stock 77.4g, assay 98.3%, MWt 163.18, Formula C8H9N3O, Purity >98%, SMILES COC1=NNC2=CC(N)=CC=C12, MDL NA |
| Drug_Names: 3-Methoxy-1H-indazol-5-amine, CAS: 1368181-72-9, stock 357.2g, assay 98.6%, MWt 163.18, Formula C8H9N3O, Purity >98%, SMILES COC1=NNC2=CC=C(N)C=C12, MDL NA |
| Drug_Names: 3-Methanesulfonylpyrrolidine hydrochloride, CAS: 1215368-15-2, stock 439.7g, assay 98.9%, MWt 185.67, Formula C5H12ClNO2S, Purity >98%, SMILES Cl.CS(=O)(=O)C1CCNC1, MDL NA |
| Drug_Names: 3-Methanesulfonylpyrrolidine, CAS: 433980-62-2, stock 615.3g, assay 98.5%, MWt 149.21, Formula C5H11NO2S, Purity >98%, SMILES CS(=O)(=O)C1CCNC1, MDL NA |
| Drug_Names: 3-Methanesulfonyl-1H-indole, CAS: 582321-06-0, stock 291.4g, assay 98.4%, MWt 195.24, Formula C9H9NO2S, Purity >98%, SMILES CS(=O)(=O)C1=CNC2=C1C=CC=C2, MDL NA |
| Drug_Names: Ethyl 6-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride, CAS: 128073-39-2, stock 320.6g, assay 98.1%, MWt 257.71, Formula C12H16ClNO3, Purity >98%, SMILES Cl.CCOC(=O)C1CC2=CC(O)=CC=C2CN1, MDL NA |
| Drug_Names: 3-Iodo-7-(trifluoromethyl)-1H-indazole, CAS: 1892533-73-1, stock 236.8g, assay 98.7%, MWt 312.03, Formula C8H4F3IN2, Purity >98%, SMILES FC(F)(F)C1=CC=CC2=C1NN=C2I, MDL NA |
| Drug_Names: 3-Iodo-6-nitro-1H-indole, CAS: 1360963-23-0, stock 796.3g, assay 98.6%, MWt 288.04, Formula C8H5IN2O2, Purity >98%, SMILES O=[N+](C1=CC2=C(C=C1)C(I)=CN2)[O-], MDL NA |
| Drug_Names: 3-Iodo-6-methylpyridazine, CAS: 1618-47-9, stock 732.2g, assay 98.9%, MWt 220.01, Formula C5H5IN2, Purity >98%, SMILES CC1=NN=C(I)C=C1, MDL NA |
| Drug_Names: 3-Iodo-5-methyl-1H-pyrazolo[3,4-b]pyridine, CAS: 1630907-17-3, stock 475.9g, assay 98.9%, MWt 259.05, Formula C7H6IN3, Purity >98%, SMILES CC1=CC2=C(NN=C2I)N=C1, MDL NA |
| Drug_Names: 3-Iodo-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine, CAS: 1142192-57-1, stock 648.9g, assay 98.5%, MWt 312.03, Formula C8H4F3IN2, Purity >98%, SMILES FC(F)(F)C1=CN=C2NC=C(I)C2=C1, MDL NA |
| Drug_Names: 3-Iodo-4-nitro-1H-pyrrolo[2,3-b]pyridine, CAS: 1000340-40-8, stock 229.7g, assay 98.1%, MWt 289.03, Formula C7H4IN3O2, Purity >98%, SMILES [O-][N+](=O)C1=C2C(I)=CNC2=NC=C1, MDL NA |
| Drug_Names: 3-Iodo-4-nitro-1H-indazole, CAS: 885521-22-2, stock 580g, assay 98.1%, MWt 289.03, Formula C7H4IN3O2, Purity >98%, SMILES [O-][N+](=O)C1=C2C(I)=NNC2=CC=C1, MDL NA |
| Drug_Names: 3-Iodo-4-methoxy-1H-pyrrolo[2,3-b]pyridine, CAS: 928653-75-2, stock 320.8g, assay 98.9%, MWt 274.06, Formula C8H7IN2O, Purity >98%, SMILES COC1=C2C(I)=CNC2=NC=C1, MDL NA |
| Drug_Names: 3-Iodo-2-methyl-6-nitro-2H-indazole, CAS: 2007921-28-8, stock 783.6g, assay 98.7%, MWt 303.06, Formula C8H6IN3O2, Purity >98%, SMILES CN1N=C2C=C(C=CC2=C1I)[N+]([O-])=O, MDL NA |
| Drug_Names: 3-Iodo-2-methyl-1H-pyrrolo[2,3-b]pyridine, CAS: 1256964-50-7, stock 86.7g, assay 98.1%, MWt 258.06, Formula C8H7IN2, Purity >98%, SMILES CC1=C(I)C2=CC=CN=C2N1, MDL NA |
| Drug_Names: 3-Iodo-2-methoxypyridin-4-amine, CAS: 1190198-21-0, stock 684.2g, assay 98.1%, MWt 250.04, Formula C6H7IN2O, Purity >98%, SMILES COC1=NC=CC(N)=C1I, MDL NA |
| Drug_Names: 3-Iodo-1-methyl-1H-pyrazolo[4,3-b]pyridine, CAS: 1354954-40-7, stock 808.2g, assay 98.5%, MWt 259.05, Formula C7H6IN3, Purity >98%, SMILES CN1N=C(I)C2=C1C=CC=N2, MDL NA |
| Drug_Names: 3-Iodo-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, CAS: 862729-12-2, stock 191.4g, assay 98%, MWt 275.05, Formula C6H6IN5, Purity >98%, SMILES CN1N=C(I)C2=C(N)N=CN=C12, MDL NA |
| Drug_Names: 3-Iodo-1-methyl-1H-pyrazolo[3,4-b]pyridine, CAS: 685522-76-3, stock 641.4g, assay 98.2%, MWt 259.05, Formula C7H6IN3, Purity >98%, SMILES CN1N=C(I)C2=C1N=CC=C2, MDL NA |
| Drug_Names: 3-Iodo-1-methyl-1H-indazole, CAS: 52088-10-5, stock 830.4g, assay 98.3%, MWt 258.06, Formula C8H7IN2, Purity >98%, SMILES CN1N=C(I)C2=C1C=CC=C2, MDL MFCD09971239 |
| Drug_Names: 3-Iodo-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid, CAS: 1221288-26-1, stock 158.6g, assay 98.1%, MWt 289.03, Formula C7H4IN3O2, Purity >98%, SMILES OC(=O)C1=CN=C2NN=C(I)C2=C1, MDL NA |
| Drug_Names: 3-Iodo-1h-indole-7-carboxylic acid, CAS: 1360953-77-0, stock 803.6g, assay 98.7%, MWt 287.05, Formula C9H6INO2, Purity >98%, SMILES OC(=O)C1=CC=CC2=C1NC=C2I, MDL NA |
| Drug_Names: 3-Iodo-1H-indole-6-carbonitrile, CAS: 1696315-42-0, stock 64.4g, assay 98.7%, MWt 268.05, Formula C9H5IN2, Purity >98%, SMILES IC1=CNC2=C1C=CC(=C2)C#N, MDL NA |
| Drug_Names: 3-Iodo-1H-indazole-5-carbaldehyde, CAS: 944899-01-8, stock 324.7g, assay 98.8%, MWt 272.04, Formula C8H5IN2O, Purity >98%, SMILES [H]C(=O)C1=CC=C2NN=C(I)C2=C1, MDL NA |
| Drug_Names: 3-Iodo-1H-indazol-6-amine, CAS: 885519-20-0, stock 224.8g, assay 98.9%, MWt 259.05, Formula C7H6IN3, Purity >98%, SMILES NC1=CC2=C(C=C1)C(I)=NN2, MDL NA |
| Drug_Names: 3-Iodo-1H-indazol-5-amine, CAS: 599183-36-5, stock 204.8g, assay 98.4%, MWt 259.05, Formula C7H6IN3, Purity >98%, SMILES NC1=CC2=C(NN=C2I)C=C1, MDL NA |
| Drug_Names: 3-Iodo-1H-indazol-4-amine, CAS: 885521-28-8, stock 344.2g, assay 98.7%, MWt 259.05, Formula C7H6IN3, Purity >98%, SMILES NC1=CC=CC2=C1C(I)=NN2, MDL NA |
| Drug_Names: 3-Iodo-1H,4H,5H,6H-cyclopenta[c]pyrazole, CAS: 1426424-00-1, stock 217.5g, assay 98.7%, MWt 234.04, Formula C6H7IN2, Purity >98%, SMILES IC1=NNC2=C1CCC2, MDL NA |
| Drug_Names: 3-Iodo-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[3,2-c]pyridine, CAS: 882562-73-4, stock 644.6g, assay 98.3%, MWt 398.22, Formula C14H11IN2O2S, Purity >98%, SMILES CC1=CC=C(C=C1)S(=O)(=O)N1C=C(I)C2=C1C=CN=C2, MDL NA |
| Drug_Names: 3-Hydroxyoxetane-3-carboxylic acid, CAS: 1450997-88-2, stock 77.5g, assay 98.1%, MWt 118.09, Formula C4H6O4, Purity >98%, SMILES OC(=O)C1(O)COC1, MDL NA |
| Drug_Names: 3-Hydroxycyclohexan-1-one, CAS: 823-19-8, stock 140.2g, assay 98.8%, MWt 114.14, Formula C6H10O2, Purity >98%, SMILES OC1CCCC(=O)C1, MDL NA |
| Drug_Names: 3-Hydroxycyclobutane-1-carbonitrile, CAS: 20249-17-6, stock 331.9g, assay 98.1%, MWt 97.12, Formula C5H7NO, Purity >98%, SMILES OC1CC(C1)C#N, MDL NA |
| Drug_Names: 3-Hydroxybicyclo[1.1.1]pentane-1-carboxylic acid, CAS: 83249-08-5, stock 646.4g, assay 98.3%, MWt 128.13, Formula C6H8O3, Purity >98%, SMILES OC(=O)C12CC(O)(C1)C2, MDL NA |
| Drug_Names: 3-Hydroxyazetidine-3-carboxylic acid, CAS: 70807-37-3, stock 513.1g, assay 98.3%, MWt 117.10, Formula C4H7NO3, Purity >98%, SMILES OC(=O)C1(O)CNC1, MDL NA |
| Drug_Names: 3-Hydroxy-3-phenylcyclobutane-1-carboxylic acid, CAS: 23761-26-4, stock 459.9g, assay 98.7%, MWt 192.21, Formula C11H12O3, Purity >98%, SMILES OC(=O)C1CC(O)(C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Hydroxy-2-iodocyclohex-2-en-1-one, CAS: 642088-17-3, stock 422.5g, assay 98.5%, MWt 238.02, Formula C6H7IO2, Purity >98%, SMILES OC1=C(I)C(=O)CCC1, MDL NA |
| Drug_Names: 3-Hydroxythietane-1,1-dioxide, CAS: 22524-35-2, stock 179.8g, assay 98.1%, MWt 122.14, Formula C3H6O3S, Purity >98%, SMILES OC1CS(=O)(=O)C1, MDL NA |
| Drug_Names: 3-Hydroxy-1',2'-dihydrospiro[cyclobutane-1,3'-pyrrolo[2,3-b]pyridine]-2'-one, CAS: 1860028-21-2, stock 878.6g, assay 98.2%, MWt 190.20, Formula C10H10N2O2, Purity >98%, SMILES OC1CC2(C1)C(=O)NC1=C2C=CC=N1, MDL NA |
| Drug_Names: 3H-Imidazo[4,5-c]pyridine-7-carboxylic acid, CAS: 1234616-39-7, stock 561g, assay 98%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=C2N=CNC2=CN=C1, MDL NA |
| Drug_Names: 3H-Imidazo[4,5-b]pyridine-7-carboxylic acid, CAS: 78316-08-2, stock 188.9g, assay 98.4%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=C2N=CNC2=NC=C1, MDL NA |
| Drug_Names: 3H-Imidazo[4,5-b]pyridine-7-carbonitrile, CAS: 78316-13-9, stock 823.3g, assay 98.6%, MWt 144.13, Formula C7H4N4, Purity >98%, SMILES N#CC1=C2N=CNC2=NC=C1, MDL NA |
| Drug_Names: Pyrido[4,3-d]pyrimidin-4(3H)-one, CAS: 16952-64-0, stock 98.2g, assay 98.1%, MWt 147.13, Formula C7H5N3O, Purity >98%, SMILES O=C1NC=NC2=C1C=NC=C2, MDL NA |
| Drug_Names: 3H,4H-Imidazo[4,3-f][1,2,4]triazin-4-one, CAS: 865444-76-4, stock 4.7g, assay 98.9%, MWt 136.11, Formula C5H4N4O, Purity >98%, SMILES O=C1NC=NN2C=NC=C12, MDL NA |
| Drug_Names: Imidazo[2,1-f][1,2,4]triazin-4(3H)-one, CAS: 1206825-06-0, stock 745.9g, assay 98.6%, MWt 136.11, Formula C5H4N4O, Purity >98%, SMILES O=C1NC=NN2C=CN=C12, MDL NA |
| Drug_Names: 3-Fluoropyrrolidine-3-carboxylic acid, CAS: 1228634-93-2, stock 793.8g, assay 98.4%, MWt 133.12, Formula C5H8FNO2, Purity >98%, SMILES OC(=O)C1(F)CCNC1, MDL NA |
| Drug_Names: 3-Fluorooxane-4,4-diol, CAS: 1523571-11-0, stock 254.3g, assay 98.4%, MWt 136.12, Formula C5H9FO3, Purity >98%, SMILES OC1(O)CCOCC1F, MDL NA |
| Drug_Names: 3-Fluorooxan-4-one, CAS: 624734-19-6, stock 448.9g, assay 98.8%, MWt 118.11, Formula C5H7FO2, Purity >98%, SMILES FC1COCCC1=O, MDL NA |
| Drug_Names: 3-Fluorotetrahydro-2H-pyran-4-ol, CAS: 1481690-51-0, stock 695.7g, assay 98.9%, MWt 120.12, Formula C5H9FO2, Purity >98%, SMILES OC1CCOCC1F, MDL NA |
| Drug_Names: 3-Fluorobicyclo[1.1.1]pentan-1-amine hydrochloride, CAS: 1826900-79-1, stock 858.4g, assay 98.4%, MWt 137.58, Formula C5H9ClFN, Purity >98%, SMILES Cl.NC12CC(F)(C1)C2, MDL NA |
| Drug_Names: 3-Fluoro-5-methylpyridine-2-carboxylic acid, CAS: 1256807-03-0, stock 582.9g, assay 98.3%, MWt 155.13, Formula C7H6FNO2, Purity >98%, SMILES CC1=CN=C(C(O)=O)C(F)=C1, MDL NA |
| Drug_Names: 3-Fluoro-5-hydroxy-1,4-dihydropyridin-4-one, CAS: 1184172-13-1, stock 78g, assay 98.4%, MWt 129.09, Formula C5H4FNO2, Purity >98%, SMILES OC1=CNC=C(F)C1=O, MDL NA |
| Drug_Names: 3-Fluoro-4-(2H-1,2,3,4-tetrazol-5-yl)aniline, CAS: 1171930-26-9, stock 662g, assay 98.3%, MWt 179.15, Formula C7H6FN5, Purity >98%, SMILES NC1=CC(F)=C(C=C1)C1=NNN=N1, MDL NA |
| Drug_Names: 3-Fluoro-3-methylpyrrolidine hydrochloride, CAS: 1427380-91-3, stock 227.4g, assay 98.1%, MWt 139.60, Formula C5H11ClFN, Purity >98%, SMILES Cl.CC1(F)CCNC1, MDL NA |
| Drug_Names: 3-Fluoro-3-methylcyclobutan-1-amine hydrochloride, CAS: 1638768-85-0, stock 242.1g, assay 98.3%, MWt 139.60, Formula C5H11ClFN, Purity >98%, SMILES Cl.CC1(F)CC(N)C1, MDL NA |
| Drug_Names: 3-Fluoro-3-methylazetidine hydrochloride, CAS: 1427379-42-7, stock 309.4g, assay 98%, MWt 125.57, Formula C4H9ClFN, Purity >98%, SMILES Cl.CC1(F)CNC1, MDL NA |
| Drug_Names: 3-Fluoro-3-(methoxymethyl)azetidine 2,2,2-trifluoroacetate, CAS: 2007909-01-3, stock 762.7g, assay 98.7%, MWt 233.16, Formula C7H11F4NO3, Purity >98%, SMILES OC(=O)C(F)(F)F.COCC1(F)CNC1, MDL NA |
| Drug_Names: 3-Fluoro-3-(iodomethyl)oxetane, CAS: 1363381-23-0, stock 460.3g, assay 98.2%, MWt 215.99, Formula C4H6FIO, Purity >98%, SMILES FC1(CI)COC1, MDL NA |
| Drug_Names: 3-Fluoro-2-(trifluoromethyl)pyridine-4-carboxylic acid, CAS: 886510-09-4, stock 497g, assay 98.9%, MWt 209.10, Formula C7H3F4NO2, Purity >98%, SMILES OC(=O)C1=C(F)C(=NC=C1)C(F)(F)F, MDL NA |
| Drug_Names: 3-Fluoro-2-(trifluoromethyl)pyridine, CAS: 886510-21-0, stock 874.3g, assay 98.8%, MWt 165.09, Formula C6H3F4N, Purity >98%, SMILES FC1=CC=CN=C1C(F)(F)F, MDL NA |
| Drug_Names: 3-Fluoro-1-[tris(propan-2-yl)silyl]-1H-pyrrole, CAS: 156304-02-8, stock 145.5g, assay 98.1%, MWt 241.42, Formula C13H24FNSi, Purity >98%, SMILES CC(C)[Si](C(C)C)(C(C)C)N1C=CC(F)=C1, MDL NA |
| Drug_Names: 3-Ethynylpyridazine, CAS: 1017793-08-6, stock 774.4g, assay 98.4%, MWt 104.11, Formula C6H4N2, Purity >98%, SMILES C#CC1=NN=CC=C1, MDL NA |
| Drug_Names: 3-Ethynyltetrahydrofuran-3-ol, CAS: 137344-86-6, stock 598.2g, assay 98.9%, MWt 112.13, Formula C6H8O2, Purity >98%, SMILES OC1(CCOC1)C#C, MDL NA |
| Drug_Names: 3-Ethynyloxetan-3-ol, CAS: 1352492-38-6, stock 669.7g, assay 98.4%, MWt 98.10, Formula C5H6O2, Purity >98%, SMILES OC1(COC1)C#C, MDL NA |
| Drug_Names: 3-Ethynylazetidin-3-ol 2,2,2-trifluoroacetate, CAS: 1408076-23-2, stock 42.7g, assay 98.7%, MWt 211.14, Formula C7H8F3NO3, Purity >98%, SMILES OC1(C#C)CNC1.OC(C(F)(F)F)=O, MDL NA |
| Drug_Names: 3-Ethynyl-5-fluoropyridin-2-amine, CAS: 936344-74-0, stock 109.2g, assay 98.2%, MWt 136.13, Formula C7H5FN2, Purity >98%, SMILES NC1=NC=C(F)C=C1C#C, MDL NA |
| Drug_Names: 3-Ethyloxetane-3-carboxylic acid, CAS: 28562-61-0, stock 487.6g, assay 98.4%, MWt 130.14, Formula C6H10O3, Purity >98%, SMILES CCC1(COC1)C(O)=O, MDL NA |
| Drug_Names: 3-Ethyloxetane-3-carbonitrile, CAS: 1414513-71-5, stock 824.4g, assay 98.9%, MWt 111.14, Formula C6H9NO, Purity >98%, SMILES CCC1(COC1)C#N, MDL NA |
| Drug_Names: 3-Ethylazetidin-3-ol hydrochloride, CAS: 935668-00-1, stock 202.7g, assay 98.7%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.CCC1(O)CNC1, MDL NA |
| Drug_Names: 3-Ethyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 791777-96-3, stock 556.5g, assay 98%, MWt 152.20, Formula C7H12N4, Purity >98%, SMILES CCC1=NN=C2CNCCN12, MDL NA |
| Drug_Names: 3-Ethyl-1-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1619991-78-4, stock 8g, assay 98.7%, MWt 236.12, Formula C12H21BN2O2, Purity >98%, SMILES CCC1=NN(C)C=C1B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 3-Ethoxyazetidine-3-carboxylic acid hydrochloride, CAS: 1523618-24-7, stock 6.4g, assay 98.3%, MWt 181.62, Formula C6H12ClNO3, Purity >98%, SMILES Cl.CCOC1(CNC1)C(O)=O, MDL NA |
| Drug_Names: 3-Cyclopropylprop-2-yn-1-ol, CAS: 101974-69-0, stock 51.9g, assay 98.3%, MWt 96.13, Formula C6H8O, Purity >98%, SMILES OCC#CC1CC1, MDL NA |
| Drug_Names: 3-Cyclopropylcyclobutan-1-one, CAS: 83961-08-4, stock 666.6g, assay 98.7%, MWt 110.15, Formula C7H10O, Purity >98%, SMILES O=C1CC(C1)C1CC1, MDL NA |
| Drug_Names: 3-Cyclopropylazetidin-3-ol hydrochloride, CAS: 848192-93-8, stock 632.9g, assay 98.1%, MWt 149.62, Formula C6H12ClNO, Purity >98%, SMILES Cl.OC1(CNC1)C1CC1, MDL NA |
| Drug_Names: 3-Cyclopropyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 945262-32-8, stock 213.5g, assay 98.7%, MWt 164.21, Formula C8H12N4, Purity >98%, SMILES C1CC1C1=NN=C2CNCCN12, MDL NA |
| Drug_Names: 3-Cyclopentylpropan-1-amine hydrochloride, CAS: 1193387-79-9, stock 305.5g, assay 98.9%, MWt 163.69, Formula C8H18ClN, Purity >98%, SMILES Cl.NCCCC1CCCC1, MDL NA |
| Drug_Names: methyl (S)-cyclohex-3-ene-1-carboxylate, CAS: 68000-21-5, stock 564.4g, assay 98.4%, MWt 140.18, Formula C8H12O2, Purity >98%, SMILES COC(=O)[C@H]1CCC=CC1, MDL NA |
| Drug_Names: methyl (1R,6R)-6-((tert-butoxycarbonyl)amino)cyclohex-3-ene-1-carboxylate, CAS: 323196-39-0, stock 740.8g, assay 98.2%, MWt 255.31, Formula C13H21NO4, Purity >98%, SMILES COC(=O)[C@@H]1CC=CC[C@H]1NC(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 3-Cyclobutyl-1-methyl-1H-pyrazol-5-amine, CAS: 92406-41-2, stock 262g, assay 98.9%, MWt 151.21, Formula C8H13N3, Purity >98%, SMILES CN1N=C(C=C1N)C1CCC1, MDL NA |
| Drug_Names: 3-Cyano-1H-indole-5-carboxylic acid, CAS: 889942-87-4, stock 137.1g, assay 98.1%, MWt 186.17, Formula C10H6N2O2, Purity >98%, SMILES OC(=O)C1=CC2=C(NC=C2C#N)C=C1, MDL NA |
| Drug_Names: 3-Cyano-1H-indole-7-carboxylic acid, CAS: 443144-25-0, stock 450.9g, assay 98.5%, MWt 186.17, Formula C10H6N2O2, Purity >98%, SMILES OC(=O)C1=CC=CC2=C1NC=C2C#N, MDL NA |
| Drug_Names: 3-Chloropyridazine hydrochloride, CAS: 856847-77-3, stock 307.3g, assay 98.2%, MWt 150.99, Formula C4H4Cl2N2, Purity >98%, SMILES ClC1=NN=CC=C1.[H]Cl, MDL NA |
| Drug_Names: 3-Chloropyrazine-2-carbaldehyde, CAS: 121246-96-6, stock 511.6g, assay 99%, MWt 142.54, Formula C5H3ClN2O, Purity >98%, SMILES ClC1=NC=CN=C1C=O, MDL MFCD07371660 |
| Drug_Names: 3-Chloroisoquinolin-5-amine, CAS: 58142-49-7, stock 713.7g, assay 98.5%, MWt 178.62, Formula C9H7ClN2, Purity >98%, SMILES NC1=C2C=C(Cl)N=CC2=CC=C1, MDL NA |
| Drug_Names: 3-Chloroazetidine hydrochloride, CAS: 313468-63-2, stock 230.1g, assay 98.2%, MWt 128.00, Formula C3H7Cl2N, Purity >98%, SMILES Cl.ClC1CNC1, MDL NA |
| Drug_Names: 3-Chloro-6-fluoro-1H-indazole, CAS: 1243360-12-4, stock 822.7g, assay 98.1%, MWt 170.57, Formula C7H4ClFN2, Purity >98%, SMILES FC1=CC2=C(C=C1)C(Cl)=NN2, MDL NA |
| Drug_Names: 3-Chloro-5-nitropyridin-4-amine, CAS: 89284-28-6, stock 339.1g, assay 98.2%, MWt 173.56, Formula C5H4ClN3O2, Purity >98%, SMILES NC1=C(Cl)C=NC=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 3-Chloro-5-iodopyrazin-2-amine, CAS: 1252597-70-8, stock 822.2g, assay 98.5%, MWt 255.44, Formula C4H3ClIN3, Purity >98%, SMILES NC1=NC=C(I)N=C1Cl, MDL NA |
| Drug_Names: 3-Chloro-5-iodo-1-methyl-1,2-dihydropyridin-2-one, CAS: 832735-68-9, stock 357.5g, assay 98.9%, MWt 269.47, Formula C6H5ClINO, Purity >98%, SMILES CN1C=C(I)C=C(Cl)C1=O, MDL NA |
| Drug_Names: 3-Chloro-5-(trifluoromethyl)pyridazine, CAS: 845617-99-4, stock 515.5g, assay 98.2%, MWt 182.53, Formula C5H2ClF3N2, Purity >98%, SMILES FC(F)(F)C1=CN=NC(Cl)=C1, MDL NA |
| Drug_Names: 3-Chloro-4-nitro-1H-pyrazole, CAS: 35852-75-6, stock 602.7g, assay 98.1%, MWt 147.52, Formula C3H2ClN3O2, Purity >98%, SMILES O=[N+](C1=CNN=C1Cl)[O-], MDL NA |
| Drug_Names: 3-Chloro-4-nitro-1H-indole, CAS: 208511-07-3, stock 473.2g, assay 98.9%, MWt 196.59, Formula C8H5ClN2O2, Purity >98%, SMILES [O-][N+](=O)C1=CC=CC2=C1C(Cl)=CN2, MDL NA |
| Drug_Names: 3-Chloro-4-methylpyridazine hydrochloride, CAS: 1566649-48-6, stock 790.4g, assay 98.2%, MWt 165.02, Formula C5H6Cl2N2, Purity >98%, SMILES Cl.CC1=CC=NN=C1Cl, MDL NA |
| Drug_Names: 3-Chloro-4-hydroxy-5-methylbenzonitrile, CAS: 173900-45-3, stock 668.5g, assay 98.1%, MWt 167.59, Formula C8H6ClNO, Purity >98%, SMILES CC1=CC(=CC(Cl)=C1O)C#N, MDL NA |
| Drug_Names: 3-Chloro-4,6-dimethylpyridazine, CAS: 17258-26-3, stock 713.8g, assay 98.9%, MWt 142.59, Formula C6H7ClN2, Purity >98%, SMILES CC1=NN=C(Cl)C(C)=C1, MDL NA |
| Drug_Names: 3-Chloro-2,2-bis(chloromethyl)propan-1-ol, CAS: 813-99-0, stock 241.4g, assay 98.2%, MWt 191.48, Formula C5H9Cl3O, Purity >98%, SMILES OCC(CCl)(CCl)CCl, MDL NA |
| Drug_Names: 3-Chloro-1-methyl-7-nitro-1H-indazole, CAS: 74209-36-2, stock 664.1g, assay 98.2%, MWt 211.61, Formula C8H6ClN3O2, Purity >98%, SMILES O=[N+](C1=CC=CC2=C1N(C)N=C2Cl)[O-], MDL NA |
| Drug_Names: 3-Chloro-1-methyl-1H-pyrazole-5-carboxylic acid, CAS: 173841-02-6, stock 874.7g, assay 98.9%, MWt 160.56, Formula C5H5ClN2O2, Purity >98%, SMILES CN1N=C(Cl)C=C1C(O)=O, MDL NA |
| Drug_Names: 3-Chloro-1-methyl-1H-pyrazol-5-amine hydrochloride, CAS: 1312949-22-6, stock 779.1g, assay 98.2%, MWt 168.02, Formula C4H7Cl2N3, Purity >98%, SMILES Cl.CN1N=C(Cl)C=C1N, MDL NA |
| Drug_Names: 3-Chloro-1H-indazole-6-carboxylic acid, CAS: 1086391-21-0, stock 228.8g, assay 98.6%, MWt 196.59, Formula C8H5ClN2O2, Purity >98%, SMILES OC(=O)C1=CC2=C(C=C1)C(Cl)=NN2, MDL NA |
| Drug_Names: 3-Chloro-1H-indazol-7-amine, CAS: 316810-88-5, stock 649.3g, assay 98.2%, MWt 167.60, Formula C7H6ClN3, Purity >98%, SMILES NC1=CC=CC2=C1NN=C2Cl, MDL NA |
| Drug_Names: 3-Chloro-1H-indazol-5-amine, CAS: 41330-49-8, stock 88.1g, assay 98.5%, MWt 167.60, Formula C7H6ClN3, Purity >98%, SMILES NC1=CC2=C(NN=C2Cl)C=C1, MDL NA |
| Drug_Names: 3-Chloro-1H-indazol-4-amine, CAS: 54768-48-8, stock 124.8g, assay 98.7%, MWt 167.60, Formula C7H6ClN3, Purity >98%, SMILES NC1=CC=CC2=C1C(Cl)=NN2, MDL NA |
| Drug_Names: 3-Chloro-1,2-dihydroquinoxalin-2-one, CAS: 35676-70-1, stock 772.6g, assay 98.7%, MWt 180.59, Formula C8H5ClN2O, Purity >98%, SMILES ClC1=NC2=CC=CC=C2NC1=O, MDL NA |
| Drug_Names: 3-Chloro-1-(oxan-2-yl)-1H-pyrazolo[3,4-b]pyridine, CAS: 1416713-35-3, stock 162.5g, assay 98.8%, MWt 237.69, Formula C11H12ClN3O, Purity >98%, SMILES ClC1=NN(C2CCCCO2)C2=NC=CC=C12, MDL NA |
| Drug_Names: 3-Chloro-[1,2,4]triazolo[4,3-a]pyridine, CAS: 4922-74-1, stock 709.6g, assay 98.7%, MWt 153.57, Formula C6H4ClN3, Purity >98%, SMILES ClC1=NN=C2C=CC=CN12, MDL NA |
| Drug_Names: Benzyl 6-oxo-3-azabicyclo[3.1.1]heptane-3-carboxylate, CAS: 1434142-13-8, stock 460.9g, assay 98.7%, MWt 245.27, Formula C14H15NO3, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N1CC2CC(C1)C2=O, MDL NA |
| Drug_Names: Benzyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate, CAS: 1434142-26-3, stock 60.9g, assay 98.8%, MWt 247.29, Formula C14H17NO3, Purity >98%, SMILES OC1C2CC1CN(C2)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Bromothieno[3,2-b]pyridine, CAS: 94191-12-5, stock 654.8g, assay 98.7%, MWt 214.08, Formula C7H4BrNS, Purity >98%, SMILES BrC1=CSC2=CC=CN=C12, MDL NA |
| Drug_Names: 3-Bromoquinolin-4-ol, CAS: 64965-47-5, stock 840.7g, assay 98.5%, MWt 224.05, Formula C9H6BrNO, Purity >98%, SMILES OC1=C(Br)C=NC2=C1C=CC=C2, MDL NA |
| Drug_Names: 3-Bromopyridine-2,6-diamine, CAS: 54903-86-5, stock 270g, assay 98.9%, MWt 188.03, Formula C5H6BrN3, Purity >98%, SMILES NC1=CC=C(Br)C(N)=N1, MDL NA |
| Drug_Names: 3-Bromopyrazolo[1,5-a]pyrimidine-6-carboxylic acid, CAS: 1273577-71-1, stock 808.6g, assay 98.2%, MWt 242.03, Formula C7H4BrN3O2, Purity >98%, SMILES OC(=O)C1=CN2N=CC(Br)=C2N=C1, MDL NA |
| Drug_Names: 3-Bromoimidazo[1,5-a]pyridine-1-carboxylic acid, CAS: 1119512-48-9, stock 517.7g, assay 98.8%, MWt 241.04, Formula C8H5BrN2O2, Purity >98%, SMILES OC(=O)C1=C2C=CC=CN2C(Br)=N1, MDL NA |
| Drug_Names: 3-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid, CAS: 1116691-26-9, stock 730.7g, assay 98.2%, MWt 241.04, Formula C8H5BrN2O2, Purity >98%, SMILES OC(=O)C1=CC=CN2C(Br)=CN=C12, MDL NA |
| Drug_Names: 3-Bromoimidazo[1,2-a]pyridin-7-amine, CAS: 1092352-46-9, stock 563g, assay 98.8%, MWt 212.05, Formula C7H6BrN3, Purity >98%, SMILES NC1=CC2=NC=C(Br)N2C=C1, MDL NA |
| Drug_Names: 3-Bromoimidazo[1,2-a]pyrazin-8-amine, CAS: 117718-92-0, stock 152.2g, assay 98.5%, MWt 213.03, Formula C6H5BrN4, Purity >98%, SMILES NC1=NC=CN2C(Br)=CN=C12, MDL NA |
| Drug_Names: 3-Bromoazetidine hydrochloride, CAS: 53913-82-9, stock 155.7g, assay 98.5%, MWt 172.45, Formula C3H7BrClN, Purity >98%, SMILES Cl.BrC1CNC1, MDL NA |
| Drug_Names: 3-Bromo-8-nitroimidazo[1,2-a]pyridine, CAS: 52310-43-7, stock 769.9g, assay 98.9%, MWt 242.03, Formula C7H4BrN3O2, Purity >98%, SMILES [O-][N+](=O)C1=CC=CN2C(Br)=CN=C12, MDL NA |
| Drug_Names: 3-Bromo-8-methylquinoline, CAS: 66438-80-0, stock 859.7g, assay 98.9%, MWt 222.08, Formula C10H8BrN, Purity >98%, SMILES CC1=C2N=CC(Br)=CC2=CC=C1, MDL NA |
| Drug_Names: 3-Bromo-8-chloropyrido[2,3-d]pyridazine, CAS: 794592-14-6, stock 254.1g, assay 98.4%, MWt 244.48, Formula C7H3BrClN3, Purity >98%, SMILES ClC1=NN=CC2=CC(Br)=CN=C12, MDL NA |
| Drug_Names: 3-Bromo-8-chloro-2-methylimidazo[1,2-a]pyrazine, CAS: 1124321-36-3, stock 16.3g, assay 98.7%, MWt 246.49, Formula C7H5BrClN3, Purity >98%, SMILES CC1=C(Br)N2C=CN=C(Cl)C2=N1, MDL NA |
| Drug_Names: 3-Bromo-8-chloro-1,7-naphthyridine, CAS: 1260670-05-0, stock 823.5g, assay 98.9%, MWt 243.49, Formula C8H4BrClN2, Purity >98%, SMILES ClC1=NC=CC2=CC(Br)=CN=C12, MDL NA |
| Drug_Names: 3-Bromo-8-chloro-1,5-naphthyridine, CAS: 97267-61-3, stock 787.2g, assay 98.8%, MWt 243.49, Formula C8H4BrClN2, Purity >98%, SMILES ClC1=CC=NC2=CC(Br)=CN=C12, MDL NA |
| Drug_Names: 3-Bromo-8-(methylsulfanyl)imidazo[1,2-a]pyrazine, CAS: 887475-39-0, stock 197.8g, assay 98.9%, MWt 244.11, Formula C7H6BrN3S, Purity >98%, SMILES CSC1=NC=CN2C(Br)=CN=C12, MDL NA |
| Drug_Names: 3-Bromo-7-iodothieno[3,2-c]pyridin-4-amine, CAS: 799293-91-7, stock 796.7g, assay 98.3%, MWt 354.99, Formula C7H4BrIN2S, Purity >98%, SMILES NC1=C2C(Br)=CSC2=C(I)C=N1, MDL NA |
| Drug_Names: 3-Bromo-7-chloroquinoline, CAS: 84973-05-7, stock 95.4g, assay 98.1%, MWt 242.50, Formula C9H5BrClN, Purity >98%, SMILES ClC1=CC=C2C=C(Br)C=NC2=C1, MDL NA |
| Drug_Names: 3-Bromo-7-[(tert-butoxy)carbonyl]-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-1-carboxylic acid, CAS: 1094091-46-9, stock 243.7g, assay 98.9%, MWt 346.18, Formula C12H16BrN3O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCN2C(Br)=NC(C(O)=O)=C2C1, MDL NA |
| Drug_Names: 3-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine, CAS: 1000340-28-2, stock 383g, assay 98.6%, MWt 211.06, Formula C8H7BrN2, Purity >98%, SMILES CC1=CC=C2C(Br)=CNC2=N1, MDL NA |
| Drug_Names: 3-Bromo-6-methoxy-1H-pyrrolo[2,3-b]pyridine, CAS: 1190317-52-2, stock 34.8g, assay 98.1%, MWt 227.06, Formula C8H7BrN2O, Purity >98%, SMILES COC1=CC=C2C(Br)=CNC2=N1, MDL NA |
| Drug_Names: 3-Bromo-6-ethyl-5-methyl-4H,7H-pyrazolo[1,5-a]pyrimidin-7-one, CAS: 1403767-27-0, stock 226.6g, assay 98.1%, MWt 256.10, Formula C9H10BrN3O, Purity >98%, SMILES CCC1=C(C)NC2=C(Br)C=NN2C1=O, MDL NA |
| Drug_Names: 3-Bromo-6-chloropyridine-2-carbonitrile, CAS: 1053659-39-4, stock 451g, assay 98.5%, MWt 217.45, Formula C6H2BrClN2, Purity >98%, SMILES ClC1=CC=C(Br)C(=N1)C#N, MDL NA |
| Drug_Names: 3-Bromo-6-chloropyrazolo[1,5-a]pyrimidine, CAS: 1314893-92-9, stock 712.6g, assay 98.3%, MWt 232.47, Formula C6H3BrClN3, Purity >98%, SMILES ClC1=CN2N=CC(Br)=C2N=C1, MDL NA |
| Drug_Names: 3-Bromo-6-chloro-1H-pyrrolo[3,2-c]pyridine, CAS: 1000341-61-6, stock 645.1g, assay 98.5%, MWt 231.48, Formula C7H4BrClN2, Purity >98%, SMILES ClC1=NC=C2C(Br)=CNC2=C1, MDL MFCD09749982 |
| Drug_Names: 3-Bromo-6-chloro-1H-pyrrolo[2,3-b]pyridine, CAS: 1190321-08-4, stock 737.9g, assay 98.5%, MWt 231.48, Formula C7H4BrClN2, Purity >98%, SMILES ClC1=CC=C2C(Br)=CNC2=N1, MDL NA |
| Drug_Names: 3-Bromo-6-chloro-1h-pyrazolo[3,4-b]pyridine, CAS: 1357946-70-3, stock 844.3g, assay 98.8%, MWt 232.47, Formula C6H3BrClN3, Purity >98%, SMILES ClC1=NC2=C(C=C1)C(Br)=NN2, MDL NA |
| Drug_Names: 3-Bromo-6-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidine, CAS: 1306829-95-7, stock 204.9g, assay 99%, MWt 245.10, Formula C6H5BrN4S, Purity >98%, SMILES CSC1=NC=C2C(Br)=NNC2=N1, MDL NA |
| Drug_Names: 3-Bromo-5-methyl-1H-pyrrolo[2,3-b]pyridine, CAS: 1190314-41-0, stock 487.5g, assay 98.7%, MWt 211.06, Formula C8H7BrN2, Purity >98%, SMILES CC1=CN=C2NC=C(Br)C2=C1, MDL NA |
| Drug_Names: 3-Bromo-5-methyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one, CAS: 66865-12-1, stock 257.8g, assay 98.4%, MWt 229.03, Formula C6H5BrN4O, Purity >98%, SMILES CN1C=NC2=C(C(Br)=NN2)C1=O, MDL NA |
| Drug_Names: 3-Bromo-5H,6H,7H,8H-imidazo[1,2-a]pyrazine dihydrochloride, CAS: 1057338-30-3, stock 108.6g, assay 98.8%, MWt 274.97, Formula C6H10BrCl2N3, Purity >98%, SMILES Cl.Cl.BrC1=CN=C2CNCCN12, MDL NA |
| Drug_Names: 3-Bromo-5-fluoro-1H-pyrrolo[2,3-b]pyridine, CAS: 1190309-71-7, stock 568.8g, assay 98.7%, MWt 215.02, Formula C7H4BrFN2, Purity >98%, SMILES FC1=CN=C2NC=C(Br)C2=C1, MDL NA |
| Drug_Names: 3-Bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine, CAS: 1256822-80-6, stock 767g, assay 98.8%, MWt 216.01, Formula C6H3BrFN3, Purity >98%, SMILES FC1=CC2=C(NN=C2Br)N=C1, MDL NA |
| Drug_Names: 3-Bromo-5-chlorothieno[3,2-b]pyridine, CAS: 912332-40-2, stock 329.9g, assay 98%, MWt 248.53, Formula C7H3BrClNS, Purity >98%, SMILES ClC1=CC=C2SC=C(Br)C2=N1, MDL NA |
| Drug_Names: 3-Bromo-5,6-dihydro-1,6-naphthyridin-5-one, CAS: 1260665-60-8, stock 548.6g, assay 98.6%, MWt 225.04, Formula C8H5BrN2O, Purity >98%, SMILES BrC1=CN=C2C=CNC(=O)C2=C1, MDL NA |
| Drug_Names: 3-Bromo-5-(morpholin-4-yl)-7H-thieno[3,2-b]pyran-7-one, CAS: 1174429-23-2, stock 116.5g, assay 98.3%, MWt 316.17, Formula C11H10BrNO3S, Purity >98%, SMILES BrC1=CSC2=C1OC(=CC2=O)N1CCOCC1, MDL NA |
| Drug_Names: 3-Bromo-4-methoxy-1H-pyrrolo[2,3-b]pyridine, CAS: 1053655-78-9, stock 572.7g, assay 99%, MWt 227.06, Formula C8H7BrN2O, Purity >98%, SMILES COC1=C2C(Br)=CNC2=NC=C1, MDL NA |
| Drug_Names: 3-Bromo-4-methoxy-1H-pyrazolo[3,4-d]pyrimidine, CAS: 190430-36-5, stock 842.2g, assay 98.8%, MWt 229.03, Formula C6H5BrN4O, Purity >98%, SMILES COC1=NC=NC2=C1C(Br)=NN2, MDL NA |
| Drug_Names: 3-Bromo-4-iodo-1H-pyrazole, CAS: 27258-15-7, stock 781.6g, assay 98.4%, MWt 272.87, Formula C3H2BrIN2, Purity >98%, SMILES BrC1=NNC=C1I, MDL NA |
| Drug_Names: 3-Bromo-4H,5H,6H,7H-thieno[3,2-c]pyridine hydrobromide, CAS: 1788044-16-5, stock 418.1g, assay 98.9%, MWt 299.03, Formula C7H9Br2NS, Purity >98%, SMILES Br.BrC1=CSC2=C1CNCC2, MDL NA |
| Drug_Names: 3-Bromo-4-chloro-1-[(4-methoxyphenyl)methyl]-1H-pyrazolo[3,4-b]pyridine, CAS: 1854056-69-1, stock 91.4g, assay 98.5%, MWt 352.61, Formula C14H11BrClN3O, Purity >98%, SMILES COC1=CC=C(CN2N=C(Br)C3=C2N=CC=C3Cl)C=C1, MDL NA |
| Drug_Names: 3-Bromo-4,5,6,7-tetrahydro-1H-indazole, CAS: 1246553-15-0, stock 287.7g, assay 98.9%, MWt 201.06, Formula C7H9BrN2, Purity >98%, SMILES BrC1=NNC2=C1CCCC2, MDL NA |
| Drug_Names: 3-Bromo-4-(2,4-difluorophenoxy)aniline hydrochloride, CAS: 2007921-24-4, stock 379.2g, assay 98.8%, MWt 336.56, Formula C12H9BrClF2NO, Purity >98%, SMILES Cl.NC1=CC(Br)=C(OC2=CC=C(F)C=C2F)C=C1, MDL NA |
| Drug_Names: 3-Bromo-2-methylquinoline, CAS: 343330-62-1, stock 345.4g, assay 98.9%, MWt 222.08, Formula C10H8BrN, Purity >98%, SMILES CC1=NC2=CC=CC=C2C=C1Br, MDL NA |
| Drug_Names: 3-Bromo-2-methylimidazo[1,2-a]pyrazine, CAS: 1609581-45-4, stock 417.3g, assay 98.8%, MWt 212.05, Formula C7H6BrN3, Purity >98%, SMILES CC1=C(Br)N2C=CN=CC2=N1, MDL NA |
| Drug_Names: 3-Bromo-2-methyl-6-nitro-2H-indazole, CAS: 74209-41-9, stock 484.8g, assay 98.9%, MWt 256.06, Formula C8H6BrN3O2, Purity >98%, SMILES CN1N=C2C=C(C=CC2=C1Br)[N+]([O-])=O, MDL NA |
| Drug_Names: 3-Bromo-2-methyl-2H-indazole, CAS: 457891-25-7, stock 433.7g, assay 98.9%, MWt 211.06, Formula C8H7BrN2, Purity >98%, SMILES CN1N=C2C=CC=CC2=C1Br, MDL NA |
| Drug_Names: 3-Bromo-2-methyl-1H-pyrrolo[2,3-c]pyridine, CAS: 869012-93-1, stock 377.7g, assay 98.9%, MWt 211.06, Formula C8H7BrN2, Purity >98%, SMILES CC1=C(Br)C2=C(N1)C=NC=C2, MDL NA |
| Drug_Names: 3-Bromo-2-methoxypyridin-4-amine, CAS: 215364-86-6, stock 72g, assay 98.7%, MWt 203.04, Formula C6H7BrN2O, Purity >98%, SMILES COC1=NC=CC(N)=C1Br, MDL NA |
| Drug_Names: 3-Bromo-2-fluoropyridin-4-amine, CAS: 1364917-17-8, stock 560.6g, assay 98.4%, MWt 191.00, Formula C5H4BrFN2, Purity >98%, SMILES NC1=C(Br)C(F)=NC=C1, MDL NA |
| Drug_Names: 3-Bromo-2-chloroquinoline, CAS: 101870-60-4, stock 775.2g, assay 98.6%, MWt 242.50, Formula C9H5BrClN, Purity >98%, SMILES ClC1=NC2=CC=CC=C2C=C1Br, MDL NA |
| Drug_Names: 3-Bromo-2,6-dichlorobenzoic acid, CAS: 80257-12-1, stock 891.5g, assay 98.7%, MWt 269.91, Formula C7H3BrCl2O2, Purity >98%, SMILES OC(=O)C1=C(Cl)C(Br)=CC=C1Cl, MDL NA |
| Drug_Names: 3-Bromo-2,6-dichloroaniline, CAS: 943830-82-8, stock 828.2g, assay 98.9%, MWt 240.91, Formula C6H4BrCl2N, Purity >98%, SMILES NC1=C(Cl)C(Br)=CC=C1Cl, MDL NA |
| Drug_Names: 3-Bromo-1-methyl-5-nitro-1H-indazole, CAS: 74209-25-9, stock 377.4g, assay 98.3%, MWt 256.06, Formula C8H6BrN3O2, Purity >98%, SMILES CN1N=C(Br)C2=CC(=CC=C12)[N+]([O-])=O, MDL NA |
| Drug_Names: 3-Bromo-1-methyl-1H-pyrazole-4-carbonitrile, CAS: 1703808-62-1, stock 227.5g, assay 98.3%, MWt 186.01, Formula C5H4BrN3, Purity >98%, SMILES CN1C=C(C#N)C(Br)=N1, MDL NA |
| Drug_Names: 3-Bromo-1-methyl-1H-indazol-7-amine, CAS: 885271-76-1, stock 615g, assay 98.1%, MWt 226.07, Formula C8H8BrN3, Purity >98%, SMILES CN1N=C(Br)C2=CC=CC(N)=C12, MDL NA |
| Drug_Names: 3-Bromo-1-methyl-1,2-dihydropyridin-2-one, CAS: 81971-38-2, stock 298.2g, assay 98.8%, MWt 188.02, Formula C6H6BrNO, Purity >98%, SMILES CN1C=CC=C(Br)C1=O, MDL NA |
| Drug_Names: 3-Bromo-1H-pyrrolo[2,3-b]pyridine-4-carboxylic acid, CAS: 1190314-17-0, stock 670g, assay 98.7%, MWt 241.04, Formula C8H5BrN2O2, Purity >98%, SMILES OC(=O)C1=C2C(Br)=CNC2=NC=C1, MDL NA |
| Drug_Names: 3-Bromo-1H-pyrrolo[2,3-b]pyridin-4-amine, CAS: 1190322-59-8, stock 208.2g, assay 98.4%, MWt 212.05, Formula C7H6BrN3, Purity >98%, SMILES NC1=C2C(Br)=CNC2=NC=C1, MDL NA |
| Drug_Names: 3-Bromo-1H-pyrazolo[3,4-b]pyrazine, CAS: 81411-68-9, stock 791.5g, assay 98.6%, MWt 199.01, Formula C5H3BrN4, Purity >98%, SMILES BrC1=NNC2=NC=CN=C12, MDL NA |
| Drug_Names: 3-Bromo-1H-indazole-6-carboxylic acid, CAS: 114086-30-5, stock 784.8g, assay 98.5%, MWt 241.04, Formula C8H5BrN2O2, Purity >98%, SMILES OC(=O)C1=CC=C2C(Br)=NNC2=C1, MDL NA |
| Drug_Names: 3-Bromo-1-{[2-(trimethylsilyl)ethoxy]methyl}-1h-pyrrolo[2,3-b]pyridine-5-carbonitrile, CAS: 1788041-63-3, stock 235.5g, assay 98.2%, MWt 352.30, Formula C14H18BrN3OSi, Purity >98%, SMILES C[Si](C)(C)CCOCN1C=C(Br)C2=C1N=CC(=C2)C#N, MDL NA |
| Drug_Names: 3-Bromo-1-(oxan-2-yl)-1H-pyrazolo[3,4-b]pyridine, CAS: 1416713-33-1, stock 470.4g, assay 98.4%, MWt 282.14, Formula C11H12BrN3O, Purity >98%, SMILES BrC1=NN(C2CCCCO2)C2=C1C=CC=N2, MDL NA |
| Drug_Names: 3-Bromo-1-(oxan-2-yl)-1h-pyrazole, CAS: 1044270-96-3, stock 574g, assay 98.3%, MWt 231.09, Formula C8H11BrN2O, Purity >98%, SMILES BrC1=NN(C=C1)C1CCCCO1, MDL NA |
| Drug_Names: 3-Bromo-1-(oxan-2-yl)-1H-indazol-5-amine, CAS: 1788054-90-9, stock 789.8g, assay 98.4%, MWt 296.16, Formula C12H14BrN3O, Purity >98%, SMILES NC1=CC2=C(C=C1)N(N=C2Br)C1CCCCO1, MDL NA |
| Drug_Names: 3-Bromo-1-(4-methylbenzenesulfonyl)-1H-pyrazolo[3,4-b]pyridine, CAS: 889451-24-5, stock 406.5g, assay 98.6%, MWt 352.21, Formula C13H10BrN3O2S, Purity >98%, SMILES CC1=CC=C(C=C1)S(=O)(=O)N1N=C(Br)C2=CC=CN=C12, MDL NA |
| Drug_Names: 3-Boc-8-hydroxyethyl-3-azabicyclo[3.2.1]octane, CAS: 1341039-65-3, stock 615.8g, assay 98.1%, MWt 255.35, Formula C14H25NO3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CCC(C1)C2CCO, MDL NA |
| Drug_Names: tert-Butyl 8-hydroxy-3-azabicyclo[3.2.1]octane-3-carboxylate, CAS: 1330766-08-9, stock 763g, assay 99%, MWt 227.30, Formula C12H21NO3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CCC(C1)C2O, MDL NA |
| Drug_Names: tert-Butyl 8-cyano-3-azabicyclo[3.2.1]octane-3-carboxylate, CAS: 1341036-62-1, stock 169.3g, assay 98.7%, MWt 236.31, Formula C13H20N2O2, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CCC(C1)C2C#N, MDL NA |
| Drug_Names: 8-Benzyl 3-tert-butyl 3,8-diazabicyclo[4.2.0]octane-3,8-dicarboxylate, CAS: 1630906-87-4, stock 708g, assay 98.7%, MWt 346.42, Formula C19H26N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC2CN(C2C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Boc-4,4-dimethyl-2,2-dioxo-[1,2,3]oxathiazolidine, CAS: 454248-55-6, stock 564.4g, assay 98.3%, MWt 251.30, Formula C9H17NO5S, Purity >98%, SMILES CC(C)(C)OC(=O)N1C(C)(C)COS1(=O)=O, MDL NA |
| Drug_Names: 3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.1]heptane-6-carboxylic acid, CAS: 1427460-12-5, stock 627.3g, assay 98.9%, MWt 241.28, Formula C12H19NO4, Purity >98%, SMILES O=C(O)C1C2CN(C(OC(C)(C)C)=O)CC1C2, MDL NA |
| Drug_Names: tert-Butyl 6-carbamoyl-3-azabicyclo[3.1.1]heptane-3-carboxylate, CAS: 1392803-91-6, stock 586.1g, assay 98.7%, MWt 240.30, Formula C12H20N2O3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CC(C1)C2C(N)=O, MDL NA |
| Drug_Names: tert-Butyl 3,7,9-triazabicyclo[3.3.1]nonane-3-carboxylate, CAS: 868407-41-4, stock 419.4g, assay 98.4%, MWt 227.30, Formula C11H21N3O2, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CNCC(C1)N2, MDL NA |
| Drug_Names: 3-Boc-1-methyl-6-oxa-3-azabicyclo[3.1.0]hexane, CAS: 897445-50-0, stock 337.6g, assay 98%, MWt 199.25, Formula C10H17NO3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2OC2(C)C1, MDL NA |
| Drug_Names: 3-(Benzyloxy)-6-(((tert-butyldimethylsilyl)oxy)methyl)-4-oxo-4H-pyran-2-carboxylic acid, CAS: 895134-29-9, stock 182.7g, assay 98.1%, MWt 390.50, Formula C20H26O6Si, Purity >98%, SMILES CC(C)(C)[Si](C)(C)OCC1=CC(=O)C(OCC2=CC=CC=C2)=C(O1)C(O)=O, MDL NA |
| Drug_Names: 3-Benzyloxetan-3-amine hydrochloride, CAS: 1638763-54-8, stock 641.8g, assay 98.9%, MWt 199.68, Formula C10H14ClNO, Purity >98%, SMILES NC1(COC1)CC2=CC=CC=C2.Cl, MDL NA |
| Drug_Names: 3-Benzyloxetan-3-amine, CAS: 1268058-28-1, stock 366.8g, assay 98.1%, MWt 163.22, Formula C10H13NO, Purity >98%, SMILES NC1(CC2=CC=CC=C2)COC1, MDL NA |
| Drug_Names: 3-Benzyl-6-oxa-3-azabicyclo[3.1.0]hexane, CAS: 75390-09-9, stock 485.3g, assay 98.4%, MWt 175.23, Formula C11H13NO, Purity >98%, SMILES C(N1CC2OC2C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Benzyl-3-azabicyclo[3.1.1]heptan-6-amine, CAS: 1245794-60-8, stock 265.2g, assay 98.3%, MWt 202.30, Formula C13H18N2, Purity >98%, SMILES NC1C2CC1CN(CC1=CC=CC=C1)C2, MDL NA |
| Drug_Names: 3-Azabicyclo[3.2.1]octane-8-carboxylic acid hydrochloride, CAS: 1240526-59-3, stock 583.7g, assay 99%, MWt 191.66, Formula C8H14ClNO2, Purity >98%, SMILES Cl.OC(=O)C1C2CCC1CNC2, MDL NA |
| Drug_Names: 3-Azabicyclo[3.2.1]octane-8-carbonitrile hydrochloride, CAS: 1788054-86-3, stock 478.6g, assay 98.7%, MWt 172.66, Formula C8H13ClN2, Purity >98%, SMILES N#CC1C2CNCC1CC2.[H]Cl, MDL MFCD28502795 |
| Drug_Names: (meso-1R,5S,6R)-tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate, CAS: 1357353-36-6, stock 517.4g, assay 98.3%, MWt 213.27, Formula C11H19NO3, Purity >98%, SMILES CC(C)(C)OC(=O)N1C[C@@H]2C[C@H](C1)[C@@H]2O, MDL NA |
| Drug_Names: 3-Azabicyclo[3.1.1]heptan-6-one hydrochloride, CAS: 1486519-87-2, stock 216.7g, assay 98.8%, MWt 147.60, Formula C6H10ClNO, Purity >98%, SMILES Cl.O=C1C2CC1CNC2, MDL NA |
| Drug_Names: 3-Azabicyclo[3.1.1]heptan-6-ol hydrochloride, CAS: 1389264-28-1, stock 416g, assay 98.1%, MWt 149.62, Formula C6H12ClNO, Purity >98%, SMILES Cl.OC1C2CC1CNC2, MDL NA |
| Drug_Names: 3-Azabicyclo[3.1.0]hexane-2-carboxylic acid hydrochloride, CAS: 1427324-35-3, stock 671.4g, assay 98.9%, MWt 163.60, Formula C6H10ClNO2, Purity >98%, SMILES Cl.OC(=O)C1NCC2CC12, MDL NA |
| Drug_Names: Methyl 3-azabicyclo[3.1.0]hexane-1-carboxylate hydrochloride, CAS: 1536392-01-4, stock 441.7g, assay 98.7%, MWt 177.63, Formula C7H12ClNO2, Purity >98%, SMILES Cl.COC(=O)C12CC1CNC2, MDL NA |
| Drug_Names: Ethyl 3-benzyl-3-azabicyclo[3.1.0]hexane-1-carboxylate, CAS: 63618-07-5, stock 40.7g, assay 98.9%, MWt 245.32, Formula C15H19NO2, Purity >98%, SMILES CCOC(=O)C12CC1CN(CC1=CC=CC=C1)C2, MDL NA |
| Drug_Names: 3-Azabicyclo[3.1.0]hexane-1-carboxylic acid hydrochloride, CAS: 1181458-33-2, stock 212.2g, assay 98.5%, MWt 163.60, Formula C6H10ClNO2, Purity >98%, SMILES Cl.OC(=O)C12CC1CNC2, MDL NA |
| Drug_Names: 3-Azabicyclo[3.1.0]hexane-1-carbonitrile hydrobromide, CAS: 2007919-32-4, stock 87.5g, assay 98.6%, MWt 189.05, Formula C6H9BrN2, Purity >98%, SMILES Br.N#CC12CC1CNC2, MDL NA |
| Drug_Names: 3-Aminodihydrofuran-2(3H)-one hydrochloride, CAS: 42417-39-0, stock 570g, assay 98.6%, MWt 137.56, Formula C4H8ClNO2, Purity >98%, SMILES Cl.NC1CCOC1=O, MDL NA |
| Drug_Names: tert-Butyl 3-amino-9-azabicyclo[3.3.1]nonane-9-carboxylate, CAS: 202797-03-3, stock 206.6g, assay 98.4%, MWt 240.34, Formula C13H24N2O2, Purity >98%, SMILES CC(C)(C)OC(=O)N1C2CCCC1CC(N)C2, MDL NA |
| Drug_Names: 3-Amino-N,N-dimethylpropanamide, CAS: 1857-18-7, stock 717.9g, assay 98.6%, MWt 116.16, Formula C5H12N2O, Purity >98%, SMILES CN(C)C(=O)CCN, MDL NA |
| Drug_Names: 3-Amino-N,N-dimethyl-1H-pyrazole-5-carboxamide, CAS: 1346948-79-5, stock 826.7g, assay 98.6%, MWt 154.17, Formula C6H10N4O, Purity >98%, SMILES CN(C)C(=O)C1=CC(N)=NN1, MDL NA |
| Drug_Names: 3-Aminocyclopentane-1-carboxylic acid hydrochloride, CAS: 1203306-05-1, stock 676.7g, assay 98.1%, MWt 165.62, Formula C6H12ClNO2, Purity >98%, SMILES O=C(C1CC(N)CC1)O.[H]Cl, MDL NA |
| Drug_Names: 3-Aminocyclobutane-1-carboxylic acid hydrochloride, CAS: 1201190-01-3, stock 742.7g, assay 99%, MWt 151.59, Formula C5H10ClNO2, Purity >98%, SMILES O=C(C1CC(N)C1)O.[H]Cl, MDL NA |
| Drug_Names: 3-Aminobicyclo[1.1.1]pentan-1-ol hydrochloride, CAS: 2007921-20-0, stock 867.9g, assay 98.4%, MWt 135.59, Formula C5H10ClNO, Purity >98%, SMILES Cl.NC12CC(O)(C1)C2, MDL NA |
| Drug_Names: 3-Amino-6-methylpyridine-2-carboxylic acid, CAS: 53636-71-8, stock 517.9g, assay 98%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES CC1=CC=C(N)C(=N1)C(O)=O, MDL NA |
| Drug_Names: 3-Amino-6-chloropyridine-2-carboxylic acid hydrochloride, CAS: 1112213-20-3, stock 282.9g, assay 98.3%, MWt 209.03, Formula C6H6Cl2N2O2, Purity >98%, SMILES NC1=C(C(O)=O)N=C(C=C1)Cl.Cl, MDL NA |
| Drug_Names: 3-Amino-5-methoxy-1H-pyrazole-4-carbonitrile, CAS: 72760-87-3, stock 678.1g, assay 98.7%, MWt 138.13, Formula C5H6N4O, Purity >98%, SMILES COC1=C(C#N)C(N)=NN1, MDL NA |
| Drug_Names: 3-Amino-5-fluoropyridine-2-carboxylic acid, CAS: 1225225-14-8, stock 604.5g, assay 98.9%, MWt 156.11, Formula C6H5FN2O2, Purity >98%, SMILES NC1=CC(F)=CN=C1C(O)=O, MDL NA |
| Drug_Names: 3-Amino-5-chloropyridine-2-carboxylic acid hydrochloride, CAS: 212378-43-3, stock 54.9g, assay 98.3%, MWt 209.03, Formula C6H6Cl2N2O2, Purity >98%, SMILES Cl.NC1=CC(Cl)=CN=C1C(O)=O, MDL NA |
| Drug_Names: 3-Amino-5-bromopyridine-2-carbaldehyde, CAS: 1289168-19-9, stock 626.8g, assay 98.1%, MWt 201.02, Formula C6H5BrN2O, Purity >98%, SMILES NC1=CC(Br)=CN=C1C=O, MDL NA |
| Drug_Names: 3-Amino-5-bromo-1-methyl-1,2-dihydropyridin-2-one, CAS: 910543-72-5, stock 2.5g, assay 98.6%, MWt 203.04, Formula C6H7BrN2O, Purity >98%, SMILES CN1C=C(Br)C=C(N)C1=O, MDL NA |
| Drug_Names: 3-Amino-1-methylpyrrolidine-2,5-dione, CAS: 67513-65-9, stock 328.6g, assay 98.6%, MWt 128.13, Formula C5H8N2O2, Purity >98%, SMILES CN1C(=O)CC(N)C1=O, MDL NA |
| Drug_Names: 3-Amino-1-methylpiperidin-2-one hydrochloride, CAS: 1422130-18-4, stock 340.5g, assay 98.1%, MWt 164.63, Formula C6H13ClN2O, Purity >98%, SMILES Cl.CN1CCCC(N)C1=O, MDL NA |
| Drug_Names: 3-Amino-1H-indazole-4-carboxylic acid, CAS: 1378774-23-2, stock 474.4g, assay 99%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES NC1=NNC2=C1C(=CC=C2)C(O)=O, MDL NA |
| Drug_Names: 3-Amino-1-[(tert-butoxy)carbonyl]azetidine-3-carboxylic acid, CAS: 1262412-13-4, stock 873g, assay 98.6%, MWt 216.23, Formula C9H16N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC(N)(C1)C(O)=O, MDL NA |
| Drug_Names: 3-Amino-1-(trifluoromethyl)cyclohexan-1-ol, CAS: 1251923-56-4, stock 109.4g, assay 98.1%, MWt 183.17, Formula C7H12F3NO, Purity >98%, SMILES NC1CCCC(O)(C1)C(F)(F)F, MDL NA |
| Drug_Names: 3-Amino-1-(trifluoromethyl)cyclobutan-1-ol, CAS: 1251924-07-8, stock 708.8g, assay 98.4%, MWt 155.12, Formula C5H8F3NO, Purity >98%, SMILES NC1CC(O)(C1)C(F)(F)F, MDL NA |
| Drug_Names: 3-{1-[(tert-Butoxy)carbonyl]piperidin-3-yl}benzoic acid, CAS: 908334-19-0, stock 211.5g, assay 98.4%, MWt 305.37, Formula C17H23NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCCC(C1)C1=CC=CC(=C1)C(O)=O, MDL NA |
| Drug_Names: 3-{[2-(2-Methoxyethoxy)ethoxy]methyl}-3-methyloxetane, CAS: 531521-23-0, stock 83.6g, assay 98.8%, MWt 204.26, Formula C10H20O4, Purity >98%, SMILES COCCOCCOCC1(C)COC1, MDL NA |
| Drug_Names: 3-((tert-Butoxycarbonyl)amino)tetrahydrofuran-3-carboxylic acid, CAS: 869785-31-9, stock 348.7g, assay 98.4%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES CC(C)(C)OC(=O)NC1(CCOC1)C(O)=O, MDL NA |
| Drug_Names: 3-{[(tert-Butoxy)carbonyl]amino}-1-(diphenylmethyl)azetidine-3-carboxylic acid, CAS: 2126160-09-4, stock 684.7g, assay 98.3%, MWt 382.45, Formula C22H26N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)NC1(CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1)C(O)=O, MDL NA |
| Drug_Names: 3-(((Benzyloxy)carbonyl)amino)oxetane-3-carboxylic acid, CAS: 1379811-81-0, stock 45.9g, assay 98.4%, MWt 251.24, Formula C12H13NO5, Purity >98%, SMILES OC(=O)C1(COC1)NC(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-[4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propan-1-ol, CAS: 1000802-50-5, stock 384.4g, assay 98%, MWt 252.12, Formula C12H21BN2O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CCCO)N=C1, MDL NA |
| Drug_Names: 3-(3-(Trifluoromethyl)phenyl)oxetan-3-amine hydrochloride, CAS: 1349719-25-0, stock 433.3g, assay 98%, MWt 253.65, Formula C10H11ClF3NO, Purity >98%, SMILES Cl.NC1(COC1)C1=CC=CC(=C1)C(F)(F)F, MDL NA |
| Drug_Names: 3-[2-(Trifluoromethyl)phenyl]oxetan-3-amine hydrochloride, CAS: 1349715-87-2, stock 380.8g, assay 98.4%, MWt 253.65, Formula C10H11ClF3NO, Purity >98%, SMILES Cl.NC1(COC1)C1=C(C=CC=C1)C(F)(F)F, MDL NA |
| Drug_Names: 3-(1-(4-Aminobutyl)-1H-1,2,3-triazol-4-yl)aniline trihydrochloride, CAS: 1788044-10-9, stock 395.1g, assay 98.5%, MWt 340.68, Formula C12H20Cl3N5, Purity >98%, SMILES Cl.Cl.Cl.NCCCCN1C=C(N=N1)C1=CC=CC(N)=C1, MDL NA |
| Drug_Names: 3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(9R)-6'-methoxycinchonan-9-yl]amino]-3-cyclobutene-1,2-dione, CAS: 1256245-79-0, stock 835.7g, assay 98.8%, MWt 630.58, Formula C32H28F6N4O3, Purity >98%, SMILES O=C1C(C(NC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)=C1N[C@@H]([C@H]3C[C@H]4[C@H](C[N@@]3CC4)C=C)C5=CC=NC6=CC=C(OC)C=C56)=O, MDL NA |
| Drug_Names: 3-[[3,5-Bis(trifluoroMethyl)phenyl]aMino]-4-[[(8a,9S)-6'-Methoxycinchonan-9-yl]amino]-3-Cyclobutene-1,2-dione, CAS: 1256245-84-7, stock 418.4g, assay 98.4%, MWt 630.58, Formula C32H28F6N4O3, Purity >98%, SMILES O=C1C(C(NC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)=C1N[C@H]([C@@H]3C[C@H]4[C@H](C[N@@]3CC4)C=C)C5=CC=NC6=CC=C(OC)C=C56)=O, MDL MFCD30802180 |
| Drug_Names: 3-((tert-Butyldimethylsilyl)oxy)cyclobutanone, CAS: 929913-18-8, stock 321.1g, assay 98.9%, MWt 200.35, Formula C10H20O2Si, Purity >98%, SMILES CC(C)(C)[Si](C)(C)OC1CC(=O)C1, MDL NA |
| Drug_Names: 3-((tert-Butyldimethylsilyl)oxy)cyclobutanol, CAS: 1089709-08-9, stock 66.7g, assay 98.6%, MWt 202.37, Formula C10H22O2Si, Purity >98%, SMILES CC(C)(C)[Si](C)(C)OC1CC(O)C1, MDL NA |
| Drug_Names: 3-[(tert-Butoxy)carbonyl]bicyclo[1.1.1]pentane-1-carboxylic acid, CAS: 1638765-30-6, stock 379.9g, assay 98.1%, MWt 212.24, Formula C11H16O4, Purity >98%, SMILES CC(C)(C)OC(=O)C12CC(C1)(C2)C(O)=O, MDL NA |
| Drug_Names: 3-(tert-Butoxycarbonyl)-3-azaspiro[5.5]undecane-9-carboxylic acid, CAS: 170228-81-6, stock 274.3g, assay 98.2%, MWt 297.39, Formula C16H27NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC2(CCC(CC2)C(O)=O)CC1, MDL NA |
| Drug_Names: 3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-1-carboxylic acid, CAS: 1363381-55-8, stock 736.5g, assay 98.1%, MWt 227.26, Formula C11H17NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CC2(C1)C(O)=O, MDL NA |
| Drug_Names: 3-(tert-Butoxycarbonyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7-carboxylic acid, CAS: 149353-73-1, stock 149g, assay 98.6%, MWt 291.34, Formula C16H21NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC2=CC=C(C=C2CC1)C(O)=O, MDL NA |
| Drug_Names: 3-((Benzyloxy)methyl)cyclobutanone, CAS: 172324-67-3, stock 42.3g, assay 98%, MWt 190.24, Formula C12H14O2, Purity >98%, SMILES O=C1CC(COCC2=CC=CC=C2)C1, MDL NA |
| Drug_Names: 3-((Phenylsulfonyl)methylene)oxetane, CAS: 1221819-46-0, stock 501.5g, assay 98.6%, MWt 210.25, Formula C10H10O3S, Purity >98%, SMILES O=S(=O)(C=C1COC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3-[(4-Methoxyphenyl)methoxy]-1,2-oxazole-5-carboxylic acid, CAS: 1463052-85-8, stock 66.9g, assay 98%, MWt 249.22, Formula C12H11NO5, Purity >98%, SMILES COC1=CC=C(COC2=NOC(=C2)C(O)=O)C=C1, MDL NA |
| Drug_Names: 3-[(2S)-piperidin-2-yl]-1-(2,3,4-trifluorobenzoyl)azetidin-3-ol, CAS: 1597407-59-4, stock 588.5g, assay 98.3%, MWt 314.30, Formula C15H17F3N2O2, Purity >98%, SMILES OC1([C@H]2NCCCC2)CN(C(C3=CC=C(F)C(F)=C3F)=O)C1, MDL NA |
| Drug_Names: 3,9-Diazaspiro[5.5]undecan-2-one hydrochloride, CAS: 2089291-46-1, stock 720.2g, assay 98.3%, MWt 204.70, Formula C9H17ClN2O, Purity >98%, SMILES Cl.O=C1CC2(CCNCC2)CCN1, MDL NA |
| Drug_Names: 3,8-Dichloro-1,5-naphthyridine, CAS: 28252-81-5, stock 69.8g, assay 98.7%, MWt 199.04, Formula C8H4Cl2N2, Purity >98%, SMILES ClC1=CC2=NC=CC(Cl)=C2N=C1, MDL NA |
| Drug_Names: 3,8-Dibromo-1,5-naphthyridine, CAS: 154015-16-4, stock 82.4g, assay 98.5%, MWt 287.94, Formula C8H4Br2N2, Purity >98%, SMILES BrC1=CC2=NC=CC(Br)=C2N=C1, MDL NA |
| Drug_Names: 3,7-Dioxabicyclo[4.1.0]heptane, CAS: 286-22-6, stock 283.2g, assay 98.9%, MWt 100.12, Formula C5H8O2, Purity >98%, SMILES C1CC2OC2CO1, MDL NA |
| Drug_Names: tert-Butyl 3,7-diazabicyclo[3.3.1]nonane-3-carboxylate hydrochloride, CAS: 1523617-92-6, stock 405.5g, assay 98.4%, MWt 262.78, Formula C12H23ClN2O2, Purity >98%, SMILES Cl.CC(C)(C)OC(=O)N1CC2CNCC(C2)C1, MDL NA |
| Drug_Names: 3-Benzyl 7-(tert-Butyl) 9-oxo-3,7-diazabicyclo[3.3.1]nonane-3,7-dicarboxylate, CAS: 1638771-93-3, stock 841.3g, assay 98.6%, MWt 374.43, Formula C20H26N2O5, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CN(CC(C1)C2=O)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3,6-Dihydro-2h-pyran-4-carbonitrile, CAS: 105772-13-2, stock 814g, assay 98.1%, MWt 109.13, Formula C6H7NO, Purity >98%, SMILES N#CC1=CCOCC1, MDL NA |
| Drug_Names: 3,6-Dihydro-2H-pyran-3-one, CAS: 98166-23-5, stock 768g, assay 98.7%, MWt 98.10, Formula C5H6O2, Purity >98%, SMILES O=C1COCC=C1, MDL NA |
| Drug_Names: 3,6-Dichloro-4-fluoropyridazine, CAS: 92920-33-7, stock 726.8g, assay 98.1%, MWt 166.97, Formula C4HCl2FN2, Purity >98%, SMILES FC1=CC(Cl)=NN=C1Cl, MDL NA |
| Drug_Names: 3,6-Dichloro-4-(pyridin-4-yl)pyridazine, CAS: 202931-70-2, stock 187.8g, assay 98.5%, MWt 226.06, Formula C9H5Cl2N3, Purity >98%, SMILES ClC1=CC(=C(Cl)N=N1)C1=CC=NC=C1, MDL NA |
| Drug_Names: 3,6-Dibromopyrazine-2-carboxylic acid, CAS: 957230-68-1, stock 359.8g, assay 99%, MWt 281.89, Formula C5H2Br2N2O2, Purity >98%, SMILES OC(=O)C1=NC(Br)=CN=C1Br, MDL NA |
| Drug_Names: Dimethyl 6-methyl-1H-indazole-3,5-dicarboxylate, CAS: 1788041-62-2, stock 140.3g, assay 98.6%, MWt 248.23, Formula C12H12N2O4, Purity >98%, SMILES COC(=O)C1=NNC2=C1C=C(C(=O)OC)C(C)=C2, MDL NA |
| Drug_Names: Dimethyl 4-nitro-1H-pyrazole-3,5-dicarboxylate, CAS: 59694-23-4, stock 776g, assay 98.2%, MWt 229.15, Formula C7H7N3O6, Purity >98%, SMILES O=C(C1=NNC(C(OC)=O)=C1[N+]([O-])=O)OC, MDL NA |
| Drug_Names: 3,5-Diiodopyridine, CAS: 53710-18-2, stock 606.4g, assay 98.5%, MWt 330.89, Formula C5H3I2N, Purity >98%, SMILES IC1=CC(I)=CN=C1, MDL NA |
| Drug_Names: 3,5-Dichloro-2-(methylthio)pyrazine, CAS: 1523571-95-0, stock 291.9g, assay 98.7%, MWt 195.07, Formula C5H4Cl2N2S, Purity >98%, SMILES CSC1=NC=C(Cl)N=C1Cl, MDL NA |
| Drug_Names: 3,5-Dibromo-1H-pyrazole, CAS: 67460-86-0, stock 525.7g, assay 98.9%, MWt 225.87, Formula C3H2Br2N2, Purity >98%, SMILES BrC1=CC(Br)=NN1, MDL NA |
| Drug_Names: 3,4-Dimethyl-1H-pyrrole-2-carboxylic acid, CAS: 89776-55-6, stock 629.8g, assay 98.3%, MWt 139.15, Formula C7H9NO2, Purity >98%, SMILES CC1=CNC(C(O)=O)=C1C, MDL NA |
| Drug_Names: 3,4-Dimethyl-1H-pyrrole-2-carbaldehyde, CAS: 19713-89-4, stock 369g, assay 98%, MWt 123.15, Formula C7H9NO, Purity >98%, SMILES CC1=CNC(C=O)=C1C, MDL MFCD00030344 |
| Drug_Names: 3,4-Dihydro-2H-benzo[b][1,4]oxazine-7-carboxylic acid, CAS: 851202-96-5, stock 68.4g, assay 99%, MWt 179.17, Formula C9H9NO3, Purity >98%, SMILES OC(=O)C1=CC=C2NCCOC2=C1, MDL NA |
| Drug_Names: 3,4-Dichloropyridin-2-amine, CAS: 188577-69-7, stock 318.2g, assay 98.8%, MWt 163.00, Formula C5H4Cl2N2, Purity >98%, SMILES NC1=NC=CC(Cl)=C1Cl, MDL NA |
| Drug_Names: 3,4-Dichloro-5-nitropyridine, CAS: 56809-84-8, stock 599.9g, assay 98.5%, MWt 192.99, Formula C5H2Cl2N2O2, Purity >98%, SMILES [O-][N+](=O)C1=CN=CC(Cl)=C1Cl, MDL NA |
| Drug_Names: 3,4,8-Trichloro-1,7-naphthyridine, CAS: 1313738-65-6, stock 392.9g, assay 98.2%, MWt 233.48, Formula C8H3Cl3N2, Purity >98%, SMILES ClC1=C(Cl)C2=C(N=C1)C(Cl)=NC=C2, MDL NA |
| Drug_Names: 3,4,5-Trichloropyridin-2-amine, CAS: 55933-91-0, stock 281.9g, assay 98.4%, MWt 197.45, Formula C5H3Cl3N2, Purity >98%, SMILES NC1=NC=C(Cl)C(Cl)=C1Cl, MDL NA |
| Drug_Names: 3,3-Dimethylpyrrolidine-2-carboxylic acid hydrochloride, CAS: 61406-78-8, stock 120g, assay 98.5%, MWt 179.64, Formula C7H14ClNO2, Purity >98%, SMILES Cl.CC1(C)CCNC1C(O)=O, MDL NA |
| Drug_Names: 3,3-Dimethylpyrrolidine hydrochloride, CAS: 792915-20-9, stock 292g, assay 98.4%, MWt 135.64, Formula C6H14ClN, Purity >98%, SMILES Cl.CC1(C)CCNC1, MDL NA |
| Drug_Names: 3,3-Dimethyldihydro-2H-pyran-4(3H)-one, CAS: 625099-31-2, stock 306.3g, assay 98.4%, MWt 128.17, Formula C7H12O2, Purity >98%, SMILES CC1(C)COCCC1=O, MDL NA |
| Drug_Names: 3,3-Dimethylcyclobut-1-ene-1-carboxylic acid, CAS: 37676-90-7, stock 546.7g, assay 98.7%, MWt 126.15, Formula C7H10O2, Purity >98%, SMILES CC1(C)CC(=C1)C(O)=O, MDL NA |
| Drug_Names: 3,3-Dimethyl-6-nitro-2,3-dihydro-1H-isoindol-1-one, CAS: 1214900-72-7, stock 165.1g, assay 98.8%, MWt 206.20, Formula C10H10N2O3, Purity >98%, SMILES O=C1NC(C)(C)C2=C1C=C([N+]([O-])=O)C=C2, MDL NA |
| Drug_Names: 3,3-Dimethyl-5-nitro-2,3-dihydro-1H-indole, CAS: 848047-43-8, stock 289.1g, assay 98.9%, MWt 192.21, Formula C10H12N2O2, Purity >98%, SMILES CC1(C)CNC2=CC=C(C=C12)[N+]([O-])=O, MDL NA |
| Drug_Names: 3,3-Dimethyl-2,3-dihydro-1H-isoindol-1-one, CAS: 19194-52-6, stock 172.4g, assay 98.5%, MWt 161.20, Formula C10H11NO, Purity >98%, SMILES CC1(C)NC(=O)C2=CC=CC=C12, MDL MFCD18449586 |
| Drug_Names: 3,3-Dimethyl-2,3-dihydro-1H-indole, CAS: 1914-02-9, stock 568.8g, assay 98.6%, MWt 147.22, Formula C10H13N, Purity >98%, SMILES CC1(C)CNC2=CC=CC=C12, MDL NA |
| Drug_Names: 3,3-Dimethyl-1H,2H,3H-pyrrolo[2,3-b]pyridine, CAS: 1595279-67-6, stock 223g, assay 98.8%, MWt 148.20, Formula C9H12N2, Purity >98%, SMILES CC1(C)CNC2=NC=CC=C12, MDL NA |
| Drug_Names: 3,3-Dimethyl-1-[(1R)-1-phenylethyl]pyrrolidine-2,4-dione, CAS: 145704-80-9, stock 697g, assay 98.4%, MWt 231.29, Formula C14H17NO2, Purity >98%, SMILES C[C@@H](N1CC(=O)C(C)(C)C1=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3,3-Dimethoxypyrrolidine hydrochloride, CAS: 1263283-20-0, stock 167.3g, assay 99%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES Cl.COC1(CCNC1)OC, MDL NA |
| Drug_Names: 3,3-Dimethoxycyclobutanecarboxylic acid, CAS: 332187-56-1, stock 669.1g, assay 98.3%, MWt 160.17, Formula C7H12O4, Purity >98%, SMILES COC1(CC(C1)C(O)=O)OC, MDL NA |
| Drug_Names: 3,3-Dimethoxy-1-methylcyclobutanecarboxylic acid, CAS: 1408075-28-4, stock 192.7g, assay 98.5%, MWt 174.19, Formula C8H14O4, Purity >98%, SMILES COC1(CC(C)(C1)C(O)=O)OC, MDL NA |
| Drug_Names: 3,3-Difluoropyrrolidin-2-one, CAS: 162970-49-2, stock 706.6g, assay 98.5%, MWt 121.09, Formula C4H5F2NO, Purity >98%, SMILES FC1(F)CCNC1=O, MDL NA |
| Drug_Names: 3,3-Difluoropiperidin-4-ol, CAS: 1239596-54-3, stock 94.3g, assay 98.9%, MWt 137.13, Formula C5H9F2NO, Purity >98%, SMILES OC1CCNCC1(F)F, MDL NA |
| Drug_Names: 3,3-Difluorocyclobutyl benzoate, CAS: 1215071-19-4, stock 599.4g, assay 98.6%, MWt 212.19, Formula C11H10F2O2, Purity >98%, SMILES FC1(F)CC(C1)OC(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3,3-Difluoro-8-azabicyclo[3.2.1]octane hydrochloride, CAS: 1254104-06-7, stock 25.5g, assay 98.7%, MWt 183.63, Formula C7H12ClF2N, Purity >98%, SMILES Cl.FC1(F)CC2CCC(C1)N2, MDL NA |
| Drug_Names: 3,3-Difluoro-4-methylpiperidine hydrochloride, CAS: 374794-78-2, stock 87.3g, assay 98.6%, MWt 171.62, Formula C6H12ClF2N, Purity >98%, SMILES Cl.CC1CCNCC1(F)F, MDL NA |
| Drug_Names: 3,3-Difluoro-2-phenylazetidine, CAS: 915190-94-2, stock 824.5g, assay 98.4%, MWt 169.17, Formula C9H9F2N, Purity >98%, SMILES FC1(F)CNC1C1=CC=CC=C1, MDL NA |
| Drug_Names: 3,3-Difluoro-1-methylcyclobutane-1-carboxylic acid, CAS: 227607-43-4, stock 753.6g, assay 98.6%, MWt 150.12, Formula C6H8F2O2, Purity >98%, SMILES CC1(CC(F)(F)C1)C(O)=O, MDL NA |
| Drug_Names: 3,3-Difluoro-1-methylcyclobutan-1-amine hydrochloride, CAS: 1523606-39-4, stock 846.5g, assay 98.2%, MWt 157.59, Formula C5H10ClF2N, Purity >98%, SMILES Cl.CC1(N)CC(F)(F)C1, MDL NA |
| Drug_Names: (3-Hydroxycyclobutane-1,1-diyl)dimethanol, CAS: 1788043-88-8, stock 11.6g, assay 99%, MWt 132.16, Formula C6H12O3, Purity >98%, SMILES OCC1(CO)CC(O)C1, MDL NA |
| Drug_Names: 3,3-Bis(chloromethyl)oxetane, CAS: 78-71-7, stock 365.6g, assay 98.6%, MWt 155.02, Formula C5H8Cl2O, Purity >98%, SMILES ClCC1(CCl)COC1, MDL NA |
| Drug_Names: 3,3-Bis(bromomethyl)-1-tosylazetidine, CAS: 1041026-61-2, stock 188.4g, assay 98.2%, MWt 397.13, Formula C12H15Br2NO2S, Purity >98%, SMILES CC1=CC=C(C=C1)S(=O)(=O)N1CC(CBr)(CBr)C1, MDL NA |
| Drug_Names: 3,3,4,4-Tetrafluoropyrrolidine hydrochloride, CAS: 1810-13-5, stock 89.5g, assay 98.7%, MWt 179.54, Formula C4H6ClF4N, Purity >98%, SMILES Cl.FC1(F)CNCC1(F)F, MDL NA |
| Drug_Names: 3,3,3-Trifluoropropanoic acid, CAS: 2516-99-6, stock 78.3g, assay 98.3%, MWt 128.05, Formula C3H3F3O2, Purity >98%, SMILES OC(=O)CC(F)(F)F, MDL NA |
| Drug_Names: 3,3'-Disulfanediylbis(2-acetamido-3-methylbutanoic acid), CAS: 67809-84-1, stock 171.8g, assay 98.3%, MWt 380.48, Formula C14H24N2O6S2, Purity >98%, SMILES CC(SSC(C)(C)C(NC(C)=O)C(O)=O)(C)C(NC(C)=O)C(O)=O, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)oxetan-3-amine hydrochloride, CAS: 1268883-21-1, stock 192.2g, assay 98.6%, MWt 177.55, Formula C4H7ClF3NO, Purity >98%, SMILES Cl.NC1(COC1)C(F)(F)F, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)cyclobutane-1-carboxylic acid, CAS: 1093750-93-6, stock 557.5g, assay 98.4%, MWt 168.11, Formula C6H7F3O2, Purity >98%, SMILES OC(=O)C1CC(C1)C(F)(F)F, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)cyclobutan-1-amine hydrochloride, CAS: 1803601-06-0, stock 305.2g, assay 98.1%, MWt 175.58, Formula C5H9ClF3N, Purity >98%, SMILES Cl.NC1CC(C1)C(F)(F)F, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)bicyclo[1.1.1]pentan-1-ol, CAS: 585532-19-0, stock 57.4g, assay 98.8%, MWt 152.11, Formula C6H7F3O, Purity >98%, SMILES OC12CC(C1)(C2)C(F)(F)F, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)bicyclo[1.1.1]pentan-1-amine hydrochloride, CAS: 262852-11-9, stock 363.4g, assay 98.5%, MWt 187.59, Formula C6H9ClF3N, Purity >98%, SMILES Cl.NC12CC(C1)(C2)C(F)(F)F, MDL MFCD17480480 |
| Drug_Names: 3-(Trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-4-amine, CAS: 1255099-01-4, stock 544.3g, assay 98.1%, MWt 201.15, Formula C8H6F3N3, Purity >98%, SMILES NC1=C2C(NC=C2C(F)(F)F)=NC=C1, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)-1H-pyrazolo[4,3-b]pyridine, CAS: 1211517-40-6, stock 27.7g, assay 98.3%, MWt 187.12, Formula C7H4F3N3, Purity >98%, SMILES FC(F)(F)C1=NNC2=CC=CN=C12, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)-1H-pyrazolo[3,4-c]pyridine, CAS: 1092459-55-6, stock 585.3g, assay 98.7%, MWt 187.12, Formula C7H4F3N3, Purity >98%, SMILES FC(F)(F)C1=NNC2=C1C=CN=C2, MDL NA |
| Drug_Names: 3-(Trifluoromethyl)-1H-indol-6-amine hydrochloride, CAS: 2007921-17-5, stock 112g, assay 98.5%, MWt 236.62, Formula C9H8ClF3N2, Purity >98%, SMILES Cl.NC1=CC2=C(C=C1)C(=CN2)C(F)(F)F, MDL NA |
| Drug_Names: 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyrimidine, CAS: 1169690-88-3, stock 732.3g, assay 98.5%, MWt 245.09, Formula C12H16BN3O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=C2N=CC=CN2N=C1, MDL NA |
| Drug_Names: 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine, CAS: 1207557-48-9, stock 154.5g, assay 98.5%, MWt 244.10, Formula C13H17BN2O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=C2C=CC=CN2N=C1, MDL NA |
| Drug_Names: 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine, CAS: 1160614-73-2, stock 718.6g, assay 98.3%, MWt 248.13, Formula C13H21BN2O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=C2CCCCN2N=C1, MDL NA |
| Drug_Names: 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[tris(1-methylethyl)silyl]-1H-pyrrole, CAS: 365564-11-0, stock 262.7g, assay 98.2%, MWt 349.39, Formula C19H36BNO2Si, Purity >98%, SMILES CC(C)[Si](C(C)C)(C(C)C)N1C=CC(=C1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 3-(Pyridin-3-yl)oxetan-3-amine dihydrochloride, CAS: 2007917-04-4, stock 883.9g, assay 98.1%, MWt 223.10, Formula C8H12Cl2N2O, Purity >98%, SMILES Cl.Cl.NC1(COC1)C1=CC=CN=C1, MDL NA |
| Drug_Names: 3-(Pyridazin-4-yl)propanoic acid, CAS: 1092297-70-5, stock 813.4g, assay 98.7%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES OC(=O)CCC1=CN=NC=C1, MDL NA |
| Drug_Names: 3-(Pyridazin-3-yl)propanoic acid, CAS: 860412-41-5, stock 212.2g, assay 98.9%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES OC(=O)CCC1=NN=CC=C1, MDL NA |
| Drug_Names: 3-(Propan-2-yloxy)azetidine hydrochloride, CAS: 871657-49-7, stock 446.2g, assay 98.5%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CC(C)OC1CNC1, MDL NA |
| Drug_Names: 3-(Propan-2-yl)azetidin-3-ol hydrochloride, CAS: 848192-94-9, stock 644.3g, assay 98%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CC(C)C1(O)CNC1, MDL NA |
| Drug_Names: 3-(Propan-2-yl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 952182-05-7, stock 793.2g, assay 98.4%, MWt 166.22, Formula C8H14N4, Purity >98%, SMILES CC(C)C1=NN=C2CNCCN12, MDL NA |
| Drug_Names: 3-(Prop-2-yn-1-yl)oxetan-3-ol, CAS: 1354550-84-7, stock 133g, assay 98.3%, MWt 112.13, Formula C6H8O2, Purity >98%, SMILES OC1(CC#C)COC1, MDL NA |
| Drug_Names: 3-(Prop-2-en-1-yl)azetidine; trifluoroacetic acid, CAS: 1630906-83-0, stock 628.2g, assay 98.9%, MWt 211.18, Formula C8H12F3NO2, Purity >98%, SMILES OC(=O)C(F)(F)F.C=CCC1CNC1, MDL NA |
| Drug_Names: 3-(Prop-2-en-1-yl)-1h-indole, CAS: 16886-09-2, stock 435.7g, assay 98.6%, MWt 157.21, Formula C11H11N, Purity >98%, SMILES C=CCC1=CNC2=C1C=CC=C2, MDL NA |
| Drug_Names: 3-(Piperidin-3-yl)benzoic acid hydrochloride, CAS: 2007921-14-2, stock 895.8g, assay 98.7%, MWt 241.71, Formula C12H16ClNO2, Purity >98%, SMILES Cl.OC(=O)C1=CC=CC(=C1)C1CCCNC1, MDL NA |
| Drug_Names: 3-(Oxetan-3-yl)pyrrolidine, CAS: 1273567-00-2, stock 744.9g, assay 98.6%, MWt 127.18, Formula C7H13NO, Purity >98%, SMILES C1OCC1C1CCNC1, MDL NA |
| Drug_Names: 3-Oxo-3-(tetrahydro-2H-pyran-4-yl)propanenitrile, CAS: 1010798-64-7, stock 246.8g, assay 98.1%, MWt 153.18, Formula C8H11NO2, Purity >98%, SMILES O=C(CC#N)C1CCOCC1, MDL NA |
| Drug_Names: 3-(Methylthio)azetidine hydrochloride, CAS: 1417793-19-1, stock 391.1g, assay 98.7%, MWt 139.65, Formula C4H10ClNS, Purity >98%, SMILES Cl.CSC1CNC1, MDL NA |
| Drug_Names: 3-(Methylamino)cyclobutanol, CAS: 1354952-94-5, stock 661.8g, assay 98.4%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES CNC1CC(O)C1, MDL NA |
| Drug_Names: 3-(Methoxymethyl)cyclobutan-1-amine, CAS: 1209654-41-0, stock 438.8g, assay 98.8%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES COCC1CC(N)C1, MDL NA |
| Drug_Names: 3-(Methoxymethyl)azetidine 2,2,2-trifluoroacetate, CAS: 1228230-82-7, stock 54.1g, assay 98.4%, MWt 215.17, Formula C7H12F3NO3, Purity >98%, SMILES COCC1CNC1.OC(=O)C(F)(F)F, MDL NA |
| Drug_Names: 3-(Methoxycarbonyl)cyclobutanecarboxylic acid, CAS: 116569-00-7, stock 247.6g, assay 98.3%, MWt 158.15, Formula C7H10O4, Purity >98%, SMILES COC(=O)C1CC(C1)C(O)=O, MDL NA |
| Drug_Names: 3-(Iodomethyl)-3-methyloxetane, CAS: 112823-30-0, stock 593.9g, assay 98.2%, MWt 212.03, Formula C5H9IO, Purity >98%, SMILES CC1(CI)COC1, MDL NA |
| Drug_Names: 3-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride, CAS: 1439900-52-3, stock 583g, assay 98.2%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES Cl.OCC1(O)CCNC1, MDL NA |
| Drug_Names: 3-(Hydroxymethyl)pyrrolidin-2-one, CAS: 76220-94-5, stock 838.6g, assay 98.1%, MWt 115.13, Formula C5H9NO2, Purity >98%, SMILES OCC1CCNC1=O, MDL NA |
| Drug_Names: 3-(Hydroxymethyl)oxetan-3-ol, CAS: 16563-93-2, stock 33.6g, assay 99%, MWt 104.10, Formula C4H8O3, Purity >98%, SMILES OCC1(O)COC1, MDL NA |
| Drug_Names: 3-(Hydroxymethyl)bicyclo[1.1.1]pentane-1-carbonitrile, CAS: 1370705-39-7, stock 304.4g, assay 98.6%, MWt 123.15, Formula C7H9NO, Purity >98%, SMILES OCC12CC(C1)(C2)C#N, MDL NA |
| Drug_Names: 3-(Hydroxymethyl)-3-methylcyclobutanone, CAS: 1523617-87-9, stock 716.6g, assay 98.1%, MWt 114.14, Formula C6H10O2, Purity >98%, SMILES CC1(CO)CC(=O)C1, MDL NA |
| Drug_Names: 3-(Hydroxymethyl)-1-methylpyridin-2(1H)-one, CAS: 36721-61-6, stock 540g, assay 98.2%, MWt 139.15, Formula C7H9NO2, Purity >98%, SMILES CN1C=CC=C(CO)C1=O, MDL NA |
| Drug_Names: 3-(Hydrazinylmethyl)pyridine dihydrochloride, CAS: 6978-97-8, stock 186.4g, assay 98.2%, MWt 196.08, Formula C6H11Cl2N3, Purity >98%, SMILES Cl.Cl.NNCC1=CN=CC=C1, MDL NA |
| Drug_Names: 3-(Fluoromethyl)pyrrolidin-3-ol hydrochloride, CAS: 1419101-39-5, stock 851.8g, assay 98.8%, MWt 155.60, Formula C5H11ClFNO, Purity >98%, SMILES Cl.OC1(CF)CCNC1, MDL NA |
| Drug_Names: 3-(Dimethylamino)cyclobutan-1-ol, CAS: 18126-77-7, stock 57.2g, assay 98.3%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CN(C)C1CC(O)C1, MDL NA |
| Drug_Names: 3-(Difluoromethyl)pyrrolidine hydrochloride, CAS: 1376176-56-5, stock 276.5g, assay 98.5%, MWt 157.59, Formula C5H10ClF2N, Purity >98%, SMILES Cl.FC(F)C1CCNC1, MDL NA |
| Drug_Names: 3-(Difluoromethyl)oxetane-3-carboxylic acid, CAS: 1782290-73-6, stock 332.1g, assay 98.1%, MWt 152.10, Formula C5H6F2O3, Purity >98%, SMILES OC(=O)C1(COC1)C(F)F, MDL NA |
| Drug_Names: 3-(Difluoromethyl)-1-methyl-1H-pyrazol-5-ol, CAS: 129922-58-3, stock 266.4g, assay 98.9%, MWt 148.11, Formula C5H6F2N2O, Purity >98%, SMILES CN1N=C(C=C1O)C(F)F, MDL NA |
| Drug_Names: 3-(Difluoromethoxy)pyrrolidine hydrochloride, CAS: 1638772-00-5, stock 38.6g, assay 98.9%, MWt 173.59, Formula C5H10ClF2NO, Purity >98%, SMILES Cl.FC(F)OC1CCNC1, MDL NA |
| Drug_Names: 3-(Dibenzylamino)oxetane-3-carbonitrile, CAS: 1021393-00-9, stock 26.8g, assay 98.6%, MWt 278.35, Formula C18H18N2O, Purity >98%, SMILES N#CC1(COC1)N(CC1=CC=CC=C1)CC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Chlorosulfonyl)-5-fluorobenzoic acid, CAS: 912577-43-6, stock 35.2g, assay 98.2%, MWt 238.62, Formula C7H4ClFO4S, Purity >98%, SMILES OC(=O)C1=CC(=CC(F)=C1)S(Cl)(=O)=O, MDL NA |
| Drug_Names: 3-(Chlorosulfonyl)-2-fluorobenzoic acid, CAS: 1909327-45-2, stock 171.4g, assay 98.5%, MWt 238.62, Formula C7H4ClFO4S, Purity >98%, SMILES OC(=O)C1=C(F)C(=CC=C1)S(Cl)(=O)=O, MDL NA |
| Drug_Names: 3-(Chloromethyl)pyridazine hydrochloride, CAS: 27349-66-2, stock 477.9g, assay 98.9%, MWt 165.02, Formula C5H6Cl2N2, Purity >98%, SMILES Cl.ClCC1=CC=CN=N1, MDL NA |
| Drug_Names: 3-(Chloromethyl)oxetane, CAS: 87498-55-3, stock 170.7g, assay 98.1%, MWt 106.55, Formula C4H7ClO, Purity >98%, SMILES ClCC1COC1, MDL NA |
| Drug_Names: 3-(Chloromethyl)-4-methyl-4,5-dihydro-1H-1,2,4-triazol-5-one, CAS: 1338226-21-3, stock 89.4g, assay 98.9%, MWt 147.56, Formula C4H6ClN3O, Purity >98%, SMILES CN1C(=O)NN=C1CCl, MDL NA |
| Drug_Names: 3-(Chloromethyl)-3-methyloxetane, CAS: 822-48-0, stock 670.3g, assay 98.8%, MWt 120.58, Formula C5H9ClO, Purity >98%, SMILES CC1(CCl)COC1, MDL NA |
| Drug_Names: 3-(Chloromethyl)-3-(iodomethyl)oxetane, CAS: 35842-61-6, stock 214.1g, assay 98.2%, MWt 246.47, Formula C5H8ClIO, Purity >98%, SMILES ClCC1(CI)COC1, MDL NA |
| Drug_Names: 3-(Chloromethyl)-1-methyl-1H-pyrazole, CAS: 84547-64-8, stock 712.2g, assay 98.6%, MWt 130.58, Formula C5H7ClN2, Purity >98%, SMILES CN1C=CC(CCl)=N1, MDL NA |
| Drug_Names: 3-(Chloromethyl)-1,5-dimethyl-1H-pyrazole, CAS: 180519-09-9, stock 303.7g, assay 98.2%, MWt 144.60, Formula C6H9ClN2, Purity >98%, SMILES CN1N=C(CCl)C=C1C, MDL NA |
| Drug_Names: 3-(Bromomethyl)-3-(chloromethyl)oxetane, CAS: 35842-60-5, stock 593.1g, assay 98.6%, MWt 199.47, Formula C5H8BrClO, Purity >98%, SMILES ClCC1(CBr)COC1, MDL NA |
| Drug_Names: 3-(Bromomethyl)-2-methylpyridine hydrobromide, CAS: 1384972-82-0, stock 784.4g, assay 98.8%, MWt 266.96, Formula C7H9Br2N, Purity >98%, SMILES Br.CC1=C(CBr)C=CC=N1, MDL NA |
| Drug_Names: 3-(Bromomethyl)-2-methoxy-5-(trifluoromethyl)pyridine, CAS: 1227576-08-0, stock 262.7g, assay 98.9%, MWt 270.05, Formula C8H7BrF3NO, Purity >98%, SMILES COC1=NC=C(C=C1CBr)C(F)(F)F, MDL NA |
| Drug_Names: 3-(Bromomethyl)-1,1-dimethylcyclobutane, CAS: 76207-22-2, stock 7.1g, assay 98.6%, MWt 177.08, Formula C7H13Br, Purity >98%, SMILES CC1(C)CC(CBr)C1, MDL NA |
| Drug_Names: 3-(Bromomethyl)-1,1-dimethoxycyclobutane, CAS: 1419101-20-4, stock 807.8g, assay 99%, MWt 209.08, Formula C7H13BrO2, Purity >98%, SMILES COC1(CC(CBr)C1)OC, MDL NA |
| Drug_Names: 3-(Benzyloxy)dihydro-2H-pyran-4(3H)-one, CAS: 1351450-56-0, stock 558.4g, assay 98.4%, MWt 206.24, Formula C12H14O3, Purity >98%, SMILES O=C1CCOCC1OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid, CAS: 119736-16-2, stock 642.5g, assay 98.2%, MWt 246.22, Formula C13H10O5, Purity >98%, SMILES OC(=O)C1=C(OCC2=CC=CC=C2)C(=O)C=CO1, MDL NA |
| Drug_Names: 3-(Benzyloxy)-4-hydroxybenzaldehyde, CAS: 50773-56-3, stock 587.9g, assay 98.3%, MWt 228.24, Formula C14H12O3, Purity >98%, SMILES OC1=C(OCC2=CC=CC=C2)C=C(C=O)C=C1, MDL NA |
| Drug_Names: 3-(Benzyloxy)-2,2-dimethylcyclobutan-1-one, CAS: 2063-92-5, stock 636.6g, assay 98.4%, MWt 204.26, Formula C13H16O2, Purity >98%, SMILES CC1(C)C(CC1=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Benzyloxy)-2,2-dimethylcyclobutan-1-ol, CAS: 17139-85-4, stock 380.1g, assay 98.7%, MWt 206.28, Formula C13H18O2, Purity >98%, SMILES CC1(C)C(O)CC1OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Benzylamino)tetrahydrofuran-3-carboxylic acid, CAS: 1340215-39-5, stock 145.7g, assay 98.6%, MWt 221.25, Formula C12H15NO3, Purity >98%, SMILES OC(=O)C1(CCOC1)NCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Benzylamino)tetrahydrofuran-3-carboxamide, CAS: 1344264-73-8, stock 196.5g, assay 98.6%, MWt 220.27, Formula C12H16N2O2, Purity >98%, SMILES NC(=O)C1(CCOC1)NCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Benzylamino)oxetane-3-carboxylic acid, CAS: 1159738-31-4, stock 764.4g, assay 98.9%, MWt 207.23, Formula C11H13NO3, Purity >98%, SMILES OC(=O)C1(COC1)NCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Benzylamino)oxetane-3-carbonitrile, CAS: 138650-20-1, stock 817.3g, assay 98.9%, MWt 188.23, Formula C11H12N2O, Purity >98%, SMILES N#CC1(COC1)NCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Phenylsulfonyl)pyrrolidine hydrochloride, CAS: 1003562-01-3, stock 256.2g, assay 98.3%, MWt 247.74, Formula C10H14ClNO2S, Purity >98%, SMILES Cl.O=S(=O)(C1CCNC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Aminomethyl)oxetan-3-ol, CAS: 1305208-47-2, stock 414.5g, assay 98.6%, MWt 103.12, Formula C4H9NO2, Purity >98%, SMILES NCC1(O)COC1, MDL NA |
| Drug_Names: 3-(Aminomethyl)oxetan-3-amine oxalate, CAS: 1523606-33-8, stock 313.5g, assay 98.9%, MWt 192.17, Formula C6H12N2O5, Purity >98%, SMILES OC(=O)C(O)=O.NCC1(N)COC1, MDL NA |
| Drug_Names: 3-(Aminomethyl)-N-benzyloxetan-3-amine, CAS: 1021392-83-5, stock 462.3g, assay 98.8%, MWt 192.26, Formula C11H16N2O, Purity >98%, SMILES NCC1(COC1)NCC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Aminomethyl)-N,N-dibenzyloxetan-3-amine, CAS: 1021392-84-6, stock 860.1g, assay 98.8%, MWt 282.38, Formula C18H22N2O, Purity >98%, SMILES NCC1(COC1)N(CC1=CC=CC=C1)CC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-(Aminomethyl)cyclobutan-1-ol hydrochloride, CAS: 1427386-91-1, stock 860.4g, assay 98.7%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.NCC1CC(O)C1, MDL NA |
| Drug_Names: 3-(Aminomethyl)bicyclo[1.1.1]pentane-1-carbonitrile, CAS: 1934858-95-3, stock 267.9g, assay 98.3%, MWt 122.17, Formula C7H10N2, Purity >98%, SMILES NCC12CC(C1)(C2)C#N, MDL NA |
| Drug_Names: 3-(Aminomethyl)bicyclo[1.1.1]pentan-1-methanol, CAS: 1823918-02-0, stock 298.4g, assay 98.6%, MWt 127.18, Formula C7H13NO, Purity >98%, SMILES NCC12CC(CO)(C1)C2, MDL NA |
| Drug_Names: 3-(Aminomethyl)-1-[(tert-butoxy)carbonyl]azetidine-3-carboxylic acid, CAS: 1158759-53-5, stock 86g, assay 98.6%, MWt 230.26, Formula C10H18N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC(CN)(C1)C(O)=O, MDL NA |
| Drug_Names: 3-(Adamantan-1-yl)-2-aminopropanoic acid hydrochloride, CAS: 182291-66-3, stock 687.9g, assay 98.7%, MWt 259.77, Formula C13H22ClNO2, Purity >98%, SMILES O=C(O)C(N)CC12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3.Cl, MDL NA |
| Drug_Names: 3-(4-Methylphenyl)oxetane-3-carboxylic acid, CAS: 1416323-07-3, stock 593.8g, assay 98.1%, MWt 192.21, Formula C11H12O3, Purity >98%, SMILES CC1=CC=C(C=C1)C1(COC1)C(O)=O, MDL NA |
| Drug_Names: 3-(4-Methyl-4H-1,2,4-triazol-3-yl)propanoic acid, CAS: 959240-56-3, stock 611g, assay 98.5%, MWt 155.15, Formula C6H9N3O2, Purity >98%, SMILES CN1C=NN=C1CCC(O)=O, MDL NA |
| Drug_Names: 3-(4-Methoxyphenyl)oxetane-3-carboxylic acid, CAS: 1416323-25-5, stock 22.3g, assay 98.6%, MWt 208.21, Formula C11H12O4, Purity >98%, SMILES COC1=CC=C(C=C1)C1(COC1)C(O)=O, MDL NA |
| Drug_Names: 3-(4-Fluorophenyl)oxetan-3-amine hydrochloride, CAS: 1332839-79-8, stock 6.9g, assay 98%, MWt 203.64, Formula C9H11ClFNO, Purity >98%, SMILES Cl.NC1(COC1)C1=CC=C(F)C=C1, MDL NA |
| Drug_Names: 3-(4-Chlorophenyl)oxetane-3-carboxylic acid, CAS: 1393534-20-7, stock 189.1g, assay 98.5%, MWt 212.63, Formula C10H9ClO3, Purity >98%, SMILES OC(=O)C1(COC1)C1=CC=C(Cl)C=C1, MDL NA |
| Drug_Names: 3-(4-Chlorophenyl)oxetan-3-amine hydrochloride, CAS: 1245782-61-9, stock 753.2g, assay 98.3%, MWt 220.10, Formula C9H11Cl2NO, Purity >98%, SMILES Cl.NC1(COC1)C1=CC=C(Cl)C=C1, MDL NA |
| Drug_Names: 3-(4-Chlorophenyl)-1,2-oxazole-5-carboxylic acid, CAS: 338982-11-9, stock 624.1g, assay 98.5%, MWt 223.61, Formula C10H6ClNO3, Purity >98%, SMILES OC(=O)C1=CC(=NO1)C1=CC=C(Cl)C=C1, MDL NA |
| Drug_Names: 3-(4-Bromophenyl)oxolan-3-amine, CAS: 1211596-34-7, stock 588.7g, assay 98.4%, MWt 242.11, Formula C10H12BrNO, Purity >98%, SMILES NC1(CCOC1)C1=CC=C(Br)C=C1, MDL NA |
| Drug_Names: 3-(4-Bromophenyl)oxetane-3-carboxylic acid, CAS: 1393585-20-0, stock 323.5g, assay 98.7%, MWt 257.08, Formula C10H9BrO3, Purity >98%, SMILES OC(=O)C1(COC1)C1=CC=C(Br)C=C1, MDL NA |
| Drug_Names: 3-(4-Bromophenyl)oxetane, CAS: 1402158-49-9, stock 568.7g, assay 98.6%, MWt 213.07, Formula C9H9BrO, Purity >98%, SMILES BrC1=CC=C(C=C1)C1COC1, MDL NA |
| Drug_Names: 3-(4-Bromophenyl)oxetan-3-ol, CAS: 1093878-32-0, stock 693.7g, assay 98.1%, MWt 229.07, Formula C9H9BrO2, Purity >98%, SMILES OC1(COC1)C1=CC=C(Br)C=C1, MDL NA |
| Drug_Names: 3-(4-Bromophenyl)isoxazole, CAS: 13484-04-3, stock 251.3g, assay 98.2%, MWt 224.05, Formula C9H6BrNO, Purity >98%, SMILES BrC1=CC=C(C=C1)C1=NOC=C1, MDL NA |
| Drug_Names: 3-(4-Bromophenyl)-3-methyloxetane, CAS: 872882-97-8, stock 333.6g, assay 98.1%, MWt 227.10, Formula C10H11BrO, Purity >98%, SMILES CC1(COC1)C1=CC=C(Br)C=C1, MDL NA |
| Drug_Names: 3-(4-Bromobenzoyl)azetidine hydrochloride, CAS: 1864074-80-5, stock 83.5g, assay 98.4%, MWt 276.56, Formula C10H11BrClNO, Purity >98%, SMILES Cl.BrC1=CC=C(C=C1)C(=O)C1CNC1, MDL NA |
| Drug_Names: 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopent-2-en-1-one, CAS: 1370008-65-3, stock 113g, assay 98.5%, MWt 208.06, Formula C11H17BO3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CC(=O)CC1, MDL NA |
| Drug_Names: 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)cyclohex-2-en-1-one, CAS: 1210418-40-8, stock 721g, assay 98.1%, MWt 290.09, Formula C13H18BF3O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CC(=O)CC(C1)C(F)(F)F, MDL NA |
| Drug_Names: 3-(3-Oxocyclobutyl)propanoic acid, CAS: 1380291-34-8, stock 249.7g, assay 98.1%, MWt 142.15, Formula C7H10O3, Purity >98%, SMILES OC(=O)CCC1CC(=O)C1, MDL NA |
| Drug_Names: 3-(3-Methylphenyl)oxetane-3-carboxylic acid, CAS: 1393568-32-5, stock 372.5g, assay 98.7%, MWt 192.21, Formula C11H12O3, Purity >98%, SMILES CC1=CC=CC(=C1)C1(COC1)C(O)=O, MDL NA |
| Drug_Names: 3-(3-Methyl-1H-indol-2-yl)-3-oxopropanenitrile, CAS: 1414944-13-0, stock 506.5g, assay 98.1%, MWt 198.22, Formula C12H10N2O, Purity >98%, SMILES CC1=C(NC2=C1C=CC=C2)C(=O)CC#N, MDL NA |
| Drug_Names: 3-(3-Methoxy-4-nitrophenyl)-3,9-diazaspiro[5.5]undecane, CAS: 1854943-72-8, stock 12.7g, assay 98.8%, MWt 305.37, Formula C16H23N3O3, Purity >98%, SMILES COC1=CC(=CC=C1[N+]([O-])=O)N1CCC2(CCNCC2)CC1, MDL NA |
| Drug_Names: 3-(3-Chlorophenyl)oxetan-3-amine hydrochloride, CAS: 1332765-66-8, stock 381.6g, assay 98.5%, MWt 220.10, Formula C9H11Cl2NO, Purity >98%, SMILES Cl.NC1(COC1)C1=CC=CC(Cl)=C1, MDL NA |
| Drug_Names: 3-(3-Bromophenyl)oxetane, CAS: 1044507-52-9, stock 213.8g, assay 98.9%, MWt 213.07, Formula C9H9BrO, Purity >98%, SMILES BrC1=CC(=CC=C1)C1COC1, MDL NA |
| Drug_Names: 3-(3-Bromophenyl)oxetan-3-ol, CAS: 1379811-98-9, stock 172.9g, assay 98.6%, MWt 229.07, Formula C9H9BrO2, Purity >98%, SMILES OC1(COC1)C1=CC=CC(Br)=C1, MDL NA |
| Drug_Names: 3-(3-Bromophenyl)oxetan-3-amine hydrochloride, CAS: 1332765-79-3, stock 497.3g, assay 98.8%, MWt 264.55, Formula C9H11BrClNO, Purity >98%, SMILES Cl.NC1(COC1)C1=CC=CC(Br)=C1, MDL NA |
| Drug_Names: 3-(3-Bromophenyl)azetidine hydrochloride, CAS: 1203683-81-1, stock 853.5g, assay 98.5%, MWt 248.55, Formula C9H11BrClN, Purity >98%, SMILES Cl.BrC1=CC(=CC=C1)C1CNC1, MDL NA |
| Drug_Names: 3-(3-Bromophenyl)-3-methyloxetane, CAS: 1123172-43-9, stock 856.2g, assay 98.9%, MWt 227.10, Formula C10H11BrO, Purity >98%, SMILES CC1(COC1)C1=CC(Br)=CC=C1, MDL NA |
| Drug_Names: 3-(3,3-Difluorocyclobutyl)-3-oxopropanenitrile, CAS: 1234616-26-2, stock 678.6g, assay 98.9%, MWt 159.13, Formula C7H7F2NO, Purity >98%, SMILES FC1(F)CC(C1)C(=O)CC#N, MDL NA |
| Drug_Names: 3-(2-Hydroxyethyl)oxetan-3-ol, CAS: 1699741-74-6, stock 112.3g, assay 98.5%, MWt 118.13, Formula C5H10O3, Purity >98%, SMILES OCCC1(O)COC1, MDL NA |
| Drug_Names: 3-(2-{Imidazo[1,2-b]pyridazin-3-yl}ethynyl)-4-methylbenzoic acid, CAS: 1300690-48-5, stock 308.9g, assay 98.7%, MWt 277.28, Formula C16H11N3O2, Purity >98%, SMILES CC1=C(C=C(C=C1)C(O)=O)C#CC1=CN=C2C=CC=NN12, MDL NA |
| Drug_Names: 3-(2,2,2-Trifluoroethyl)azetidine hydrochloride, CAS: 1394041-81-6, stock 378.1g, assay 98.5%, MWt 175.58, Formula C5H9ClF3N, Purity >98%, SMILES Cl.FC(F)(F)CC1CNC1, MDL MFCD22375347 |
| Drug_Names: 3-(1,1-Difluoroethyl)oxetane-3-carboxylic acid, CAS: 1780909-55-8, stock 354.1g, assay 98.8%, MWt 166.12, Formula C6H8F2O3, Purity >98%, SMILES CC(F)(F)C1(COC1)C(O)=O, MDL NA |
| Drug_Names: 3-(((tert-Butoxycarbonyl)amino)methyl)cyclobutanecarboxylic acid, CAS: 1630907-04-8, stock 441.5g, assay 98%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES CC(C)(C)OC(=O)NCC1CC(C1)C(O)=O, MDL NA |
| Drug_Names: 3-(((tert-Butoxycarbonyl)amino)methyl)azetidine-3-carboxylic acid, CAS: 1158759-58-0, stock 587.9g, assay 98.7%, MWt 230.26, Formula C10H18N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)NCC1(CNC1)C(O)=O, MDL NA |
| Drug_Names: 2-Methoxythiophene-3-carbaldehyde, CAS: 41057-07-2, stock 298g, assay 98.2%, MWt 142.18, Formula C6H6O2S, Purity >98%, SMILES COC1=C(C=O)C=CS1, MDL NA |
| Drug_Names: 3-tert-Butylcyclobutanone, CAS: 20614-90-8, stock 90.7g, assay 98.2%, MWt 126.20, Formula C8H14O, Purity >98%, SMILES O=C1CC(C(C)(C)C)C1, MDL NA |
| Drug_Names: Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate, CAS: 906088-96-8, stock 268.3g, assay 98.1%, MWt 381.28, Formula C17H11F4N3O3, Purity >98%, SMILES FC1=CC(F)=C(N2C(C=C(F)C(F)=C3)=C3C(C(C(OCC)=O)=C2)=O)N=C1N, MDL NA |
| Drug_Names: Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate, CAS: 1788043-98-0, stock 755g, assay 99%, MWt 434.37, Formula C20H17F3N4O4, Purity >98%, SMILES CCOC(=O)C1=CN(C2=CC(N3CC(O)C3)=C(F)C=C2C1=O)C1=NC(N)=C(F)C=C1F, MDL NA |
| Drug_Names: 3-Phenoxycyclobutanecarboxylic acid, CAS: 1263284-46-3, stock 94g, assay 98.5%, MWt 192.21, Formula C11H12O3, Purity >98%, SMILES OC(=O)C1CC(C1)OC1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Oxaspiro[5.5]undecan-9-one, CAS: 1159280-53-1, stock 824.2g, assay 98.2%, MWt 168.23, Formula C10H16O2, Purity >98%, SMILES O=C(CC1)CCC21CCOCC2, MDL NA |
| Drug_Names: tert-Butyl 3-(1-(((benzyloxy)carbonyl)amino)-2-methoxy-2-oxoethyl)azetidine-1-carboxylate, CAS: 1620451-40-2, stock 154.9g, assay 98.5%, MWt 378.42, Formula C19H26N2O6, Purity >98%, SMILES COC(=O)C(NC(=O)OCC1=CC=CC=C1)C1CN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 3-(N-Boc-aminomethyl)-3-fluoropiperidine, CAS: 1262408-83-2, stock 859.2g, assay 98.6%, MWt 232.30, Formula C11H21FN2O2, Purity >98%, SMILES FC1(CNC(OC(C)(C)C)=O)CNCCC1, MDL NA |
| Drug_Names: 2-Trifluoromethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, CAS: 837392-61-7, stock 768g, assay 98.6%, MWt 311.11, Formula C15H17BF3NO2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CC2=C(NC(=C2)C(F)(F)F)C=C1, MDL NA |
| Drug_Names: 2-(Thiazol-2-yl)acetonitrile, CAS: 101010-74-6, stock 685g, assay 98.2%, MWt 124.16, Formula C5H4N2S, Purity >98%, SMILES N#CCC1=NC=CS1, MDL NA |
| Drug_Names: 2-Thia-6-azaspiro[3.3]heptane 2,2-dioxide hydrochloride, CAS: 1427388-39-3, stock 210.9g, assay 98.2%, MWt 183.66, Formula C5H10ClNO2S, Purity >98%, SMILES Cl.O=S1(=O)CC2(CNC2)C1, MDL NA |
| Drug_Names: 2-Thia-6-azaspiro[3.3]heptane oxalate(2:1), CAS: 1233143-48-0, stock 761.9g, assay 98.2%, MWt 320.43, Formula C12H20N2O4S2, Purity >98%, SMILES OC(=O)C(O)=O.C1NCC11CSC1.C1NCC11CSC1, MDL NA |
| Drug_Names: 2-Thia-6-azaspiro[3.3]heptane, CAS: 920491-09-4, stock 751.7g, assay 98%, MWt 115.20, Formula C5H9NS, Purity >98%, SMILES C1NCC11CSC1, MDL NA |
| Drug_Names: 2-tert-Butyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1379340-25-6, stock 713.5g, assay 98.5%, MWt 209.68, Formula C10H12ClN3, Purity >98%, SMILES CC(C)(C)C1=NC(Cl)=C2C=CNC2=N1, MDL NA |
| Drug_Names: 2-tert-Butyl 9-ethyl 2,7-diazaspiro[4.4]nonane-2,9-dicarboxylate, CAS: 1357354-49-4, stock 134.9g, assay 98%, MWt 298.38, Formula C15H26N2O4, Purity >98%, SMILES CCOC(=O)C1CNCC11CCN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 2-tert-Butyl 8a-methyl (8aS)-6-oxo-1,2,3,4,6,7,8,8a-octahydroisoquinoline-2,8a-dicarboxylate, CAS: 445312-78-7, stock 702.9g, assay 98.8%, MWt 309.36, Formula C16H23NO5, Purity >98%, SMILES O=C(N(CCC1=C2)C[C@]1(C(OC)=O)CCC2=O)OC(C)(C)C, MDL NA |
| Drug_Names: 2-tert-Butyl 8a-methyl (8aR)-6-oxo-1,2,3,4,6,7,8,8a-octahydroisoquinoline-2,8a-dicarboxylate, CAS: 445312-74-3, stock 2.4g, assay 98.9%, MWt 309.36, Formula C16H23NO5, Purity >98%, SMILES O=C(N(CCC1=C2)C[C@@]1(C(OC)=O)CCC2=O)OC(C)(C)C, MDL NA |
| Drug_Names: 2-tert-Butyl 6-methyl 2-azaspiro[3.3]heptane-2,6-dicarboxylate, CAS: 1408074-81-6, stock 745.5g, assay 98.1%, MWt 255.31, Formula C13H21NO4, Purity >98%, SMILES COC(=O)C1CC2(C1)CN(C2)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 2-tert-Butyl 6-methyl 1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-2,6-dicarboxylate, CAS: 1363383-12-3, stock 512.7g, assay 98.7%, MWt 280.32, Formula C14H20N2O4, Purity >98%, SMILES COC(=O)C1=CC=C2CN(CCN12)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 2-tert-Butyl 1-methyl 2-azabicyclo[4.1.0]heptane-1,2-dicarboxylate, CAS: 2106477-57-8, stock 352.1g, assay 98.3%, MWt 255.31, Formula C13H21NO4, Purity >98%, SMILES COC(=O)C12CC1CCCN2C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 2-Thioxo-2,3-dihydropyrido[3,4-d]pyrimidin-4(1H)-one, CAS: 412341-42-5, stock 212.6g, assay 98.6%, MWt 179.20, Formula C7H5N3OS, Purity >98%, SMILES O=C1NC(=S)NC2=C1C=CN=C2, MDL MFCD07437913 |
| Drug_Names: 3-(4-Chlorophenyl)pyrazine-2-carbaldehyde, CAS: 1404373-80-3, stock 381g, assay 98.4%, MWt 218.64, Formula C11H7ClN2O, Purity >98%, SMILES ClC1=CC=C(C=C1)C1=C(C=O)N=CC=N1, MDL NA |
| Drug_Names: 2-Phenyltetrahydrofuran, CAS: 16133-83-8, stock 812g, assay 98.2%, MWt 148.20, Formula C10H12O, Purity >98%, SMILES C1COC(C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 2-Phenylcyclobutan-1-one, CAS: 42436-86-2, stock 890.5g, assay 98.9%, MWt 146.19, Formula C10H10O, Purity >98%, SMILES O=C1CCC1C1=CC=CC=C1, MDL MFCD19382274 |
| Drug_Names: 2-Oxopyrrolidine-3-carboxylic acid, CAS: 96905-67-8, stock 147.1g, assay 98.1%, MWt 129.11, Formula C5H7NO3, Purity >98%, SMILES OC(=O)C1CCNC1=O, MDL NA |
| Drug_Names: 2-Oxo-1H,2H,3H-pyrrolo[2,3-b]pyridine-5-carboxylic acid, CAS: 1260665-66-4, stock 49.2g, assay 98.6%, MWt 178.14, Formula C8H6N2O3, Purity >98%, SMILES OC(=O)C1=CN=C2NC(=O)CC2=C1, MDL NA |
| Drug_Names: 2-Oxo-1H,2H,3H-pyrrolo[2,3-b]pyridine-5-carbonitrile, CAS: 1190321-76-6, stock 118.9g, assay 98.4%, MWt 159.14, Formula C8H5N3O, Purity >98%, SMILES O=C1CC2=CC(=CN=C2N1)C#N, MDL NA |
| Drug_Names: 2-Oxo-1H,2H,3H-pyrrolo[2,3-b]pyridine-4-carbonitrile, CAS: 1190313-69-9, stock 195.1g, assay 98.2%, MWt 159.14, Formula C8H5N3O, Purity >98%, SMILES O=C1CC2=C(C=CN=C2N1)C#N, MDL NA |
| Drug_Names: 2-Oxo-1-(propan-2-yl)-1,2-dihydropyridine-4-carboxylic acid, CAS: 1203544-02-8, stock 6.1g, assay 98.8%, MWt 181.19, Formula C9H11NO3, Purity >98%, SMILES CC(C)N1C=CC(=CC1=O)C(O)=O, MDL NA |
| Drug_Names: 2-Oxaspiro[3.5]nonane-7-methanamine, CAS: 1256667-38-5, stock 217.4g, assay 98.2%, MWt 155.24, Formula C9H17NO, Purity >98%, SMILES NCC1CCC2(COC2)CC1, MDL NA |
| Drug_Names: 2-Oxaspiro[3.5]nonane-7-carboxylic acid, CAS: 1416323-16-4, stock 428.3g, assay 98.5%, MWt 170.21, Formula C9H14O3, Purity >98%, SMILES OC(=O)C1CCC2(COC2)CC1, MDL NA |
| Drug_Names: 2-Oxaspiro[3.5]nonane-6,8-dione, CAS: 1630907-24-2, stock 658.3g, assay 98.3%, MWt 154.16, Formula C8H10O3, Purity >98%, SMILES O=C1CC(=O)CC2(COC2)C1, MDL NA |
| Drug_Names: 2-Oxaspiro[3.5]nonan-7-ylmethanol, CAS: 1256546-76-5, stock 718.9g, assay 98.1%, MWt 156.22, Formula C9H16O2, Purity >98%, SMILES OCC1CCC2(COC2)CC1, MDL NA |
| Drug_Names: 2-Oxaspiro[3.3]heptan-6-ylmethanol, CAS: 1363380-95-3, stock 77.8g, assay 98%, MWt 128.17, Formula C7H12O2, Purity >98%, SMILES OCC1CC2(COC2)C1, MDL NA |
| Drug_Names: 2-Oxaspiro[3.3]heptan-6-ylmethanamine, CAS: 1438241-18-9, stock 456.6g, assay 98.9%, MWt 127.18, Formula C7H13NO, Purity >98%, SMILES NCC1CC2(COC2)C1, MDL NA |
| Drug_Names: 2-Oxabicyclo[3.1.0]hexane-6-carboxylic acid, CAS: 99418-15-2, stock 76.3g, assay 98.6%, MWt 128.13, Formula C6H8O3, Purity >98%, SMILES OC(=O)C1C2CCOC12, MDL NA |
| Drug_Names: 2-Oxabicyclo[2.2.2]octane-4-carbaldehyde, CAS: 1212021-23-2, stock 20.1g, assay 98.8%, MWt 140.18, Formula C8H12O2, Purity >98%, SMILES [H]C(=O)C12CCC(CC1)OC2, MDL NA |
| Drug_Names: 2-Oxa-7-azaspiro[4.4]nonane, CAS: 175-97-3, stock 454.8g, assay 98.6%, MWt 127.18, Formula C7H13NO, Purity >98%, SMILES C1CC2(CCOC2)CN1, MDL NA |
| Drug_Names: 2-Oxa-6-azaspiro[3.4]octane hemioxalate, CAS: 1523570-96-8, stock 314.1g, assay 98.4%, MWt 316.35, Formula C14H24N2O6, Purity >98%, SMILES OC(=O)C(O)=O.C1OCC11CCNC1.C1OCC11CCNC1, MDL NA |
| Drug_Names: 2-Oxa-5-azaspiro[3.4]octane hemioxalate, CAS: 1380571-82-3, stock 28.3g, assay 98.7%, MWt 316.35, Formula C14H24N2O6, Purity >98%, SMILES OC(=O)C(O)=O.C1OCC11CCCN1.C1OCC11CCCN1, MDL NA |
| Drug_Names: 2-Oxa-5-azabicyclo[2.2.2]octane oxalate(2:1), CAS: 1523606-41-8, stock 596.6g, assay 98.8%, MWt 316.35, Formula C14H24N2O6, Purity >98%, SMILES OC(=O)C(O)=O.C1CC2CNC1CO2.C1CC2CNC1CO2, MDL NA |
| Drug_Names: 2-Oxa-5-azabicyclo[2.2.1]heptane oxalate(2:1), CAS: 1523606-31-6, stock 554.9g, assay 98.8%, MWt 288.30, Formula C12H20N2O6, Purity >98%, SMILES OC(=O)C(O)=O.C1NC2COC1C2.C1NC2COC1C2, MDL NA |
| Drug_Names: 2-Methylpyrrolidine hydrochloride, CAS: 54677-53-1, stock 29.2g, assay 98.1%, MWt 121.61, Formula C5H12ClN, Purity >98%, SMILES Cl.CC1CCCN1, MDL NA |
| Drug_Names: 3-Cyano-2-methylpyridine, CAS: 1721-23-9, stock 122g, assay 98%, MWt 118.14, Formula C7H6N2, Purity >98%, SMILES CC1=NC=CC=C1C#N, MDL NA |
| Drug_Names: 2-Methylpiperidine-2-carboxylic acid hydrochloride, CAS: 1094072-12-4, stock 694g, assay 98.6%, MWt 179.64, Formula C7H14ClNO2, Purity >98%, SMILES O=C(C1(C)NCCCC1)O.[H]Cl, MDL NA |
| Drug_Names: 2-Methylpiperidin-4-ol, CAS: 344329-35-7, stock 171.4g, assay 98.2%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CC1CC(O)CCN1, MDL NA |
| Drug_Names: 2-Methyloxetan-3-one, CAS: 87385-83-9, stock 273.1g, assay 98.9%, MWt 86.09, Formula C4H6O2, Purity >98%, SMILES CC1OCC1=O, MDL NA |
| Drug_Names: 2-Methyloxetan-3-ol, CAS: 1420681-59-9, stock 210.3g, assay 98.4%, MWt 88.11, Formula C4H8O2, Purity >98%, SMILES CC1OCC1O, MDL NA |
| Drug_Names: 2-Methyloxan-4-ol, CAS: 89791-47-9, stock 255.9g, assay 98.1%, MWt 116.16, Formula C6H12O2, Purity >98%, SMILES CC1CC(O)CCO1, MDL NA |
| Drug_Names: 2-Methyl-octahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride, CAS: 2007921-13-1, stock 171.5g, assay 98.4%, MWt 213.15, Formula C8H18Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CC2CCNCC2C1, MDL NA |
| Drug_Names: 2-Methylimidazo[1,2-a]pyridine-8-carboxylic acid, CAS: 133427-10-8, stock 554g, assay 98.9%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CC1=CN2C=CC=C(C(O)=O)C2=N1, MDL NA |
| Drug_Names: 2-Methylimidazo[1,2-a]pyridin-7-amine, CAS: 1375110-97-6, stock 683.1g, assay 98.9%, MWt 147.18, Formula C8H9N3, Purity >98%, SMILES CC1=CN2C=CC(N)=CC2=N1, MDL NA |
| Drug_Names: 2-Methylidene-5,8-dioxaspiro[3.4]octane, CAS: 99620-40-3, stock 459.2g, assay 98.6%, MWt 126.15, Formula C7H10O2, Purity >98%, SMILES C=C1CC2(C1)OCCO2, MDL NA |
| Drug_Names: 2-Methylazetidine hydrochloride, CAS: 1152113-37-5, stock 858g, assay 98.1%, MWt 107.58, Formula C4H10ClN, Purity >98%, SMILES Cl.CC1CCN1, MDL NA |
| Drug_Names: 2-Methyl-7-azaspiro[3.5]nonan-2-ol hydrochloride, CAS: 1630907-15-1, stock 662.9g, assay 98.1%, MWt 191.70, Formula C9H18ClNO, Purity >98%, SMILES Cl.CC1(O)CC2(C1)CCNCC2, MDL NA |
| Drug_Names: 2-Methyl-7-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, CAS: 845751-67-9, stock 558.9g, assay 98.7%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CN1C=C2C=CC=C(B3OC(C)(C)C(C)(C)O3)C2=N1, MDL NA |
| Drug_Names: 2-Methyl-6-nitro-2H-indazole, CAS: 6850-22-2, stock 844.4g, assay 98.1%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES CN1C=C2C=CC(=CC2=N1)[N+]([O-])=O, MDL MFCD00456075 |
| Drug_Names: 2-Methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, CAS: 1204580-79-9, stock 744.9g, assay 99%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CN1C=C2C=CC(=CC2=N1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-Methyl-5-nitro-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, CAS: 1008138-66-6, stock 420.8g, assay 98.3%, MWt 264.09, Formula C12H17BN2O4, Purity >98%, SMILES CC1=NC=C(C=C1B1OC(C)(C)C(C)(C)O1)[N+]([O-])=O, MDL NA |
| Drug_Names: 2-Methyl-5-nitro-2H-indazole, CAS: 5228-48-8, stock 759g, assay 99%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES CN1C=C2C=C(C=CC2=N1)[N+]([O-])=O, MDL NA |
| Drug_Names: 2-Methyl-5-nitro-1H-pyrrolo[2,3-b]pyridine, CAS: 1190322-73-6, stock 567.8g, assay 98.7%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES CC1=CC2=CC(=CN=C2N1)[N+]([O-])=O, MDL NA |
| Drug_Names: 2-Methyl-5-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole, CAS: 1056456-24-6, stock 253.5g, assay 99%, MWt 286.13, Formula C15H19BN2O3, Purity >98%, SMILES CC1=NN=C(O1)C1=CC=C(C=C1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-Methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, CAS: 1189746-27-7, stock 271.1g, assay 98.9%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CN1C=C2C=C(C=CC2=N1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-Methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyrrolo[2,3-b]pyridine, CAS: 1111638-03-9, stock 312.1g, assay 98%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CC1=CC2=CC(=CN=C2N1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-Methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, CAS: 837392-54-8, stock 777.5g, assay 98.2%, MWt 257.14, Formula C15H20BNO2, Purity >98%, SMILES CC1=CC2=C(N1)C=CC(=C2)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-Methyl-4-nitro-2H-indazole, CAS: 26120-44-5, stock 324.9g, assay 99%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES O=[N+](C1=CC=CC2=NN(C)C=C12)[O-], MDL NA |
| Drug_Names: 2-Methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, CAS: 955979-22-3, stock 545g, assay 98.1%, MWt 257.14, Formula C15H20BNO2, Purity >98%, SMILES CC1=CC2=C(N1)C=CC=C2B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-Methyl-3-nitropyridine-4-carboxylic acid, CAS: 18699-86-0, stock 507.4g, assay 98.4%, MWt 182.13, Formula C7H6N2O4, Purity >98%, SMILES CC1=NC=CC(C(O)=O)=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 2-Methyl-3-nitro-5-(trifluoromethyl)pyridine, CAS: 1211537-69-7, stock 398.1g, assay 98.9%, MWt 206.12, Formula C7H5F3N2O2, Purity >98%, SMILES CC1=NC=C(C=C1[N+]([O-])=O)C(F)(F)F, MDL NA |
| Drug_Names: 2-Methyl-2H-pyrazolo[3,4-b]pyridin-5-amine hydrochloride, CAS: 2007916-97-2, stock 40.8g, assay 98%, MWt 184.63, Formula C7H9ClN4, Purity >98%, SMILES Cl.CN1C=C2C=C(N)C=NC2=N1, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-7-carboxylic acid, CAS: 1234615-75-8, stock 59.7g, assay 99%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1C=C2C=CC=C(C(O)=O)C2=N1, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-7-carbonitrile, CAS: 1159511-51-9, stock 0.2g, assay 98.4%, MWt 157.17, Formula C9H7N3, Purity >98%, SMILES CN1C=C2C=CC=C(C#N)C2=N1, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-7-carbaldehyde, CAS: 1337880-42-8, stock 71.8g, assay 98.8%, MWt 160.17, Formula C9H8N2O, Purity >98%, SMILES CN1C=C2C=CC=C(C=O)C2=N1, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-6-carboxylic acid, CAS: 1031417-46-5, stock 284.4g, assay 98.6%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1C=C2C=CC(=CC2=N1)C(O)=O, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-6-carbonitrile, CAS: 1159511-50-8, stock 259.1g, assay 98.4%, MWt 157.17, Formula C9H7N3, Purity >98%, SMILES CN1C=C2C=CC(=CC2=N1)C#N, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-6-carbaldehyde, CAS: 1337881-08-9, stock 570.2g, assay 98%, MWt 160.17, Formula C9H8N2O, Purity >98%, SMILES CN1C=C2C=CC(C=O)=CC2=N1, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-5-carboxylic acid, CAS: 1197943-94-4, stock 227.6g, assay 98.4%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1C=C2C=C(C=CC2=N1)C(O)=O, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-5-carbonitrile, CAS: 1159511-49-5, stock 48.1g, assay 98.1%, MWt 157.17, Formula C9H7N3, Purity >98%, SMILES CN1C=C2C=C(C=CC2=N1)C#N, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-4-carboxylic acid, CAS: 1071433-06-1, stock 260.8g, assay 98.4%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1C=C2C(C=CC=C2C(O)=O)=N1, MDL NA |
| Drug_Names: 2-Methyl-2H-indazole-4-carbaldehyde, CAS: 1079992-61-2, stock 455.7g, assay 98.2%, MWt 160.17, Formula C9H8N2O, Purity >98%, SMILES CN1C=C2C(C=CC=C2C=O)=N1, MDL NA |
| Drug_Names: 2-Methyl-2h-indazole-3,7-dicarbaldehyde, CAS: 1788041-66-6, stock 830.1g, assay 98.8%, MWt 188.18, Formula C10H8N2O2, Purity >98%, SMILES CN1N=C2C(C=CC=C2C=O)=C1C=O, MDL NA |
| Drug_Names: 2-Methyl-2H-indazol-7-amine, CAS: 90223-02-2, stock 166.6g, assay 98.6%, MWt 147.18, Formula C8H9N3, Purity >98%, SMILES CN1C=C2C=CC=C(N)C2=N1, MDL MFCD03787880 |
| Drug_Names: 2-Methyl-2H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one, CAS: 21230-41-1, stock 730.9g, assay 98%, MWt 150.14, Formula C6H6N4O, Purity >98%, SMILES CN1C=C2C(=N1)N=CNC2=O, MDL NA |
| Drug_Names: 2-Methyl-2H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid, CAS: 129560-01-6, stock 685.4g, assay 98.9%, MWt 166.18, Formula C8H10N2O2, Purity >98%, SMILES CN1N=C2CCCC2=C1C(O)=O, MDL NA |
| Drug_Names: 2-Methyl-2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propan-1-ol, CAS: 1040377-18-1, stock 300.8g, assay 98.9%, MWt 266.14, Formula C13H23BN2O3, Purity >98%, SMILES CC(C)(CO)N1C=C(C=N1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-Methyl-2,7-diazaspiro[4.4]nonan-1-one hydrochloride, CAS: 1203686-07-0, stock 291.3g, assay 98.8%, MWt 190.67, Formula C8H15ClN2O, Purity >98%, SMILES Cl.CN1CCC2(CCNC2)C1=O, MDL NA |
| Drug_Names: 2-Methyl-2,5-diazabicyclo[2.2.2]octane dihydrochloride, CAS: 52321-18-3, stock 764.3g, assay 98.3%, MWt 199.12, Formula C7H16Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CC2CCC1CN2, MDL NA |
| Drug_Names: 2-Methyl-2-(4-nitrophenyl)propanoic acid, CAS: 42206-47-3, stock 223.3g, assay 98.5%, MWt 209.20, Formula C10H11NO4, Purity >98%, SMILES CC(C)(C(O)=O)C1=CC=C(C=C1)[N+]([O-])=O, MDL NA |
| Drug_Names: 2-Methyl-1-oxo-1,2-dihydroisoquinoline-4-carboxylic acid, CAS: 54931-62-3, stock 859.3g, assay 98.6%, MWt 203.19, Formula C11H9NO3, Purity >98%, SMILES CN1C=C(C(O)=O)C2=C(C=CC=C2)C1=O, MDL NA |
| Drug_Names: 2-Methyl-1H-pyrrolo[2,3-c]pyridine, CAS: 65645-56-9, stock 699.9g, assay 98.2%, MWt 132.16, Formula C8H8N2, Purity >98%, SMILES CC1=CC2=CC=NC=C2N1, MDL NA |
| Drug_Names: 2-Methyl-1H-indole-4-carboxylic acid, CAS: 34058-50-9, stock 283.2g, assay 98.4%, MWt 175.18, Formula C10H9NO2, Purity >98%, SMILES CC1=CC2=C(N1)C=CC=C2C(O)=O, MDL NA |
| Drug_Names: 2-Methyl-1H,4H-pyrazolo[1,5-a][1,3,5]triazin-4-one, CAS: 55457-17-5, stock 194.6g, assay 99%, MWt 150.14, Formula C6H6N4O, Purity >98%, SMILES CC1=NC(=O)N2N=CC=C2N1, MDL NA |
| Drug_Names: 2-Methyl-1-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propan-2-ol, CAS: 1082503-77-2, stock 730.2g, assay 98.7%, MWt 266.14, Formula C13H23BN2O3, Purity >98%, SMILES CC(C)(O)CN1C=C(C=N1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-amine, CAS: 14097-40-6, stock 879.4g, assay 98.1%, MWt 162.23, Formula C10H14N2, Purity >98%, SMILES CN1CCC2=CC=C(N)C=C2C1, MDL NA |
| Drug_Names: 2-Methoxy-N-methyl-4-{9-methyl-3,9-diazaspiro[5.5]undecan-3-yl}aniline, CAS: 2055840-56-5, stock 616.6g, assay 98.2%, MWt 303.44, Formula C18H29N3O, Purity >98%, SMILES CNC1=CC=C(C=C1OC)N1CCC2(CCN(C)CC2)CC1, MDL NA |
| Drug_Names: 2-Methoxy-7,7-dimethyl-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one, CAS: 1440519-80-1, stock 170.5g, assay 98%, MWt 192.21, Formula C10H12N2O2, Purity >98%, SMILES COC1=CC=C2C(=O)NC(C)(C)C2=N1, MDL NA |
| Drug_Names: 2-Methanesulfonyl-2,6-diazaspiro[3.3]heptane, CAS: 1433176-83-0, stock 438.4g, assay 98.4%, MWt 176.24, Formula C6H12N2O2S, Purity >98%, SMILES CS(=O)(=O)N1CC2(CNC2)C1, MDL NA |
| Drug_Names: 2-Iodo-5-methyl-1H-pyrrolo[2,3-b]pyridine, CAS: 1227270-15-6, stock 159.9g, assay 98.7%, MWt 258.06, Formula C8H7IN2, Purity >98%, SMILES CC1=CN=C2NC(I)=CC2=C1, MDL NA |
| Drug_Names: 2-Iodooxazole, CAS: 877614-97-6, stock 559.1g, assay 98.1%, MWt 194.96, Formula C3H2INO, Purity >98%, SMILES IC1=NC=CO1, MDL NA |
| Drug_Names: 2-Hydroxy-4-(trifluoromethyl)benzaldehyde, CAS: 58914-34-4, stock 641.2g, assay 98.4%, MWt 190.12, Formula C8H5F3O2, Purity >98%, SMILES OC1=C(C=O)C=CC(=C1)C(F)(F)F, MDL MFCD04039240 |
| Drug_Names: 2-Hydrazinyl-1-methylpyridin-1-ium 4-methylbenzenesulfonate, CAS: 1404375-16-1, stock 210.3g, assay 98.8%, MWt 295.36, Formula C13H17N3O3S, Purity >98%, SMILES C[N+]1=C(NN)C=CC=C1.CC1=CC=C(C=C1)S([O-])(=O)=O, MDL NA |
| Drug_Names: 4-Ethyltetrahydro-2H-pyran-4-amine hydrochloride, CAS: 1385696-70-7, stock 896.1g, assay 98.4%, MWt 165.66, Formula C7H16ClNO, Purity >98%, SMILES Cl.CCC1(N)CCOCC1, MDL NA |
| Drug_Names: (S)-(Tetrahydro-2H-pyran-3-yl)methyl benzoate, CAS: 219701-50-5, stock 273.3g, assay 98.6%, MWt 220.26, Formula C13H16O3, Purity >98%, SMILES O=C(OC[C@H]1CCCOC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: (R)-(Tetrahydro-2H-pyran-3-yl)methyl benzoate, CAS: 1612884-82-8, stock 454.5g, assay 98.2%, MWt 220.26, Formula C13H16O3, Purity >98%, SMILES O=C(OC[C@@H]1CCCOC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Tritylaziridine-2-carbaldehyde, CAS: 173277-15-1, stock 408.3g, assay 98.7%, MWt 313.39, Formula C22H19NO, Purity >98%, SMILES O=CC1CN1C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4, MDL NA |
| Drug_Names: 2-Fluoropyrimidin-4-amine, CAS: 96548-91-3, stock 873.7g, assay 98.3%, MWt 113.09, Formula C4H4FN3, Purity >98%, SMILES NC1=NC(F)=NC=C1, MDL NA |
| Drug_Names: 2-Fluoroisophthalic acid, CAS: 1583-65-9, stock 633.5g, assay 98.9%, MWt 184.12, Formula C8H5FO4, Purity >98%, SMILES OC(=O)C1=CC=CC(C(O)=O)=C1F, MDL NA |
| Drug_Names: 2-Fluoro-4-(1-methyl-1H-pyrazol-4-yl)benzoic acid, CAS: 1178280-85-7, stock 678.7g, assay 98.3%, MWt 220.20, Formula C11H9FN2O2, Purity >98%, SMILES CN1C=C(C=N1)C1=CC=C(C(O)=O)C(F)=C1, MDL NA |
| Drug_Names: 2-Fluoro-3-hydroxycyclohept-2-en-1-one, CAS: 910999-46-1, stock 144.5g, assay 98.6%, MWt 144.14, Formula C7H9FO2, Purity >98%, SMILES OC1=C(F)C(=O)CCCC1, MDL NA |
| Drug_Names: 2-Fluoro-3-hydroxy-5,5-dimethylcyclohex-2-en-1-one, CAS: 109801-21-0, stock 498.7g, assay 98.7%, MWt 158.17, Formula C8H11FO2, Purity >98%, SMILES CC1(C)CC(O)=C(F)C(=O)C1, MDL NA |
| Drug_Names: 2-Fluoro-3-(methoxycarbonyl)benzoic acid, CAS: 914301-44-3, stock 540.2g, assay 98.1%, MWt 198.15, Formula C9H7FO4, Purity >98%, SMILES COC(=O)C1=C(F)C(=CC=C1)C(O)=O, MDL NA |
| Drug_Names: 2-Ethynylpyrrolidine hydrochloride, CAS: 1314937-87-5, stock 284.5g, assay 98.9%, MWt 131.60, Formula C6H10ClN, Purity >98%, SMILES Cl.C#CC1CCCN1, MDL NA |
| Drug_Names: 2-Ethylpyridin-4-amine, CAS: 50826-64-7, stock 35g, assay 98.1%, MWt 122.17, Formula C7H10N2, Purity >98%, SMILES CCC1=NC=CC(N)=C1, MDL NA |
| Drug_Names: [1,1'-Bi(cyclopropane)]-2-carboxylic acid, CAS: 89851-39-8, stock 309.7g, assay 98.8%, MWt 126.15, Formula C7H10O2, Purity >98%, SMILES O=C(C1C(C2CC2)C1)O, MDL NA |
| Drug_Names: 2-Cyclopropylacetonitrile, CAS: 6542-60-5, stock 255g, assay 98.8%, MWt 81.12, Formula C5H7N, Purity >98%, SMILES N#CCC1CC1, MDL NA |
| Drug_Names: 2-Cyclopentyl-6-methoxypyridine-4-carboxylic acid, CAS: 1122089-67-1, stock 235.5g, assay 99%, MWt 221.25, Formula C12H15NO3, Purity >98%, SMILES COC1=NC(=CC(=C1)C(O)=O)C1CCCC1, MDL NA |
| Drug_Names: 2-Cyclohexylpropan-2-ol, CAS: 16664-07-6, stock 459.4g, assay 98.8%, MWt 142.24, Formula C9H18O, Purity >98%, SMILES CC(C)(O)C1CCCCC1, MDL NA |
| Drug_Names: 2-Cyanopyrimidine-5-carboxylic acid, CAS: 1115962-72-5, stock 529.7g, assay 98.1%, MWt 149.11, Formula C6H3N3O2, Purity >98%, SMILES OC(=O)C1=CN=C(N=C1)C#N, MDL NA |
| Drug_Names: 2-Cyano-6-fluorobenzoic acid, CAS: 887266-96-8, stock 790.5g, assay 98.8%, MWt 165.12, Formula C8H4FNO2, Purity >98%, SMILES OC(=O)C1=C(C=CC=C1F)C#N, MDL NA |
| Drug_Names: 3-Azabicyclo[3.1.0]hexane-2-carbonitrile, CAS: 115182-91-7, stock 286.4g, assay 98.7%, MWt 108.14, Formula C6H8N2, Purity >98%, SMILES N#CC1NCC2CC12, MDL NA |
| Drug_Names: 2-Chloropyrrolo[2,1-f][1,2,4]triazine, CAS: 1363383-25-8, stock 93.5g, assay 98.8%, MWt 153.57, Formula C6H4ClN3, Purity >98%, SMILES ClC1=NN2C=CC=C2C=N1, MDL NA |
| Drug_Names: 2-Chloroisonicotinohydrazide, CAS: 58481-04-2, stock 753.6g, assay 98.4%, MWt 171.58, Formula C6H6ClN3O, Purity >98%, SMILES NNC(=O)C1=CC(Cl)=NC=C1, MDL NA |
| Drug_Names: 2-Chloropyridine-3-sulfonyl chloride, CAS: 6684-06-6, stock 714.6g, assay 98.6%, MWt 212.05, Formula C5H3Cl2NO2S, Purity >98%, SMILES ClC1=NC=CC=C1S(Cl)(=O)=O, MDL NA |
| Drug_Names: 2-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid, CAS: 1638767-99-3, stock 220.5g, assay 98.7%, MWt 211.61, Formula C8H6ClN3O2, Purity >98%, SMILES CN1C(=CC2=CN=C(Cl)N=C12)C(O)=O, MDL NA |
| Drug_Names: 2-Chloro-7-iodo-5H-pyrrolo[2,3-b]pyrazine, CAS: 889447-20-5, stock 693.5g, assay 98.4%, MWt 279.47, Formula C6H3ClIN3, Purity >98%, SMILES ClC1=CN=C2NC=C(I)C2=N1, MDL NA |
| Drug_Names: 2-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid, CAS: 1060816-55-8, stock 500.6g, assay 98.8%, MWt 197.58, Formula C7H4ClN3O2, Purity >98%, SMILES OC(=O)C1=CNC2=NC(Cl)=NC=C12, MDL NA |
| Drug_Names: 2-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde, CAS: 1367868-00-5, stock 402.2g, assay 98.1%, MWt 181.58, Formula C7H4ClN3O, Purity >98%, SMILES O=CC1=CNC2=NC(Cl)=NC=C21, MDL NA |
| Drug_Names: 2-Chloro-7H-pyrrolo[2,3-d]pyrimidine-4-carboxylic acid, CAS: 1292287-11-6, stock 197.5g, assay 98.9%, MWt 197.58, Formula C7H4ClN3O2, Purity >98%, SMILES OC(=O)C1=C2C=CNC2=NC(Cl)=N1, MDL NA |
| Drug_Names: 2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CAS: 1192711-88-8, stock 599.1g, assay 98.6%, MWt 168.58, Formula C6H5ClN4, Purity >98%, SMILES NC1=NC(Cl)=NC2=C1C=CN2, MDL NA |
| Drug_Names: 2-Chloro-7-(trifluoromethyl)quinazoline, CAS: 1388043-95-5, stock 693.8g, assay 98.8%, MWt 232.59, Formula C9H4ClF3N2, Purity >98%, SMILES FC(F)(F)C1=CC=C2C=NC(Cl)=NC2=C1, MDL NA |
| Drug_Names: 2-Chloro-6-methylthieno[2,3-d]pyrimidine, CAS: 1225875-20-6, stock 8.4g, assay 98.9%, MWt 184.65, Formula C7H5ClN2S, Purity >98%, SMILES CC1=CC2=CN=C(Cl)N=C2S1, MDL NA |
| Drug_Names: 2-Chloro-6-methylpyridine-4-carbonitrile, CAS: 25462-98-0, stock 775.5g, assay 98.9%, MWt 152.58, Formula C7H5ClN2, Purity >98%, SMILES CC1=NC(Cl)=CC(=C1)C#N, MDL NA |
| Drug_Names: 2-Chloro-6-methylpyridin-4-amine, CAS: 79055-63-3, stock 300.7g, assay 98.6%, MWt 142.59, Formula C6H7ClN2, Purity >98%, SMILES CC1=NC(Cl)=CC(N)=C1, MDL NA |
| Drug_Names: 2-Chloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1060816-56-9, stock 658.3g, assay 98.2%, MWt 167.60, Formula C7H6ClN3, Purity >98%, SMILES CC1=CC2=CN=C(Cl)N=C2N1, MDL NA |
| Drug_Names: 2-Chloro-6-iodo-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1638763-24-2, stock 358.8g, assay 98.4%, MWt 279.47, Formula C6H3ClIN3, Purity >98%, SMILES ClC1=NC=C2C=C(I)NC2=N1, MDL NA |
| Drug_Names: 2-Chloro-6-hydroxybenzonitrile, CAS: 89999-90-6, stock 633.7g, assay 98%, MWt 153.57, Formula C7H4ClNO, Purity >98%, SMILES OC1=CC=CC(Cl)=C1C#N, MDL NA |
| Drug_Names: 2-Chloro-6-(trifluoromethyl)pyridine-4-carboxylic acid, CAS: 796090-23-8, stock 494.1g, assay 98.1%, MWt 225.55, Formula C7H3ClF3NO2, Purity >98%, SMILES OC(=O)C1=CC(=NC(Cl)=C1)C(F)(F)F, MDL NA |
| Drug_Names: 2-Chloro-6-(trifluoromethyl)pyridin-4-amine, CAS: 34486-22-1, stock 425.9g, assay 98.4%, MWt 196.56, Formula C6H4ClF3N2, Purity >98%, SMILES NC1=CC(=NC(Cl)=C1)C(F)(F)F, MDL NA |
| Drug_Names: 2-Chloro-5-vinylpyrimidine, CAS: 131467-06-6, stock 35.5g, assay 98.3%, MWt 140.57, Formula C6H5ClN2, Purity >98%, SMILES ClC1=NC=C(C=C)C=N1, MDL NA |
| Drug_Names: 2-Chloro-5-methyl-n-(3-nitrophenyl)pyrimidin-4-amine, CAS: 1202759-74-7, stock 400.5g, assay 99%, MWt 264.67, Formula C11H9ClN4O2, Purity >98%, SMILES CC1=C(NC2=CC(=CC=C2)[N+]([O-])=O)N=C(Cl)N=C1, MDL NA |
| Drug_Names: 2-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine, CAS: 909562-81-8, stock 730.2g, assay 98.8%, MWt 167.60, Formula C7H6ClN3, Purity >98%, SMILES CC1=CNC2=NC(Cl)=NC=C12, MDL NA |
| Drug_Names: 2-Chloro-5-methyl-5H,6H,7H-pyrrolo[2,3-d]pyrimidin-6-one, CAS: 1638767-37-9, stock 493.3g, assay 98.7%, MWt 183.60, Formula C7H6ClN3O, Purity >98%, SMILES CC1C(=O)NC2=NC(Cl)=NC=C12, MDL NA |
| Drug_Names: 2-Chloro-5-methyl-4-nitropyridine, CAS: 97944-45-1, stock 239.5g, assay 98.5%, MWt 172.57, Formula C6H5ClN2O2, Purity >98%, SMILES CC1=CN=C(Cl)C=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 2-Chloro-5-methyl-1H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one, CAS: 129872-84-0, stock 890.2g, assay 98.5%, MWt 183.60, Formula C7H6ClN3O, Purity >98%, SMILES CN1C=CC2=C1C(=O)N=C(Cl)N2, MDL NA |
| Drug_Names: 2-Chloro-5-methoxynicotinic acid, CAS: 74650-71-8, stock 557g, assay 98.2%, MWt 187.58, Formula C7H6ClNO3, Purity >98%, SMILES O=C(C1=CC(OC)=CN=C1Cl)O, MDL MFCD16610607 |
| Drug_Names: 2-Chloro-5-methoxypyridine-3-carbonitrile, CAS: 74650-73-0, stock 767.5g, assay 98.9%, MWt 168.58, Formula C7H5ClN2O, Purity >98%, SMILES COC1=CN=C(Cl)C(=C1)C#N, MDL NA |
| Drug_Names: 2-Chloro-5-iodopyridin-4-ol, CAS: 1226878-99-4, stock 853.8g, assay 98.2%, MWt 255.44, Formula C5H3ClINO, Purity >98%, SMILES OC1=CC(Cl)=NC=C1I, MDL NA |
| Drug_Names: 2-Chloro-5-hydroxypyridine-3-carbonitrile, CAS: 74650-75-2, stock 370.1g, assay 98.7%, MWt 154.55, Formula C6H3ClN2O, Purity >98%, SMILES OC1=CN=C(Cl)C(=C1)C#N, MDL MFCD18256810 |
| Drug_Names: 2-Chloro-5H,6H,7H-pyrrolo[3,4-b]pyridine hydrochloride, CAS: 1841081-37-5, stock 448g, assay 98.2%, MWt 191.06, Formula C7H8Cl2N2, Purity >98%, SMILES Cl.ClC1=NC2=C(CNC2)C=C1, MDL NA |
| Drug_Names: 2-Chloro-5H,6H,7H-pyrrolo[2,3-d]pyrimidin-6-one hydrochloride, CAS: 1404373-76-7, stock 242.3g, assay 98.8%, MWt 206.03, Formula C6H5Cl2N3O, Purity >98%, SMILES Cl.ClC1=NC=C2CC(=O)NC2=N1, MDL NA |
| Drug_Names: 2-Chloro-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine hydrochloride, CAS: 1314723-39-1, stock 761.4g, assay 98.8%, MWt 206.07, Formula C7H9Cl2N3, Purity >98%, SMILES Cl.ClC1=NC=C2CNCCC2=N1, MDL NA |
| Drug_Names: 2-Chloro-5-fluoropyridine-3-carbonitrile, CAS: 791644-48-9, stock 669.7g, assay 98.2%, MWt 156.54, Formula C6H2ClFN2, Purity >98%, SMILES FC1=CN=C(Cl)C(=C1)C#N, MDL NA |
| Drug_Names: 2-Chloro-5-fluoro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine, CAS: 2068150-40-1, stock 112.9g, assay 98.5%, MWt 185.59, Formula C7H5ClFN3, Purity >98%, SMILES CN1C=C(F)C2=C1N=C(Cl)N=C2, MDL NA |
| Drug_Names: 2-Chloro-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1638768-28-1, stock 704.8g, assay 98.1%, MWt 171.56, Formula C6H3ClFN3, Purity >98%, SMILES FC1=CNC2=NC(Cl)=NC=C12, MDL NA |
| Drug_Names: 2-Chloro-5-ethoxypyrimidine, CAS: 82153-68-2, stock 8.1g, assay 98%, MWt 158.59, Formula C6H7ClN2O, Purity >98%, SMILES CCOC1=CN=C(Cl)N=C1, MDL NA |
| Drug_Names: 2-Chloro-5-[(2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-[(benzyloxy)methyl]oxan-2-yl]benzoic acid, CAS: 842133-80-6, stock 760g, assay 98.8%, MWt 679.20, Formula C41H39ClO7, Purity >98%, SMILES OC(=O)C1=CC(=CC=C1Cl)[C@@H]1O[C@H](COCC2=CC=CC=C2)[C@@H](OCC2=CC=CC=C2)[C@H](OCC2=CC=CC=C2)[C@H]1OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 2-Chloro-5-[(1-methylpiperidin-4-yl)methoxy]pyrimidine, CAS: 1408074-71-4, stock 629.7g, assay 98.5%, MWt 241.72, Formula C11H16ClN3O, Purity >98%, SMILES CN1CCC(COC2=CN=C(Cl)N=C2)CC1, MDL NA |
| Drug_Names: 2-Chloro-5,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1638772-13-0, stock 592.8g, assay 98.2%, MWt 181.62, Formula C8H8ClN3, Purity >98%, SMILES CN1C=C(C)C2=C1N=C(Cl)N=C2, MDL NA |
| Drug_Names: 2-Chloro-5,6,7,8-tetrahydro-1,6-naphthyridin-5-one, CAS: 1226898-93-6, stock 538g, assay 98.9%, MWt 182.61, Formula C8H7ClN2O, Purity >98%, SMILES ClC1=NC2=C(C=C1)C(=O)NCC2, MDL NA |
| Drug_Names: 2-Chloro-5,5-dimethyl-5H,6H,7H-pyrrolo[2,3-d]pyrimidin-6-one, CAS: 1638772-11-8, stock 726.8g, assay 98.4%, MWt 197.62, Formula C8H8ClN3O, Purity >98%, SMILES CC1(C)C(=O)NC2=NC(Cl)=NC=C12, MDL NA |
| Drug_Names: 2-Chloro-5-(trichloromethyl)pyridine, CAS: 69045-78-9, stock 248.9g, assay 98.2%, MWt 230.91, Formula C6H3Cl4N, Purity >98%, SMILES ClC(C1=CN=C(Cl)C=C1)(Cl)Cl, MDL MFCD00160145 |
| Drug_Names: 2-Chloro-5-(chloromethyl)pyrimidine, CAS: 148406-13-7, stock 260.6g, assay 98.5%, MWt 163.00, Formula C5H4Cl2N2, Purity >98%, SMILES ClCC1=CN=C(Cl)N=C1, MDL NA |
| Drug_Names: 2-Chloro-4-fluoro-5-iodopyridine, CAS: 1370534-60-3, stock 557.4g, assay 98.8%, MWt 257.43, Formula C5H2ClFIN, Purity >98%, SMILES FC1=CC(Cl)=NC=C1I, MDL NA |
| Drug_Names: 2-Chloro-4,6-dimethylpyridine-3-carboxamide, CAS: 140413-44-1, stock 101.9g, assay 98.9%, MWt 184.62, Formula C8H9ClN2O, Purity >98%, SMILES CC1=CC(C)=C(C(N)=O)C(Cl)=N1, MDL NA |
| Drug_Names: 2-Chloro-4,5-dimethylpyrimidine, CAS: 34916-68-2, stock 556.3g, assay 98.2%, MWt 142.59, Formula C6H7ClN2, Purity >98%, SMILES CC1=CN=C(Cl)N=C1C, MDL NA |
| Drug_Names: 2-Chloro-4-(morpholin-4-yl)pyrrolo[2,1-f][1,2,4]triazine-6-carbaldehyde, CAS: 1401334-36-8, stock 349.8g, assay 98.8%, MWt 266.68, Formula C11H11ClN4O2, Purity >98%, SMILES ClC1=NN2C=C(C=O)C=C2C(=N1)N1CCOCC1, MDL NA |
| Drug_Names: 2-Chloro-4-(3-nitrophenoxy)thieno[3,2-d]pyrimidine, CAS: 1353553-07-7, stock 80.3g, assay 98.7%, MWt 307.71, Formula C12H6ClN3O3S, Purity >98%, SMILES [O-][N+](=O)C1=CC=CC(OC2=NC(Cl)=NC3=C2SC=C3)=C1, MDL NA |
| Drug_Names: 2-chloro-3-nitroisonicotinic acid, CAS: 353281-15-9, stock 648.5g, assay 98.4%, MWt 202.55, Formula C6H3ClN2O4, Purity >98%, SMILES O=C(C1=C([N+]([O-])=O)C(Cl)=NC=C1)O, MDL NA |
| Drug_Names: 2-Chloro-3-methoxy-4-nitropyridine, CAS: 109613-91-4, stock 397.5g, assay 98.5%, MWt 188.57, Formula C6H5ClN2O3, Purity >98%, SMILES COC1=C(Cl)N=CC=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 2-Chloro-3-methanesulfonylpyridine, CAS: 70682-09-6, stock 801.9g, assay 98.5%, MWt 191.64, Formula C6H6ClNO2S, Purity >98%, SMILES CS(=O)(=O)C1=CC=CN=C1Cl, MDL NA |
| Drug_Names: 2-Chloro-3-hydroxyquinoline-4-carboxylic acid, CAS: 847547-91-5, stock 235g, assay 99%, MWt 223.61, Formula C10H6ClNO3, Purity >98%, SMILES OC(=O)C1=C(O)C(Cl)=NC2=CC=CC=C12, MDL NA |
| Drug_Names: 2-Chloro-3H,4H-thieno[3,2-d]pyrimidin-4-one, CAS: 1245811-20-4, stock 558.5g, assay 98.4%, MWt 186.62, Formula C6H3ClN2OS, Purity >98%, SMILES ClC1=NC2=C(SC=C2)C(=O)N1, MDL NA |
| Drug_Names: 2-Chloro-3,5-diiodopyridin-4-amine, CAS: 1171919-00-8, stock 427.4g, assay 98.8%, MWt 380.35, Formula C5H3ClI2N2, Purity >98%, SMILES NC1=C(I)C(Cl)=NC=C1I, MDL NA |
| Drug_Names: 2-Chloro-3-(1,3-dithian-2-yl)pyrazine, CAS: 874114-28-0, stock 420.4g, assay 98.7%, MWt 232.75, Formula C8H9ClN2S2, Purity >98%, SMILES ClC1=NC=CN=C1C1SCCCS1, MDL NA |
| Drug_Names: 2-Chloro-1H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one, CAS: 1613751-69-1, stock 289g, assay 98%, MWt 169.57, Formula C6H4ClN3O, Purity >98%, SMILES ClC1=NC(=O)C2=CC=CN2N1, MDL NA |
| Drug_Names: 2-Chlorobenzo[d]thiazol-7-ol, CAS: 96489-54-2, stock 594.5g, assay 98%, MWt 185.63, Formula C7H4ClNOS, Purity >98%, SMILES OC1=C(SC(Cl)=N2)C2=CC=C1, MDL NA |
| Drug_Names: 2-Chloro-1,3-benzothiazol-6-ol, CAS: 2591-16-4, stock 134.2g, assay 98.5%, MWt 185.63, Formula C7H4ClNOS, Purity >98%, SMILES OC1=CC=C2N=C(Cl)SC2=C1, MDL NA |
| Drug_Names: 2-Chloro-1-(oxan-2-yl)-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole, CAS: 1029684-36-3, stock 164.1g, assay 98.8%, MWt 312.60, Formula C14H22BClN2O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN=C(Cl)N1C1CCCCO1, MDL NA |
| Drug_Names: 2-Carbamoylcyclopropanecarboxylic acid, CAS: 716362-29-7, stock 545.1g, assay 98.7%, MWt 129.11, Formula C5H7NO3, Purity >98%, SMILES NC(=O)C1CC1C(O)=O, MDL NA |
| Drug_Names: 2-Bromopyridin-3-yl acetate, CAS: 92671-70-0, stock 359.6g, assay 98.3%, MWt 216.03, Formula C7H6BrNO2, Purity >98%, SMILES CC(=O)OC1=C(Br)N=CC=C1, MDL NA |
| Drug_Names: 2-Bromo-N-{3-[(4-methoxyphenyl)methoxy]phenyl}thieno[3,2-b]pyridin-7-amine, CAS: 1228102-89-3, stock 431.7g, assay 98.3%, MWt 441.34, Formula C21H17BrN2O2S, Purity >98%, SMILES COC1=CC=C(COC2=CC=CC(NC3=CC=NC4=C3SC(Br)=C4)=C2)C=C1, MDL NA |
| Drug_Names: 2-Bromoimidazo[1,2-a]pyridine-8-carbaldehyde, CAS: 372147-48-3, stock 325.7g, assay 98.1%, MWt 225.04, Formula C8H5BrN2O, Purity >98%, SMILES O=CC1=CC=CN2C1=NC(Br)=C2, MDL NA |
| Drug_Names: 2-Bromo-7-chloro-3H-imidazo[4,5-b]pyridine, CAS: 1401687-53-3, stock 99.5g, assay 98.7%, MWt 232.47, Formula C6H3BrClN3, Purity >98%, SMILES ClC1=CC=NC2=C1N=C(Br)N2, MDL NA |
| Drug_Names: 2-Bromo-6-methylpyridine-3-carbonitrile, CAS: 155265-57-9, stock 221.2g, assay 98.7%, MWt 197.03, Formula C7H5BrN2, Purity >98%, SMILES CC1=CC=C(C#N)C(Br)=N1, MDL NA |
| Drug_Names: 2-Bromo-6-methyl-5H-pyrrolo[2,3-b]pyrazine, CAS: 1228450-58-5, stock 543.1g, assay 98%, MWt 212.05, Formula C7H6BrN3, Purity >98%, SMILES CC1=CC2=NC(Br)=CN=C2N1, MDL NA |
| Drug_Names: 2-Bromo-5-methylpyrazine, CAS: 98006-90-7, stock 621.5g, assay 98.8%, MWt 173.01, Formula C5H5BrN2, Purity >98%, SMILES CC1=CN=C(Br)C=N1, MDL NA |
| Drug_Names: 2-Bromo-5-fluoroisonicotinonitrile, CAS: 1256822-16-8, stock 784.9g, assay 99%, MWt 201.00, Formula C6H2BrFN2, Purity >98%, SMILES FC1=CN=C(Br)C=C1C#N, MDL NA |
| Drug_Names: 2-Bromo-5-fluoropyridine-3-carbonitrile, CAS: 1305208-36-9, stock 542.7g, assay 98.7%, MWt 201.00, Formula C6H2BrFN2, Purity >98%, SMILES FC1=CC(C#N)=C(Br)N=C1, MDL NA |
| Drug_Names: 2-Bromo-5-fluoropyridin-4-amine, CAS: 887570-94-7, stock 397.3g, assay 98.5%, MWt 191.00, Formula C5H4BrFN2, Purity >98%, SMILES NC1=C(F)C=NC(Br)=C1, MDL NA |
| Drug_Names: 2-Bromo-5-fluoro-1,3-thiazole, CAS: 1209458-83-2, stock 872.2g, assay 98.5%, MWt 182.01, Formula C3HBrFNS, Purity >98%, SMILES FC1=CN=C(Br)S1, MDL NA |
| Drug_Names: 2-Bromo-5-ethoxypyrimidine, CAS: 1209459-25-5, stock 375.8g, assay 98.2%, MWt 203.04, Formula C6H7BrN2O, Purity >98%, SMILES CCOC1=CN=C(Br)N=C1, MDL NA |
| Drug_Names: 2-Bromo-5,8-dioxaspiro[3.4]octane, CAS: 1257996-82-9, stock 387.8g, assay 98.4%, MWt 193.04, Formula C6H9BrO2, Purity >98%, SMILES BrC1CC2(C1)OCCO2, MDL MFCD20637976 |
| Drug_Names: 2-Bromo-5-(1-methyl-piperidin-4-ylmethoxy)pyrimidine, CAS: 1419101-22-6, stock 252.9g, assay 98.6%, MWt 286.17, Formula C11H16BrN3O, Purity >98%, SMILES CN1CCC(COC2=CN=C(Br)N=C2)CC1, MDL NA |
| Drug_Names: 2-Bromo-4-chloropyridine-3-carbaldehyde, CAS: 1289197-78-9, stock 196.5g, assay 98.7%, MWt 220.45, Formula C6H3BrClNO, Purity >98%, SMILES ClC1=CC=NC(Br)=C1C=O, MDL NA |
| Drug_Names: 2-Bromo-4-chloro-3-methylpyridine, CAS: 1211521-46-8, stock 431.6g, assay 98.1%, MWt 206.47, Formula C6H5BrClN, Purity >98%, SMILES CC1=C(Cl)C=CN=C1Br, MDL NA |
| Drug_Names: 2-Bromo-3H-imidazo[4,5-c]pyridine, CAS: 1557344-85-0, stock 140.8g, assay 99%, MWt 198.02, Formula C6H4BrN3, Purity >98%, SMILES BrC1=NC2=CC=NC=C2N1, MDL NA |
| Drug_Names: 2-Bromo-3H-imidazo[4,5-b]pyridine, CAS: 1380245-88-4, stock 66.1g, assay 98.4%, MWt 198.02, Formula C6H4BrN3, Purity >98%, SMILES BrC1=NC2=C(N1)N=CC=C2, MDL NA |
| Drug_Names: 2-Bromo-3,5,6-trifluoropyridine, CAS: 1186194-66-0, stock 787.7g, assay 98.7%, MWt 211.97, Formula C5HBrF3N, Purity >98%, SMILES FC1=CC(F)=C(F)N=C1Br, MDL NA |
| Drug_Names: 2-Bromo-1-cyclopropylpropan-1-one, CAS: 34650-66-3, stock 752.1g, assay 98.1%, MWt 177.04, Formula C6H9BrO, Purity >98%, SMILES CC(Br)C(=O)C1CC1, MDL NA |
| Drug_Names: 2-Bromo-1-(3,3-difluorocyclobutyl)ethan-1-one, CAS: 1619911-80-6, stock 538.5g, assay 98.3%, MWt 213.02, Formula C6H7BrF2O, Purity >98%, SMILES FC1(F)CC(C1)C(=O)CBr, MDL NA |
| Drug_Names: tert-Butyl 7-formyl-3,4-dihydro-[1,4]diazepino[6,7,1-hi]indole-2(1H)-carboxylate, CAS: 1122597-86-7, stock 293.3g, assay 98.3%, MWt 300.35, Formula C17H20N2O3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCN2C=C(C=O)C3=CC=CC(C1)=C23, MDL NA |
| Drug_Names: 2-Boc-6-hydroxy-2-azabicyclo[2.2.2]octane, CAS: 1311391-25-9, stock 615.3g, assay 98.3%, MWt 227.30, Formula C12H21NO3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CCC1C(O)C2, MDL NA |
| Drug_Names: 2-(tert-Butoxycarbonyl)-5-thia-2-azaspiro[3.4]octane-8-carboxylic acid 5,5-dioxide, CAS: 1340481-81-3, stock 576.7g, assay 98.8%, MWt 305.35, Formula C12H19NO6S, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2(C1)C(CCS2(=O)=O)C(O)=O, MDL NA |
| Drug_Names: 2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.2]octane-6-carboxylic acid, CAS: 1250997-05-7, stock 282.1g, assay 98.4%, MWt 255.31, Formula C13H21NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CCC1C(C2)C(O)=O, MDL NA |
| Drug_Names: tert-Butyl 2,6-diazabicyclo[3.2.0]heptane-2-carboxylate, CAS: 1204405-68-4, stock 716g, assay 98.3%, MWt 198.26, Formula C10H18N2O2, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC2NCC12, MDL NA |
| Drug_Names: 2-Benzyl-2-azabicyclo[2.2.2]octan-6-ol, CAS: 41959-29-9, stock 43.8g, assay 98.9%, MWt 217.31, Formula C14H19NO, Purity >98%, SMILES OC1CC2CCC1N(CC1=CC=CC=C1)C2, MDL NA |
| Drug_Names: 2-Benzyl-4-chloro-2H-pyrazolo[4,3-c]pyridine, CAS: 41372-95-6, stock 790.9g, assay 98.6%, MWt 243.69, Formula C13H10ClN3, Purity >98%, SMILES ClC1=NC=CC2=NN(CC3=CC=CC=C3)C=C12, MDL NA |
| Drug_Names: 2-Benzyl-4-bromo-2H-indazole, CAS: 952734-38-2, stock 75.8g, assay 98.6%, MWt 287.15, Formula C14H11BrN2, Purity >98%, SMILES BrC1=CC=CC2=NN(CC3=CC=CC=C3)C=C12, MDL NA |
| Drug_Names: 2-Benzyl-2-azabicyclo[3.1.1]heptane-1-carboxylic acid, CAS: 1334367-72-4, stock 1.1g, assay 98.2%, MWt 231.29, Formula C14H17NO2, Purity >98%, SMILES OC(=O)C12CC(C1)CCN2CC1=CC=CC=C1, MDL NA |
| Drug_Names: 2-Benzyl-2,7-diazaspiro[4.4]nonane-1,3-dione hydrochloride, CAS: 1949836-83-2, stock 436.7g, assay 98.2%, MWt 280.75, Formula C14H17ClN2O2, Purity >98%, SMILES Cl.O=C1CC2(CCNC2)C(=O)N1CC1=CC=CC=C1, MDL NA |
| Drug_Names: 2-Benzyl-2,6-diazaspiro[3.3]heptane oxalate, CAS: 1394840-24-4, stock 617.1g, assay 98.8%, MWt 278.30, Formula C14H18N2O4, Purity >98%, SMILES OC(=O)C(O)=O.C(N1CC2(CNC2)C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: (S)-1-methylazetidine-2-carboxylic acid, CAS: 255882-95-2, stock 745.3g, assay 98.4%, MWt 115.13, Formula C5H9NO2, Purity >98%, SMILES CN1CC[C@H]1C(O)=O, MDL NA |
| Drug_Names: (R)-1-methylazetidine-2-carboxylic acid, CAS: 255883-21-7, stock 697.5g, assay 98.9%, MWt 115.13, Formula C5H9NO2, Purity >98%, SMILES CN1CC[C@@H]1C(O)=O, MDL NA |
| Drug_Names: Methyl 2-azaadamantane-5-carboxylate, CAS: 1389264-13-4, stock 512.8g, assay 98.6%, MWt 195.26, Formula C11H17NO2, Purity >98%, SMILES O=C(OC)[C@@]12C[C@H](C3)C[C@H](N[C@H]3C2)C1, MDL NA |
| Drug_Names: 2-Azaspiro[4.5]decane-7-carboxylic acid, CAS: 1363382-89-1, stock 109.5g, assay 98.4%, MWt 183.25, Formula C10H17NO2, Purity >98%, SMILES OC(=O)C1CCCC2(CCNC2)C1, MDL NA |
| Drug_Names: 2-Azaspiro[4.5]decane-3,8-dione, CAS: 914780-96-4, stock 356.9g, assay 99%, MWt 167.21, Formula C9H13NO2, Purity >98%, SMILES O=C1CC2(CN1)CCC(=O)CC2, MDL NA |
| Drug_Names: 2-Azaspiro[4.5]decane hydrochloride, CAS: 36392-74-2, stock 665.3g, assay 98.4%, MWt 175.70, Formula C9H18ClN, Purity >98%, SMILES Cl.C1CC2(CN1)CCCCC2, MDL NA |
| Drug_Names: 2-Azaspiro[3.5]nonane, CAS: 666-08-0, stock 356.5g, assay 98.5%, MWt 125.21, Formula C8H15N, Purity >98%, SMILES C1NCC11CCCCC1, MDL NA |
| Drug_Names: 2-Azaspiro[3.4]octane oxalate(2:1), CAS: 1523617-94-8, stock 681.9g, assay 98.5%, MWt 312.40, Formula C16H28N2O4, Purity >98%, SMILES OC(=O)C(O)=O.C1NCC11CCCC1.C1NCC11CCCC1, MDL NA |
| Drug_Names: 2-Azaspiro[3.3]heptane oxalate(2:1), CAS: 1365639-13-9, stock 144.4g, assay 98.7%, MWt 284.35, Formula C14H24N2O4, Purity >98%, SMILES OC(=O)C(O)=O.C1CC2(C1)CNC2.C1CC2(C1)CNC2, MDL NA |
| Drug_Names: 2-Azaspiro[3.3]heptan-6-one trifluoroacetate, CAS: 1818847-38-9, stock 835.3g, assay 98.8%, MWt 225.17, Formula C8H10F3NO3, Purity >98%, SMILES OC(=O)C(F)(F)F.O=C1CC2(CNC2)C1, MDL NA |
| Drug_Names: 2-Azabicyclo[4.1.0]heptane-1-carboxylic acid hydrochloride, CAS: 1628734-73-5, stock 846.7g, assay 98.1%, MWt 177.63, Formula C7H12ClNO2, Purity >98%, SMILES Cl.OC(=O)C12CC1CCCN2, MDL NA |
| Drug_Names: 2-Azabicyclo[3.1.1]heptane-1-carboxylic acid hydrochloride, CAS: 1172802-41-3, stock 547.7g, assay 98.5%, MWt 177.63, Formula C7H12ClNO2, Purity >98%, SMILES Cl.OC(=O)C12CC(C1)CCN2, MDL NA |
| Drug_Names: 2-Azabicyclo[2.2.2]octane hydrochloride, CAS: 5845-15-8, stock 200.4g, assay 98.6%, MWt 147.65, Formula C7H14ClN, Purity >98%, SMILES Cl.C1CC2CCC1CN2, MDL NA |
| Drug_Names: 2-Azabicyclo[2.2.2]octan-5-one, CAS: 1514112-02-7, stock 53.8g, assay 98.5%, MWt 125.17, Formula C7H11NO, Purity >98%, SMILES O=C1C2CNC(CC2)C1, MDL NA |
| Drug_Names: 1-(Hydroxymethyl)-2-azabicyclo[2.2.2]octan-3-one, CAS: 1334412-35-9, stock 225.4g, assay 98.1%, MWt 155.19, Formula C8H13NO2, Purity >98%, SMILES OCC12CCC(CC1)C(=O)N2, MDL NA |
| Drug_Names: 2-Azabicyclo[2.2.2]octan-3-one, CAS: 3306-69-2, stock 247.7g, assay 98.1%, MWt 125.17, Formula C7H11NO, Purity >98%, SMILES O=C1N[C@@H]2CC[C@H]1CC2, MDL NA |
| Drug_Names: 2-Aza-bicyclo[2.2.1]heptane-2,6-dicarboxylic acid 2-tert-butyl ester, CAS: 1860028-20-1, stock 190.9g, assay 98.5%, MWt 241.28, Formula C12H19NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CC1C(C2)C(O)=O, MDL NA |
| Drug_Names: 2-Azabicyclo[2.2.1]heptan-6-ol hydrochloride, CAS: 2007916-89-2, stock 661g, assay 98.8%, MWt 149.62, Formula C6H12ClNO, Purity >98%, SMILES Cl.OC1CC2CNC1C2, MDL NA |
| Drug_Names: 2-Azabicyclo[2.2.1]heptan-5-ol hydrochloride, CAS: 1780693-48-2, stock 755.2g, assay 98.5%, MWt 149.62, Formula C6H12ClNO, Purity >98%, SMILES Cl.OC1CC2CC1CN2, MDL NA |
| Drug_Names: 2-Azabicyclo[2.1.1]hexane hydrochloride, CAS: 871658-02-5, stock 748.3g, assay 98.1%, MWt 119.59, Formula C5H10ClN, Purity >98%, SMILES Cl.C1C2CC1NC2, MDL NA |
| Drug_Names: 2-Aminobenzo[d]thiazol-5-ol, CAS: 118526-19-5, stock 88.5g, assay 98.7%, MWt 166.20, Formula C7H6N2OS, Purity >98%, SMILES NC1=NC2=CC(O)=CC=C2S1, MDL NA |
| Drug_Names: 8-Methyl-8-azabicyclo[3.2.1]octan-2-amine, CAS: 1314981-01-5, stock 704.2g, assay 98.7%, MWt 140.23, Formula C8H16N2, Purity >98%, SMILES CN1C2CCC1C(N)CC2, MDL NA |
| Drug_Names: 2-Amino-7-bromo-1H,4H-imidazo[2,1-f][1,2,4]triazin-4-one, CAS: 1379323-68-8, stock 583.2g, assay 98.2%, MWt 230.02, Formula C5H4BrN5O, Purity >98%, SMILES NC1=NC(=O)C2=NC=C(Br)N2N1, MDL NA |
| Drug_Names: 2-Amino-6-methylpyridine-4-carboxylic acid, CAS: 65169-64-4, stock 884.1g, assay 98.9%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES CC1=CC(=CC(N)=N1)C(O)=O, MDL NA |
| Drug_Names: 2-Amino-5-fluoropyridine-3-carboxylic acid, CAS: 1196154-03-6, stock 65.9g, assay 98.1%, MWt 156.11, Formula C6H5FN2O2, Purity >98%, SMILES NC1=NC=C(F)C=C1C(O)=O, MDL NA |
| Drug_Names: 2-Amino-5-bromo-4-methylpyridine-3-carbonitrile, CAS: 180994-87-0, stock 93.9g, assay 98.5%, MWt 212.05, Formula C7H6BrN3, Purity >98%, SMILES CC1=C(C#N)C(N)=NC=C1Br, MDL NA |
| Drug_Names: 2-Amino-4-fluoro-5-methoxybenzoic acid, CAS: 637347-90-1, stock 728.6g, assay 98.8%, MWt 185.15, Formula C8H8FNO3, Purity >98%, SMILES COC1=C(F)C=C(N)C(=C1)C(O)=O, MDL NA |
| Drug_Names: 4-(Dimethoxymethyl)pyridin-2-amine, CAS: 889945-19-1, stock 392g, assay 98.4%, MWt 168.19, Formula C8H12N2O2, Purity >98%, SMILES NC1=NC=CC(C(OC)OC)=C1, MDL NA |
| Drug_Names: 2-Amino-4,4-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-5-one, CAS: 1621686-10-9, stock 52.7g, assay 98%, MWt 196.27, Formula C9H12N2OS, Purity >98%, SMILES CC1(C)C2=C(CCC1=O)SC(N)=N2, MDL NA |
| Drug_Names: 2-Amino-3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}propanoic acid, CAS: 1255666-24-0, stock 612.8g, assay 98.9%, MWt 272.34, Formula C13H24N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC(CC(N)C(O)=O)CC1, MDL NA |
| Drug_Names: 2-Amino-2-(oxetan-3-yl)acetic acid, CAS: 1270019-87-8, stock 616.1g, assay 98.2%, MWt 131.13, Formula C5H9NO3, Purity >98%, SMILES NC(C1COC1)C(O)=O, MDL NA |
| Drug_Names: 2-Amino-2-(1-methylcyclopropyl)acetic acid hydrochloride, CAS: 938058-08-3, stock 817.2g, assay 98%, MWt 165.62, Formula C6H12ClNO2, Purity >98%, SMILES Cl.CC1(CC1)C(N)C(O)=O, MDL NA |
| Drug_Names: 2-Amino-1,3-oxazole-4-carboxylic acid, CAS: 944900-52-1, stock 402.9g, assay 98.9%, MWt 128.09, Formula C4H4N2O3, Purity >98%, SMILES NC1=NC(=CO1)C(O)=O, MDL NA |
| Drug_Names: 2-Acetyl-6-bromobenzofuran-4,7-dione, CAS: 1392804-26-0, stock 814.9g, assay 98.5%, MWt 269.05, Formula C10H5BrO4, Purity >98%, SMILES CC(=O)C1=CC2=C(O1)C(=O)C(Br)=CC2=O, MDL NA |
| Drug_Names: 2-Acetyl-5-bromobenzofuran-4,7-dione, CAS: 1389264-29-2, stock 869.3g, assay 98.4%, MWt 269.05, Formula C10H5BrO4, Purity >98%, SMILES CC(=O)C1=CC2=C(O1)C(=O)C=C(Br)C2=O, MDL NA |
| Drug_Names: 2-{Bicyclo[1.1.1]pentan-1-yl}propanoic acid, CAS: 2102409-83-4, stock 205.9g, assay 98.6%, MWt 140.18, Formula C8H12O2, Purity >98%, SMILES CC(C(O)=O)C12CC(C1)C2, MDL NA |
| Drug_Names: 2-(8-Oxabicyclo[3.2.1]octan-3-yl)acetic acid, CAS: 1098432-95-1, stock 642g, assay 98%, MWt 170.21, Formula C9H14O3, Purity >98%, SMILES OC(=O)CC1CC2CCC(C1)O2, MDL NA |
| Drug_Names: 2-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)isoindoline-1,3-dione, CAS: 741686-49-7, stock 197.8g, assay 98.3%, MWt 264.24, Formula C14H8N4O2, Purity >98%, SMILES O=C1N(C(=O)C2=C1C=CC=C2)C1=C2C=CNC2=NC=N1, MDL NA |
| Drug_Names: 2-{5-Azaspiro[2.4]heptan-7-yl}acetic acid, CAS: 2055841-30-8, stock 443g, assay 98.8%, MWt 155.19, Formula C8H13NO2, Purity >98%, SMILES OC(=O)CC1CNCC11CC1, MDL NA |
| Drug_Names: 2-{4-Aminobicyclo[2.2.2]octan-1-yl}acetic acid hydrochloride, CAS: 28345-44-0, stock 389.8g, assay 98.1%, MWt 219.71, Formula C10H18ClNO2, Purity >98%, SMILES Cl.NC12CCC(CC(O)=O)(CC1)CC2, MDL NA |
| Drug_Names: 2-{2-Methyl-5-[4-(methylsulfanyl)phenyl]-1H-pyrrol-1-yl}ethan-1-ol, CAS: 494850-27-0, stock 59.3g, assay 98.4%, MWt 247.36, Formula C14H17NOS, Purity >98%, SMILES CSC1=CC=C(C=C1)C1=CC=C(C)N1CCO, MDL NA |
| Drug_Names: 2-{2-[(tert-Butoxy)carbonyl]-2-azaspiro[3.3]heptan-6-yl}acetic acid, CAS: 1251002-39-7, stock 322g, assay 98.5%, MWt 255.31, Formula C13H21NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2(CC(CC(O)=O)C2)C1, MDL NA |
| Drug_Names: 2-(1H-Pyrrolo[2,3-b]pyridin-1-yl)acetic acid, CAS: 1048913-13-8, stock 631.7g, assay 98.1%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES OC(=O)CN1C=CC2=CC=CN=C12, MDL NA |
| Drug_Names: 2-(1-((Benzyloxy)carbonyl)piperidin-3-yl)acetic acid, CAS: 86827-10-3, stock 787.9g, assay 99%, MWt 277.32, Formula C15H19NO4, Purity >98%, SMILES OC(=O)CC1CCCN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 2-(1-((Benzyloxy)carbonyl)azetidin-3-yl)acetic acid, CAS: 319470-14-9, stock 649.4g, assay 98.7%, MWt 249.26, Formula C13H15NO4, Purity >98%, SMILES OC(=O)CC1CN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 2-((tert-Butoxycarbonyl)amino)-3-cyclobutylpropanoic acid, CAS: 565456-75-9, stock 90.3g, assay 98.4%, MWt 243.30, Formula C12H21NO4, Purity >98%, SMILES CC(C)(C)OC(=O)NC(CC1CCC1)C(O)=O, MDL NA |
| Drug_Names: 2-((tert-Butoxycarbonyl)amino)-3-(3,3-difluorocyclobutyl)propanoic acid, CAS: 681128-43-8, stock 147.1g, assay 98.3%, MWt 279.28, Formula C12H19F2NO4, Purity >98%, SMILES CC(C)(C)OC(=O)NC(CC1CC(F)(F)C1)C(O)=O, MDL NA |
| Drug_Names: 2-((tert-Butoxycarbonyl)amino)-2-(oxetan-3-yl)acetic acid, CAS: 1408074-43-0, stock 115g, assay 99%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES CC(C)(C)OC(=O)NC(C1COC1)C(O)=O, MDL NA |
| Drug_Names: 2-{[(tert-Butoxy)carbonyl]amino}-2-(1-methyl-1H-pyrazol-4-yl)acetic acid, CAS: 1394970-92-3, stock 764.2g, assay 98.9%, MWt 255.27, Formula C11H17N3O4, Purity >98%, SMILES CN1C=C(C=N1)C(NC(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: rel-2-((1r,4r)-4-Aminocyclohexyl)acetonitrile hydrochloride, CAS: 1313279-48-9, stock 95.9g, assay 98.2%, MWt 174.67, Formula C8H15ClN2, Purity >98%, SMILES N[C@H]1CC[C@@H](CC1)CC#N.Cl, MDL MFCD30146461 |
| Drug_Names: 2-[trans-3-Aminocyclobutyl]propan-2-ol hydrochloride, CAS: 2058249-61-7, stock 804.9g, assay 98.7%, MWt 165.66, Formula C7H16ClNO, Purity >98%, SMILES Cl.CC(C)(O)[C@H]1C[C@H](N)C1, MDL NA |
| Drug_Names: 2-[Cyclopropyl(ethoxy)methylidene]propanedinitrile, CAS: 1935012-39-7, stock 639.2g, assay 98.3%, MWt 162.19, Formula C9H10N2O, Purity >98%, SMILES CCOC(C1CC1)=C(C#N)C#N, MDL NA |
| Drug_Names: rel-2-((1s,3s)-3-((tert-Butoxycarbonyl)amino)cyclobutyl)acetic acid, CAS: 1434141-68-0, stock 601.5g, assay 98.9%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES O=C(O)C[C@@H]1C[C@H](NC(OC(C)(C)C)=O)C1, MDL MFCD27956897 |
| Drug_Names: 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile, CAS: 138500-86-4, stock 579.8g, assay 98.5%, MWt 243.11, Formula C14H18BNO2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CC=C(CC#N)C=C1, MDL NA |
| Drug_Names: 2-(2-(Methoxymethoxy)-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 517864-11-8, stock 154g, assay 98.8%, MWt 278.15, Formula C15H23BO4, Purity >98%, SMILES COCOC1=C(C=CC(C)=C1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-[1-(Trifluoromethyl)cyclopropyl]ethan-1-amine hydrochloride, CAS: 1454690-80-2, stock 332.4g, assay 98.5%, MWt 189.61, Formula C6H11ClF3N, Purity >98%, SMILES Cl.NCCC1(CC1)C(F)(F)F, MDL NA |
| Drug_Names: 2-[1-(Ethanesulfonyl)piperidin-4-ylidene]acetonitrile, CAS: 2102412-13-3, stock 290.3g, assay 98.8%, MWt 214.28, Formula C9H14N2O2S, Purity >98%, SMILES CCS(=O)(=O)N1CCC(CC1)=CC#N, MDL NA |
| Drug_Names: 2-[1-(Bromomethyl)cyclopropyl]acetonitrile, CAS: 338392-48-6, stock 896.3g, assay 98.9%, MWt 174.04, Formula C6H8BrN, Purity >98%, SMILES BrCC1(CC#N)CC1, MDL NA |
| Drug_Names: 2-(1-(Benzyloxy)-2-methylpropan-2-yl)-6-fluoro-5-nitro-1H-indole, CAS: 1638771-94-4, stock 631.7g, assay 98.1%, MWt 342.36, Formula C19H19FN2O3, Purity >98%, SMILES CC(C)(COCC1=CC=CC=C1)C1=CC2=C(N1)C=C(F)C(=C2)[N+]([O-])=O, MDL NA |
| Drug_Names: 2-(tert-Butoxycarbonyl)-5-oxooctahydrocyclopenta[c]pyrrole-1-carboxylic acid, CAS: 1419100-98-3, stock 872.4g, assay 98.8%, MWt 269.29, Formula C13H19NO5, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CC(=O)CC2C1C(O)=O, MDL NA |
| Drug_Names: 2-(tert-Butoxycarbonyl)-2-azaspiro[5.5]undecane-9-carboxylic acid, CAS: 1352882-80-4, stock 700.5g, assay 98.8%, MWt 297.39, Formula C16H27NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCCC2(CCC(CC2)C(O)=O)C1, MDL NA |
| Drug_Names: 2-Boc-2-azaspiro[4.5]decane-8-carboxylic acid, CAS: 1363381-87-6, stock 892.6g, assay 98.1%, MWt 283.36, Formula C15H25NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC2(C1)CCC(CC2)C(O)=O, MDL NA |
| Drug_Names: 2-[(tert-Butoxy)carbonyl]-2-azaspiro[4.5]decane-7-carboxylic acid, CAS: 1363381-11-6, stock 771.5g, assay 98.9%, MWt 283.36, Formula C15H25NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC2(C1)CCCC(C2)C(O)=O, MDL NA |
| Drug_Names: 2-[(tert-Butoxy)carbonyl]-2-azaspiro[3.5]nonane-7-carboxylic acid, CAS: 1363381-18-3, stock 346.5g, assay 98.9%, MWt 269.34, Formula C14H23NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2(C1)CCC(CC2)C(O)=O, MDL NA |
| Drug_Names: 2-[(tert-Butoxy)carbonyl]-2-azabicyclo[2.2.2]octane-4-carboxylic acid, CAS: 1936695-68-9, stock 306.1g, assay 98.3%, MWt 255.31, Formula C13H21NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2(CCC1CC2)C(O)=O, MDL NA |
| Drug_Names: 2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-5-carboxylic acid, CAS: 1363210-41-6, stock 167.5g, assay 98.4%, MWt 241.28, Formula C12H19NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC2CC1CC2C(O)=O, MDL NA |
| Drug_Names: (E)-2-(2-Ethoxyvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 1201905-61-4, stock 680.5g, assay 98%, MWt 198.07, Formula C10H19BO3, Purity >98%, SMILES CC1(C)C(C)(C)OB(/C=C/OCC)O1, MDL MFCD09998813 |
| Drug_Names: 2-((Benzyloxy)carbonyl)-2-azaspiro[3.3]heptane-6-carboxylic acid, CAS: 1291487-33-6, stock 677.8g, assay 98.7%, MWt 275.30, Formula C15H17NO4, Purity >98%, SMILES OC(=O)C1CC2(C1)CN(C2)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-6-oxodecahydroisoquinoline-3-carboxylic acid, CAS: 1403766-52-8, stock 144g, assay 98.1%, MWt 419.47, Formula C25H25NO5, Purity >98%, SMILES OC(=O)C1CC2CC(=O)CCC2CN1C(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2, MDL NA |
| Drug_Names: 2-((S)-Dec-1-yn-5-yloxy)tetrahydro-2H-pyran, CAS: 223734-62-1, stock 896g, assay 98.8%, MWt 238.37, Formula C15H26O2, Purity >98%, SMILES CCCCC[C@@H](CCC#C)OC1CCCCO1, MDL NA |
| Drug_Names: (S)-2-(2,2-Dimethyl-[1,3]dioxolan-4-yl)ethanol, CAS: 32233-43-5, stock 819.1g, assay 98.2%, MWt 146.18, Formula C7H14O3, Purity >98%, SMILES CC1(C)OC[C@H](CCO)O1, MDL NA |
| Drug_Names: 2-((4-Methylpiperazin-1-yl)methyl)quinolin-6-amine, CAS: 832102-03-1, stock 217.2g, assay 98.8%, MWt 256.35, Formula C15H20N4, Purity >98%, SMILES CN1CCN(CC2=NC3=C(C=C2)C=C(N)C=C3)CC1, MDL NA |
| Drug_Names: 2-(4-Fluorobenzyl)-5-iodothiophene, CAS: 154355-88-1, stock 123.4g, assay 98.6%, MWt 318.15, Formula C11H8FIS, Purity >98%, SMILES FC1=CC=C(CC2=CC=C(I)S2)C=C1, MDL NA |
| Drug_Names: (S)-2-(Pyrrolidin-3-yl)propan-2-ol, CAS: 1245645-24-2, stock 679.9g, assay 99%, MWt 129.20, Formula C7H15NO, Purity >98%, SMILES CC(C)(O)[C@H]1CCNC1, MDL NA |
| Drug_Names: (S)-2-(Pyrrolidin-3-yl)acetic acid, CAS: 122442-02-8, stock 554.7g, assay 99%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES OC(=O)C[C@@H]1CCNC1, MDL NA |
| Drug_Names: (R)-2-(Pyrrolidin-3-yl)propan-2-ol, CAS: 1245649-03-9, stock 303.1g, assay 98.7%, MWt 129.20, Formula C7H15NO, Purity >98%, SMILES CC(C)(O)[C@@H]1CCNC1, MDL NA |
| Drug_Names: (R)-2-(1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)acetic acid, CAS: 204688-60-8, stock 0.2g, assay 98.3%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC[C@H](CC(O)=O)C1, MDL NA |
| Drug_Names: (S)-2-(Pyrrolidin-2-yl)propan-2-ol, CAS: 92053-25-3, stock 88.5g, assay 98%, MWt 129.20, Formula C7H15NO, Purity >98%, SMILES CC(C)(O)[C@@H]1CCCN1, MDL NA |
| Drug_Names: 2-[(2S)-azetidin-2-yl]propan-2-ol hydrochloride, CAS: 935669-11-7, stock 424.7g, assay 98.1%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CC(C)(O)[C@@H]1CCN1, MDL NA |
| Drug_Names: 2,9-diazaspiro[5.5]undecan-1-one hydrochloride, CAS: 1187173-73-4, stock 664.5g, assay 98.2%, MWt 204.70, Formula C9H17ClN2O, Purity >98%, SMILES Cl.O=C1NCCCC11CCNCC1, MDL NA |
| Drug_Names: 2,8-Dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-amine, CAS: 1417637-80-9, stock 491.9g, assay 98.5%, MWt 162.19, Formula C8H10N4, Purity >98%, SMILES CC1=NN2C=C(N)C=C(C)C2=N1, MDL NA |
| Drug_Names: 2,8-Dichloro-1,5-naphthyridine, CAS: 28252-76-8, stock 321.7g, assay 98.2%, MWt 199.04, Formula C8H4Cl2N2, Purity >98%, SMILES ClC1=NC2=C(C=C1)N=CC=C2Cl, MDL NA |
| Drug_Names: 2,8-Dibromo-1,5-naphthyridine, CAS: 1363380-58-8, stock 451.8g, assay 98.7%, MWt 287.94, Formula C8H4Br2N2, Purity >98%, SMILES BrC1=CC=C2N=CC=C(Br)C2=N1, MDL NA |
| Drug_Names: 2,7-Naphthyridine-3-carboxylic acid, CAS: 250674-48-7, stock 44.3g, assay 98.6%, MWt 174.16, Formula C9H6N2O2, Purity >98%, SMILES OC(=O)C1=CC2=CC=NC=C2C=N1, MDL NA |
| Drug_Names: 2,7-Diazaspiro[4.4]nonan-1-one hydrochloride, CAS: 1203682-17-0, stock 642.2g, assay 98%, MWt 176.64, Formula C7H13ClN2O, Purity >98%, SMILES Cl.O=C1NCCC11CCNC1, MDL NA |
| Drug_Names: 2,7-Diazaspiro[3.5]nonane dihydrochloride, CAS: 1334499-85-2, stock 176.8g, assay 98.9%, MWt 199.12, Formula C7H16Cl2N2, Purity >98%, SMILES Cl.Cl.C1NCC11CCNCC1, MDL NA |
| Drug_Names: Diethyl spiro[3.3]heptane-2,6-dicarboxylate, CAS: 132616-34-3, stock 276.4g, assay 99%, MWt 240.30, Formula C13H20O4, Purity >98%, SMILES CCOC(=O)C1CC2(C1)CC(C2)C(=O)OCC, MDL NA |
| Drug_Names: 2,6-Dichloroquinazoline, CAS: 67092-18-6, stock 520.1g, assay 98.5%, MWt 199.04, Formula C8H4Cl2N2, Purity >98%, SMILES ClC1=CC2=CN=C(Cl)N=C2C=C1, MDL NA |
| Drug_Names: 2,6-Dichloro-8-methyl-9H-purine, CAS: 57476-37-6, stock 804.4g, assay 98.3%, MWt 203.03, Formula C6H4Cl2N4, Purity >98%, SMILES CC1=NC2=C(Cl)N=C(Cl)N=C2N1, MDL NA |
| Drug_Names: 2,6-Dichloro-9-isopropyl-8-methyl-9H-purine, CAS: 1313026-86-6, stock 136.4g, assay 99%, MWt 245.11, Formula C9H10Cl2N4, Purity >98%, SMILES CC(C)N1C(C)=NC2=C(Cl)N=C(Cl)N=C12, MDL NA |
| Drug_Names: 2,6-Dichloro-4-cyanobenzoic acid, CAS: 1258298-05-3, stock 67.1g, assay 98.8%, MWt 216.02, Formula C8H3Cl2NO2, Purity >98%, SMILES OC(=O)C1=C(Cl)C=C(C=C1Cl)C#N, MDL NA |
| Drug_Names: 2,6-Dibromonicotinaldehyde, CAS: 55304-83-1, stock 132.5g, assay 98.9%, MWt 264.90, Formula C6H3Br2NO, Purity >98%, SMILES O=CC1=CC=C(N=C1Br)Br, MDL NA |
| Drug_Names: 2,6-Diazaspiro[3.4]octane dihydrochloride, CAS: 1630906-93-2, stock 145.4g, assay 98.4%, MWt 185.09, Formula C6H14Cl2N2, Purity >98%, SMILES Cl.Cl.C1NCC11CCNC1, MDL NA |
| Drug_Names: 2,6-Diazaspiro[3.4]octan-7-one hydrochloride, CAS: 1956355-12-6, stock 271.5g, assay 98.2%, MWt 162.62, Formula C6H11ClN2O, Purity >98%, SMILES Cl.O=C1CC2(CNC2)CN1, MDL NA |
| Drug_Names: 2,6-Diazaspiro[3.4]octan-5-one hydrochloride, CAS: 1203683-28-6, stock 142g, assay 98.5%, MWt 162.62, Formula C6H11ClN2O, Purity >98%, SMILES Cl.O=C1NCCC11CNC1, MDL NA |
| Drug_Names: 2,6-Diazaspiro[3.4]octan-5-one, CAS: 1203797-62-9, stock 499.1g, assay 98.5%, MWt 126.16, Formula C6H10N2O, Purity >98%, SMILES O=C1NCCC11CNC1, MDL NA |
| Drug_Names: 2,5-Dichloropyridine-3,4-diamine, CAS: 405230-94-6, stock 516.5g, assay 99%, MWt 178.02, Formula C5H5Cl2N3, Purity >98%, SMILES NC1=C(N)C(Cl)=NC=C1Cl, MDL NA |
| Drug_Names: 2,5-Dichloro-1,3-thiazole, CAS: 16629-14-4, stock 327.3g, assay 98%, MWt 154.02, Formula C3HCl2NS, Purity >98%, SMILES ClC1=CN=C(Cl)S1, MDL NA |
| Drug_Names: 2,5-Dibromopyridin-3-amine, CAS: 90902-84-4, stock 108g, assay 98.5%, MWt 251.91, Formula C5H4Br2N2, Purity >98%, SMILES NC1=CC(Br)=CN=C1Br, MDL MFCD09266224 |
| Drug_Names: 2,5-Dibromo-1-methyl-1H-imidazole, CAS: 53857-59-3, stock 455.2g, assay 98.7%, MWt 239.90, Formula C4H4Br2N2, Purity >98%, SMILES CN1C(Br)=CN=C1Br, MDL NA |
| Drug_Names: 2,5-Diazaspiro[3.4]octan-6-one hydrochloride, CAS: 1630906-86-3, stock 297g, assay 98.3%, MWt 162.62, Formula C6H11ClN2O, Purity >98%, SMILES Cl.O=C1CCC2(CNC2)N1, MDL NA |
| Drug_Names: 2,5-Diazabicyclo[4.1.0]heptane, CAS: 87640-95-7, stock 308.3g, assay 98.2%, MWt 98.15, Formula C5H10N2, Purity >98%, SMILES C12NCCNC1C2, MDL NA |
| Drug_Names: 2,4-Dimethylpyridine-3-carboxylic acid, CAS: 55314-30-2, stock 644.3g, assay 98.4%, MWt 151.16, Formula C8H9NO2, Purity >98%, SMILES CC1=C(C(O)=O)C(C)=NC=C1, MDL MFCD03265250 |
| Drug_Names: 2,4-Diiodopyridin-3-ol, CAS: 750638-97-2, stock 175g, assay 98.6%, MWt 346.89, Formula C5H3I2NO, Purity >98%, SMILES OC1=C(I)C=CN=C1I, MDL NA |
| Drug_Names: 2,4-Difluoro-5-iodobenzoic acid, CAS: 161531-51-7, stock 112.8g, assay 98.3%, MWt 284.00, Formula C7H3F2IO2, Purity >98%, SMILES OC(=O)C1=CC(I)=C(F)C=C1F, MDL NA |
| Drug_Names: Diethyl 1H-pyrrole-2,4-dicarboxylate, CAS: 55942-40-0, stock 238.7g, assay 99%, MWt 211.21, Formula C10H13NO4, Purity >98%, SMILES CCOC(=O)C1=CC(=CN1)C(=O)OCC, MDL NA |
| Drug_Names: 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid, CAS: 1638760-72-1, stock 31.7g, assay 98.3%, MWt 232.02, Formula C7H3Cl2N3O2, Purity >98%, SMILES OC(=O)C1=CC2=C(Cl)N=C(Cl)N=C2N1, MDL NA |
| Drug_Names: 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid, CAS: 1638768-02-1, stock 754.9g, assay 99%, MWt 232.02, Formula C7H3Cl2N3O2, Purity >98%, SMILES OC(=O)C1=CNC2=NC(Cl)=NC(Cl)=C12, MDL NA |
| Drug_Names: 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, CAS: 1379367-43-7, stock 365.9g, assay 98.3%, MWt 213.02, Formula C7H2Cl2N4, Purity >98%, SMILES ClC1=NC(Cl)=C2C(NC=C2C#N)=N1, MDL NA |
| Drug_Names: 2,4-Dichloro-7-(propan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1227635-12-2, stock 165.6g, assay 98.6%, MWt 230.09, Formula C9H9Cl2N3, Purity >98%, SMILES CC(C)N1C=CC2=C(Cl)N=C(Cl)N=C12, MDL NA |
| Drug_Names: 2,4-Dichloro-6-methylthieno[3,2-d]pyrimidine, CAS: 35265-82-8, stock 681.3g, assay 98.4%, MWt 219.09, Formula C7H4Cl2N2S, Purity >98%, SMILES CC1=CC2=NC(Cl)=NC(Cl)=C2S1, MDL NA |
| Drug_Names: 2,4-Dichloro-6-methylthieno[2,3-d]pyrimidine, CAS: 76872-23-6, stock 136.8g, assay 98.9%, MWt 219.09, Formula C7H4Cl2N2S, Purity >98%, SMILES CC1=CC2=C(Cl)N=C(Cl)N=C2S1, MDL NA |
| Drug_Names: 2,4-Dichloro-6,7-dimethoxyquinoline, CAS: 72407-17-1, stock 343.3g, assay 98.1%, MWt 258.10, Formula C11H9Cl2NO2, Purity >98%, SMILES COC1=C(OC)C=C2C(Cl)=CC(Cl)=NC2=C1, MDL NA |
| Drug_Names: 2,4-Dichloro-6-(methylsulfanyl)pyrimidin-5-amine, CAS: 1630906-59-0, stock 692.9g, assay 98.2%, MWt 210.08, Formula C5H5Cl2N3S, Purity >98%, SMILES CSC1=NC(Cl)=NC(Cl)=C1N, MDL NA |
| Drug_Names: 2,4-Dichloro-6-(methylsulfanyl)-5-nitropyrimidine, CAS: 1451885-60-1, stock 255.2g, assay 98.7%, MWt 240.07, Formula C5H3Cl2N3O2S, Purity >98%, SMILES CSC1=NC(Cl)=NC(Cl)=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 2,4-Dichloro-5-methylthieno[2,3-d]pyrimidine, CAS: 56844-38-3, stock 356.9g, assay 98.3%, MWt 219.09, Formula C7H4Cl2N2S, Purity >98%, SMILES CC1=CSC2=NC(Cl)=NC(Cl)=C12, MDL NA |
| Drug_Names: 2,4-Dichloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1060815-86-2, stock 259.1g, assay 98.9%, MWt 202.04, Formula C7H5Cl2N3, Purity >98%, SMILES CC1=CNC2=NC(Cl)=NC(Cl)=C12, MDL NA |
| Drug_Names: 2,4-Dichloro-5H,7H-thieno[3,4-d]pyrimidine, CAS: 74901-71-6, stock 297.1g, assay 98.1%, MWt 207.08, Formula C6H4Cl2N2S, Purity >98%, SMILES ClC1=NC2=C(CSC2)C(Cl)=N1, MDL NA |
| Drug_Names: 2,4-Dichloro-5H,7H,8H-pyrano[4,3-d]pyrimidine, CAS: 944902-88-9, stock 768.8g, assay 98.9%, MWt 205.04, Formula C7H6Cl2N2O, Purity >98%, SMILES ClC1=NC2=C(COCC2)C(Cl)=N1, MDL NA |
| Drug_Names: 2,4-Dichloro-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one, CAS: 1520452-96-3, stock 800.7g, assay 98.5%, MWt 204.01, Formula C6H3Cl2N3O, Purity >98%, SMILES O=C1CC2=C(Cl)N=C(Cl)N=C2N1, MDL MFCD27987437 |
| Drug_Names: 2,4-Dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine hydrochloride, CAS: 1187830-76-7, stock 807.2g, assay 98.7%, MWt 240.52, Formula C7H8Cl3N3, Purity >98%, SMILES ClC1=C2C(CNCC2)=NC(Cl)=N1.[H]Cl, MDL MFCD11518996 |
| Drug_Names: 2,4-Dichloro-5-(4-methoxyphenyl)pyrimidine, CAS: 1523618-07-6, stock 105.5g, assay 98.6%, MWt 255.10, Formula C11H8Cl2N2O, Purity >98%, SMILES COC1=CC=C(C=C1)C1=CN=C(Cl)N=C1Cl, MDL NA |
| Drug_Names: 2,3-Dihydroxy-5-isopropylcyclohepta-2,4,6-trienone, CAS: 29346-20-1, stock 895.5g, assay 98.8%, MWt 180.20, Formula C10H12O3, Purity >98%, SMILES CC(C)C1=CC(=O)C(O)=C(O)C=C1, MDL NA |
| Drug_Names: 2,3-Dimethyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, CAS: 1310383-43-7, stock 776g, assay 98.2%, MWt 272.15, Formula C15H21BN2O2, Purity >98%, SMILES CN1N=C2C=CC=C(B3OC(C)(C)C(C)(C)O3)C2=C1C, MDL NA |
| Drug_Names: 2,3-Dimethyl-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine, CAS: 933725-60-1, stock 749.6g, assay 98.3%, MWt 151.21, Formula C8H13N3, Purity >98%, SMILES CN1C(C)=NC2=C1CNCC2, MDL NA |
| Drug_Names: 2,3-Dimethyl-2H-indazole-6-carbaldehyde, CAS: 1234615-85-0, stock 846.2g, assay 98.5%, MWt 174.20, Formula C10H10N2O, Purity >98%, SMILES CN1N=C2C=C(C=O)C=CC2=C1C, MDL NA |
| Drug_Names: 2,3-Dimethyl-2H-indazol-6-amine hydrochloride, CAS: 635702-60-2, stock 710.8g, assay 98.1%, MWt 197.66, Formula C9H12ClN3, Purity >98%, SMILES Cl.CN1N=C2C=C(N)C=CC2=C1C, MDL NA |
| Drug_Names: 2,3-Dimethyl-2H-indazol-5-amine, CAS: 221681-94-3, stock 197.3g, assay 98.3%, MWt 161.20, Formula C9H11N3, Purity >98%, SMILES CN1N=C2C=CC(N)=CC2=C1C, MDL NA |
| Drug_Names: 2,3-Dimethyl 6-chloropyridine-2,3-dicarboxylate, CAS: 32383-03-2, stock 205.3g, assay 98.4%, MWt 229.62, Formula C9H8ClNO4, Purity >98%, SMILES COC(=O)C1=C(N=C(Cl)C=C1)C(=O)OC, MDL NA |
| Drug_Names: 5-((4-Methylpiperazin-1-yl)methyl)-2,3-dihydro-1H-isoindole, CAS: 912999-93-0, stock 313.2g, assay 98.4%, MWt 231.34, Formula C14H21N3, Purity >98%, SMILES CN1CCN(CC2=CC=C3CNCC3=C2)CC1, MDL NA |
| Drug_Names: 2,3-Dichloro-5-(methylthio)pyrazine, CAS: 1174517-48-6, stock 479.6g, assay 98.6%, MWt 195.07, Formula C5H4Cl2N2S, Purity >98%, SMILES CSC1=NC(Cl)=C(Cl)N=C1, MDL NA |
| Drug_Names: 2,3-Dibromo-6-methoxy-1H-pyrrolo[2,3-b]pyridine, CAS: 2055841-29-5, stock 854.5g, assay 98.7%, MWt 305.95, Formula C8H6Br2N2O, Purity >98%, SMILES COC1=NC2=C(C=C1)C(Br)=C(Br)N2, MDL NA |
| Drug_Names: 2,3,4,7-Tetrahydro-1H-isoindol-1-one, CAS: 2007916-73-4, stock 352.3g, assay 98.1%, MWt 135.16, Formula C8H9NO, Purity >98%, SMILES O=C1NCC2=C1CC=CC2, MDL NA |
| Drug_Names: 2,3,4,5-Tetrahydro-1H-benzo[d]azepine hydrochloride, CAS: 17379-01-0, stock 305.6g, assay 98.4%, MWt 183.68, Formula C10H14ClN, Purity >98%, SMILES Cl.C1CC2=CC=CC=C2CCN1, MDL NA |
| Drug_Names: 1,2,3-Oxathiazolidine 2,2-dioxide, CAS: 19044-42-9, stock 871.2g, assay 98.5%, MWt 123.13, Formula C2H5NO3S, Purity >98%, SMILES O=S1(=O)NCCO1, MDL NA |
| Drug_Names: 2,2-Dimethylmorpholine hydrochloride, CAS: 167946-94-3, stock 498.2g, assay 98.9%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CC1(C)CNCCO1, MDL NA |
